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ABSTRACT 
Early life experiences, including mode of delivery and nutrition during the neonatal period, have 
been proven to have an impact on health in later life. Studying human metabolic development has 
major implications for understanding the aetiology and risk of disease, including metabolic 
syndrome. 
Initially, a sample preparation protocol was developed and optimised using metabonomic 
procedures for studying urine and faeces from infants, to accommodate for limited sample volume 
and to take into account the compositional differences between adult and infant biofluids. This 
primarily indicated that age is an important variable that contributes to the metabolic profile of 
biofluids.  
Faecal metabonomics is fast becoming a useful tool for defining interactions among host, microbial 
communities and nutritional interventions. Infant development trajectory was assessed through 
analysis of faecal metabolic profiling by 1H NMR. A large non-clinical cohort longitudinal study was 
obtained; 1802 faecal samples from 524 infants at 6 time points from 4 days to 730 days 
postpartum. Furthermore, 1H NMR, UPLC-MS and metagenomic phenotyping techniques was 
performed on urine (n=278) and faecal (n=308) samples from 150 infants born term or preterm (<37 
wks gestational age). This multi-omics approach provided further demonstration of contribution of 
microbial co-metabolites to infant metabolism early in life and therefore the potential impact on 
overall health.  
This PhD project was able to identify certain metabolic pathways which were shown to be different 
in relation to gestation age as well as postnatal age, mode of delivery, BMI status and nutrition. In 
particular, choline and methylamine derivatives (e.g. betaine, trimethylamine), short chain fatty 
acids (SCFA) and amino acids related to nutrition and the gut microbiome functionality as well as 
metabolites indicating infant renal development from birth (e.g. myo-inositol, 1-N-
methylnicotinamide).  
Overall, these investigations have shown that an understanding of the sources of variation in biofluid 
metabolite profiles are essential for interpretation of data acquired during normal infant 
development.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
1.1. INTRODUCTION 
Early life environmental exposures have been proven to impact health in later life, including mode of 
delivery, nutrition and the use of antibiotics during the neonatal period. These experiences have also 
been associated with disease risk; including increased possibility of developing specific allergies, 
asthma and even potentially metabolic syndrome in later life (Arrieta et al., 2015; Despres et al., 
2006). The study of infant development has major implications for understanding the aetiology and 
risk of diseases, including metabolic syndrome and cardiovascular disease, in later life.  
Metabolic profiling can be used to provide a baseline for knowledge and understanding of infant 
development and characterise the physiological or pathological processes through childhood and 
later life. There have been many more adult studies using metabolic profiling to further understand 
the biochemical composition of biofluids compared to neonatal and infant studies; this is especially 
true in regards to the normal metabolic trajectory of the healthy infant.  
Human faecal metabolome studies is an area of research still very much in its infancy, in not only 
baby studies but adults too. Metabolic profiling of faeces can provide information on human health 
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but also the influence of diet and the gut microbiome (Saric et al., 2007; Jacobs et al., 2008). Both 
nutrition and the gut microbiome, which are intrinsically linked, in early life play a vital role in infant 
development (Chow et al., 2014). Further knowledge of the functionality of the gut microbiome on 
human development health would have a huge impact on further understanding this beneficial 
relationship.  
The overall aim of this PhD thesis is to investigate the urinary and faecal metabolic profiles from full 
term and preterm infants, as well as characterise the developing infant faecal metabolome for the 
first time. This will generate new biochemical information on infant development in relation to 
gestational age as well as early life experiences including mode of delivery and nutrition.   
1.2. PRETERM INFANTS  
Gestational age at birth has been proven to have a large impact on the metabolic profile, as well as 
the composition of gut microbiome. At 40 weeks of gestation the infant is regarded as full term and 
ready to be born, but many infants born after 37-weeks of gestation are regarded as term as well. 
During the neonatal period, infants are rapidly adjusting to life outside of the womb; maturing and 
developing physically, immunologically, and neurologically (Carlo, 2016, Malina et al., 2004).  
Preterm infants (<37 weeks of gestation) can be classified as early (before 32 weeks of gestation) 
and late (32-36 weeks of gestation) preterm. These can be further categorised into four different 
groups; extreme (GA ≤27 weeks), severe (GA 28-31 weeks), moderate (32-33 weeks) and near-term 
(34-36 weeks) (Moutquin et al., 2003; Wen et al., 2004; Tucker et al., 1991); these categories are 
important as lower gestational age is associated with increased adverse conditions; including 
mortality (Frey et al., 2016; Blencowe et al., 2012). In the UK, just over 1% of births are to infants 
born before 31 weeks of gestation, whereas this statistic rises considerably to 11% in developing 
countries (Goldenberg et al., 2008).  Most of these births (about 8%) occur in the near term stage of 
preterm birth (34-36 weeks of gestation) period (Martin et al., 2013; Frey et al., 2016).  
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Birth weight of the infant can also give a better indication of how well the baby is developed as 
gestational age is difficult to calculate accurately. The birthweight of the infant generally indicates 
how well-nourished the infant is during foetal development and can be an important predictor of 
health in later life. This is especially true for brain development and subsequent IQ in later life 
(Grantham-McGregor et al., 1998; Walhould et al., 2012). The World Health Organisation (Edmond 
and Bahl, 2006) have defined low birth weight infants to be born as less than 2,500 grams. From 
their data, 15.5% of births worldwide are of infants of a low birth weight (WHO, 2006) and, as 
recorded in 2014, approximately 7% of births in the UK are to infants of low birth weight (Norman et 
al., 2005; ONS, 2015). Low birth weight (LBW) can arise from both preterm birth or fetal growth 
restriction, meaning that LBW doesn’t necessarily mean that infants are preterm (Thomas et al., 
2012). Knowledge of both the gestational age and birth weight is valuable in learning about the 
potential outcomes of infants (Simmons et al., 2010).  
 
 
Figure 1-1: Schematic to represent the categorisation of term and preterm birth in relation to 
gestational weeks (wks) and pregnancy.  
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Prematurity is the leading cause of death in babies during the neonatal period in developed 
countries and there is much still unknown about premature birth. (Howson et al., 2013; Blencowe et 
al., 2012). While advances in neonatal medicine have seen an increase in the survival of babies born 
preterm since the 1990s; this has resulted in a significant burden to health and education services, 
with increased risk for several childhood and later life diseases (Behrman et al., 2007; Blencowe et 
al., 2012). The aetiology of the most prevalent disorders as a result of preterm birth remains 
unclear. Preterm birth outcomes are more favourable with increasing gestational age, and birth 
weight is also a contributing factor (Tucker et al., 2004). The main issue with preterm birth is that 
there is currently no method to predict the adverse outcomes of the event. 
1.2.1. CONTRIBUTIONS AND TYPES OF PRETERM BIRTH  
There are a number of different factors which can increase the associated risk of having a preterm 
birth. This includes maternal age, maternal lifestyle (including smoking and BMI), in-vitro 
fertilization, low-socioeconomic status, genetic influences as well as prior pregnancy history; this list 
is not exhaustive (Simmons et al., 2010; Frey et al., 2016; Moutquin, 2003; Goldenberg et al., 2008).  
There are three main conditions which lead to preterm birth: spontaneous or idiopathic preterm 
birth, preterm premature rupture of membranes (PPROM) and medically indicated due to maternal 
or fetal difficulties (Moutquin, 2003). Averagely, medically indicated preterm births accounted for 
25-35% of preterm birth, 45-50% were caused due to spontaneous births and 25-30% were caused 
by PPROM (Tucker et al., 1991; Goldenberg et al., 2008; Simmons et al., 2010). It is believed that 
over 40% of preterm births are caused by inter-uterine infections and that most early preterm births 
(less than 32 weeks of gestation) are also caused by this (Goldenberg et al., 2000; Carroll et al 1996; 
Goldenberg et al., 2008).  
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1.2.2. NUTRITION IN PRETERM NEONATES 
Full-term infants are normally fed breast or formula milk orally, referred to as enteral nutrition. 
However, this is often not the case for infants born preterm, as they have different abilities 
depending on the gestational age at which they are born. This includes the ability to feed properly 
and what nutrients they need to develop outside the womb. Influence of the diet on the metabolism 
of the infant using metabolic profiling has not been investigated in depth yet. However, 
investigations using metabolic profiling has the potential to further understand the needs of the 
infants nutritionally.  
They may need intravenous supplementation, called parenteral nutrition (PN) as well as enteral 
feeding. Furthermore, total parenteral nutrition (TPN) means that nutrition is not taken orally at all 
and only intravenously.  
Neonatal nutrition for preterm infants aims to make sure that infants gain body weight (and ideally 
the same body development of a foetus of the same gestational age) and therefore, obtain the same 
functional outcomes that would be expected from an infant born full term (Brennan et al., 2016). 
Preterm infants are also more predisposed to postnatal weight loss and for being deficient in 
nutrients (Lapillonne et al., 2013).  
1.2.2.1.  Enteral nutrition 
The different types of enteral nutrition include mother or donor human breast milk and formula 
feed for preterm infants at different stages of development (Brennan et al., 2016).  
Human breast milk contains oligosaccharides which are complex carbohydrates. These are 
undigested by humans but utilised by the developing gut microbiome; this will be explained further 
later in this chapter. For many mothers, the composition of their breast milk is unique and recently it 
has been discovered that there is a higher concentration of oligosaccharides found in the mother’s 
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milk from a preterm birth compared to full term (Bertino et al., 2013).  Preterm infants which were 
fed mother’s breast milk were half as likely to go on to develop nectrotising enterocolitis (NEC) or 
late on-set sepsis compared to being fed by donor breast milk or formula feed (Schanler et al., 2005; 
Cristofalo et al., 2013).  
Human breast milk from the mother is recommended for any infant however this is not always 
available, especially from mothers with preterm infants (Jones et al., 2007; Radmacher et al., 2016).  
Donor human breast milk can be made available for preterm infants when their mother’s milk is not 
obtainable (Bertino et al., 2013; Arslanoglu et al., 2013). This milk is usually pasteurised, removing 
any beneficial bacteria but also inactivating potentially pathogenic bacterial or viral agents 
(Arslanoglu et al., 2012). If no human milk is available, preterm formulas have been developed to 
ensure the nutritional needs of preterm infants are met to support growth. This formula needs to 
contain the correct composition and balance of lipids, carbohydrates and amino acids that are 
necessary to sustain this healthy growth in preterm infants (Hay et al., 2016).  
Enteral feeding is important to start as soon as possible for any infant as it will decrease the risk of 
developing necrotising enterocolitis (NEC) as well as hypoglycaemia. However, due to the associated 
co-morbidities of prematurity, mainly abdominal abnormalities, enteral feeding may be delayed for 
preterm infants from birth compared to their full term counterparts (Patel et al., 2016).  
1.2.2.2. Parenteral Nutrition 
Even though breast milk is the recommended feed of choice, human milk is seen as insufficient and 
too variable in composition to provide preterm infants with all the nutrients they need, especially 
proteins and minerals (Wojcik et al., 2009; Radmacher et al., 2016). Due to their developmental 
immaturity the majority of preterm infants receive parenteral nutrition (PN) as well.  This vital time 
in development means that not only is the infant needing additional nutrients for day to day growth 
but also to facilitate catch up growth due to prematurity.  
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This type of nutrition is administered intravenously, and is mainly for infants born before 34 weeks 
of gestation, as this is when motor skills needed for sucking, and therefore feeding, are developed. 
The time which the infant is spent on parenteral nutrition depends on gestational age, body weight 
and morbidities associated with prematurity. Preterm infants have low body stores which includes 
fat stored vitamins which they would have received through the placenta towards the end of 
gestation. Therefore, it has been recommended that these infants should be provided with water 
and fat soluble vitamins in PN feeds (Ho et al., 2015).  
1.2.2.3. Total Parenteral Nutrition 
Severe preterm infants and very ill babies have total parenteral nutrition (TPN) initiated and 
administered as soon as possible (Patel et al., 2016).  As this type of nutrition is administered 
intravenously, these infants have no oral feeding experience and this could have a detrimental affect 
their body development including the lack of gastrin production (Ho et al., 2015). Furthermore, 
prolonged use of TPN has been found to increase body fat over time in different species (including 
piglets) (Meyers et al., 2013).  This can lead to the higher risk of obesity, hypertension and insulin 
resistance later in life. These disorders have been recognised in adult metabonomic studies to have a 
perturbed metabolic profile compared to healthy subjects. By investigating the metabolic profile in 
early life, biochemical information may be available to predict future outcomes from this.   
1.2.3. DEVELOPMENTAL DISORDERS ASSOCIATED WITH PREMATURITY 
1.2.3.1. Early in life 
During the neonatal period there is a significant risk of neonatal mortality and morbidity in preterm 
infants, with infants born before 32 weeks of gestation being at the highest risk (Thomas et al., 
2012). Preterm infants are usually treated in a neonatal unit until the infant meets a set of criteria 
before discharged from hospital. These criteria determine the functional physiological maturity of 
the infant rather than relying on weight gain as a measure. These functions include: 
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thermoregulation, control of breathing, cardiac and respiratory stability as well as capable feeding 
skills (Jefferies et al., 2014).  
Preterm infants are generally born immature as organ systems develop at different times of the 
gestational period. For example, a foetus’ lungs in the womb are filled with liquid to help them grow 
and develop. At 36 weeks of gestation, the lungs are fully developed and during birth this liquid is 
absorbed so that the baby can start to breathe air once outside of the womb (Kotecha, 2000). 
Preterm infants born before this time have a higher risk of developing breathing problems as their 
lungs are not yet fully matured and may therefore need to be on a ventilator. Infants born before 34 
weeks gestation are regularly administered surfactants, a complex mixture of phospholipids and 
proteins which coat the alveoli to improve the tension around it to keep it open; therefore this helps 
with oxygen intake (Nkadi et al., 2009).  
As an extreme preterm infant, there is a much higher risk of having hypothermia, hypoglycaemia, a 
higher risk of low blood pressure as well as being susceptible to infections. The risk of these 
conditions reduce as the gestational age of the infant increases. Near to term infants, who are not 
likely to have similar breathing problems as their lungs are much more developed, however, still 
have some risk of blood sugar levels and blood pressure being too low, as well as potential feeding 
difficulties.   
Microbial dysbiosis has been linked to several functional gut disorders, including inflammatory 
bowel disease, stomach cancer, obesity and necrotising enterocolitis (NEC) (Turroni et al., 2012).  
Preterm infants are at a greater risk of developing NEC which can be fatal if not recognised early. 
NEC is a gastrointestinal disorder that affects primarily preterm babies and is marked by overgrowth 
of bacteria in the intestinal wall, which can lead to necrosis of the affected region of the intestine 
(Wang Y et al., 2009). When NEC is first suspected, the infant is usually subject to TPN or fasting all 
together. The second recommended treatment for NEC is to initiate a short course of antibiotics, 
with some extreme cases requiring surgery to remove a diseased portion of the intestine (Wang et 
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al., 2009). All of these interventions results in the disruption of the microbiome and could cause 
further dysbiosis. Therefore, many studies are analysing the role of the gut microbiome in the 
development of NEC to help understand the cause and prevent it from occurring.  
1.2.3.2. Later in life 
Preterm and LBW babies who survive the neonatal period face the possibility of a lifetime of 
different disorders and disabilities (Howson et al., 2013). Due to their metabolic, anatomical and 
functional immaturity, these infants are associated with a higher risk of wide-ranging and long-term 
medical consequences. These include cardiovascular and metabolic disorders, abdominal obesity 
later in life and neurodevelopmental disorders (Moster, et al., 2008).   
Preterm birth may predispose children to the development of the symptom complex referred to as 
the metabolic syndrome. Metabolic syndrome starts with early insulin resistance, with the 
consequent development of type II diabetes, abdominal obesity, and hypertension (Abitbol et al., 
2012). Ex-preterm adults have higher plasma insulin, triglyceride, and cholesterol, compared to 
lower high-density lipoprotein cholesterol later in life (Irving et al., 2000). Cardiovascular disorders 
are also very common and varied among preterm infants, including an association with a higher 
blood pressure when measured as young adults (de Jong et al., 2012).  
Preterm infants have low levels of body fat at birth as the third trimester is when the foetus will gain 
the main fat reserves (Thomas et al., 2012). Therefore, catch up growth using high fat nutrition is 
common but this also contributes to an increased adiposity (Brennan et al., 2016). Uthaya et al., 
(2005) found that preterm infants had increased abdominal adipose tissue and less subcutaneous 
adipose tissue compared to term infants, once they had reached term equivalent age. At adulthood, 
this increase in adiposity in preterm born individuals can still be seen (Thomas et al., 2011).  
LBW and preterm babies are also associated with the development of insulin resistance and diabetes 
later in life. According to many studies in the past, not many very preterm infants would have 
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survived the neonatal period so could not be included in studies when researching preterm infants 
as adults (Thomas et al., 2012).   
By 33 weeks of gestation, the nervous system of the foetus and the brain are fully developed. Many 
preterm infants develop cognitive and motor disabilities, including Cerebral Palsy and Autism 
Spectrum Disorders (ASD).  It has previously been reported that up to 21-25% of preterm infants go 
on to develop ASD (Johnson, et al., 2010). This is a much higher prevalence compared to the general 
population; 0.2-0.7%. However, other studies have suggested a 2 or 3-fold increase risk of ASD in 
preterm infants, hence the true risk is still unknown (Stephens et al., 2012).  
1.3. THE MUTUALISTIC RELATIONSHIP OF THE GUT MICROBIOME 
The human gut consists of the stomach, small intestine and large intestine. These organs are 
responsible for the breakdown of food including carbohydrates, proteins and fats, which provide us 
with energy. The intestinal microbiota can also be described as another ‘organ’ (Eckburg et al., 2005) 
as the composition of bacteria can provide our bodies with essential nutrients through homeostatic 
symbiosis (Leser and Molbak, 2009). We provide the bacteria with a stable environment, whereas 
the bacterium can provide us with nutrients such as, vitamin B12, which we cannot get from food. 
In the human gut, there is thought to be over 1014 microorganisms, equivalent to about 10 times 
more bacterial cells than human cells in our bodies and most of which live within the colon. The 
diversity of these microbes is within a large range and intensely under investigation. This complex 
community of bacteria and some archaea, fungi and protozoa can help to keep our guts healthy by 
protecting us from the overgrowth of pathogenic bacteria (Gill et al., 2006).  
Each part of the GI tract differs greatly in function and environment, especially referring to pH levels, 
and this affects the species which live there. However, it is known that over 99% of these bacteria 
are from the bacterial divisions; Bacteroides and Firmicutes (Gill et al., 2006). It is known that 
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Bifidobacterium and Lactobacillus species are the most common genera in the human colon and are 
important in promoting the host’s health (Kim et al., 2004).  
Many of these bacteria have not been characterised and are uncultivable, which makes them very 
difficult to study and, therefore, many metagenomic studies have been used to explore this complex 
microbial community (Kuroawa et al., 2007). The gut microbiota was first investigated through 
anaerobic culture techniques. Although, they did provide pioneering research about this microbial 
community, these techniques were very time consuming and they could only identify easily 
cultivable microorganisms. It was difficult to produce the right environment which resembled the 
gut for a more reliable indication of this environment microbiota composition. By using 
metagenomic analysis to isolate and clone DNA, the insight into the gut microbiota has improved 
our understanding of this uncultured world (Handelsman, 2004).  
The human gut does have defences against the colonisation of microbes, which protect against 
pathogens and overgrowth. The most effective defence is the low pH content of the stomach that is 
harmful to most bacteria, which enter through the consumption of food. However, the bacterium 
Helicobacter pylori are able to survive in the stomach by producing the enzyme urease, which breaks 
down the acid around it and will colonise in the stomach’s mucus (Leser and Molbak, 2009). This 
bacterium is commonly known to cause peptic ulcers, which can lead to cancer. The small intestine 
contains a much larger amount of bacteria than the stomach, which eventually leads to the large 
intestine, where there is the highest concentration of bacteria. In the small intestine there are 
antimicrobial systems that keep control of the growth of the bacteria. This includes the fact that, as 
material travels through the gut, it dislodges some of the bacteria attached to the epithelial cells. It 
also includes the secretion of antimicrobial peptides, proteolytic enzymes and bile (Ridlon et al., 
2006). If these methods stop working then the bacteria will overgrow and we would have to 
compete for our nutrients much more, resulting in non-symbiotic relationship and possible infection 
(Inagaki et al., 2006). 
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The gut virobiota is another area of research which has expanded recently; however, there are also 
many challenges that face these types of studies and is many aspects are still largely unclear 
(Duerkop & Hooper, 2013). It is believed that many of the virus which reside in our guts are 
bacteriophages (viruses that infect and replicate inside bacterial cells), which can in effect influence 
the composition of the bacterial community also. However, both eukaryotic and plant viruses (from 
the diet) have been found to be present as well (Handley et al., 2012). Investigations into the infant 
gut virobiota found that, similar to the bacterial community, there is a low diversity at birth and 
early life. It was also found that the most abundant viral species did not originally come from breast 
milk, suggesting another source may seed the viral community in early life (Breitbart et al., 2008).   
1.3.1. FUNCTIONS AND METABOLIC ACTIVITIES OF THE GUT MICROBIOME 
The function of the gut microbiome can be very complex due to the diversity of enzymes that the 
microbes utilise. These enzymes are usually different to the ones that we produce and contribute to 
many different metabolic pathways.  
Studies on germ free (GF) mice also emphasises the importance of the gut microbiota on 
development; physically, biochemically and immunologically. Mice without a gut microbiome have a 
larger caecum, decreased intestinal surface area and many of their organs are reduced in size; 
including the liver, heart and adrenal glands (Berg et al., 1996). Furthermore, the effectiveness of 
the immune system as well as the inflammatory responses are also greatly reduced in the GF animal 
(Berg et al., 1996). Therefore, the presence and mutualistic relationship of commensal bacteria is 
thought to be essential in maintaining the physiology of the digestive tract as well as other organs in 
the body.  
For bacteria in the colon, most of the available dietary components are the insoluble particles which 
the human body cannot break down. These undigested carbohydrates (e.g. starches, cellulose, and 
some oligosaccharides) are mainly fermented into short chain fatty acids (SCFAs) and gases (e.g. 
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hydrogen, carbon dioxide and methane). SCFAs are very useful as they are a local energy source for 
the colonic epithelial cells (especially butyrate) as well as some becoming readily available for the 
rest of the body (especially acetate) (Flint et al., 2012). Fermentation from bacterial species of high 
protein diets increases the concentration of branched chain amino acids (BCAA) into branched chain 
fatty acids (Russell et al., 2011). These metabolites have been associated with hormone receptor 
control and therefore involved in appetite control. This shows a potential link between microbial 
activity and a contribution to the need to eat (Sleeth et al., 2010). Colonic microorganisms are also 
known to be involved in the synthesis of vitamins (B & K) from the production of SCFAs and the 
absorption of iron and magnesium (Guarner and Malagelada, 2003).  
Choline is an essential nutrient found in many different foods including eggs, soy beans and milk. It is 
mainly used to make phosphocholine for the construction and stability of cell membranes in the 
body. The gut microbiome utilises this metabolite and catabolises it into trimethylamine (TMA); TMA 
is then absorbed by the body and further metabolised into trimethylamine-n-oxide (TMAO) in the 
liver. An increase in urinary levels of TMAO has been reported after the consumption of fish within 
24 hours (O’Gorman et al., 2013). Lloyd et al. (2011) investigated the urine from healthy participants 
after they had consumed specific foods; one of these foods was salmon. Urine was taken at different 
time points after the consumption of the foods, analysed using mass spectrometry and metabolites 
were identified from the result of eating the specific foods. It was clear, from this investigation, that 
TMAO, anserine and 1-methylhistidine was highly associated with the consumption of fish (Lloyd et 
al 2011). Equally, high concentrations of TMAO in human plasma has also been implication in the 
potential risk for liver and cardiovascular disease (Nicholson et al., 2012). 
Bile acids are cholesterol steroids that are conjugated with glycine or taurine and are effective lipid 
detergents. Some gut microbes can deconjugate and metabolise bile acids to make them harmless 
and even use them as a source of carbon, nitrogen and energy sources (Begley et al., 2005). In 
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addition, the microbiota actively regulates fat storage by promoting lipid absorption through the 
chemical modulation of bile acids. 
Another link to health which is currently under intense investigation, is that SCFAs, including 
butyrate and propionate, have anti-inflammatory properties and therefore anti-cancer properties 
(Flint et al., 2012). This relationship between the microbiota and cancer development is still unclear. 
Furthermore, SCFAs can interact with G protein-coupled receptors (GPCRs) to affect insulin 
sensitivity in adipocytes and peripheral organs, thus regulating energy metabolism (Backhed et al., 
2004).  
The composition of the gut microbiota is dramatically influenced by the host’s diet and how the gut 
microbiome is altered by obesity. Jumpertz et al. (2011) investigated the change in the composition 
of the gut microbiome in lean and obese individuals when they had their diets changed and nutrient 
load is changed. They concluded that the amount of nutrient that individuals consume greatly 
influences the composition of the gut microbiome and an increase in the community of Firmicutes 
was associated with an increase in calorie intake in lean individuals (Jumpertz et al., 2011). Other 
studies have also revealed that patients suffering from obesity have a higher number of Firmicutes 
residing in their gut (Le Chatelier et al., 2013; Ley et al., 2006). These bacteria are more adapted to 
breaking down carbohydrates, which our body cannot breakdown normally and from which we 
cannot gain nutrients. However, when obese individuals are put on a diet containing less fat over a 
course of a year, it was found that the Firmicutes numbers slowly decreased and Bacteroides 
increased in abundance (Frank and Race, 2008). Further studies have also revealed that a high fat 
diet can also alter the composition of the gut microbiome; with a lower abundance of bacteria 
including Bacteroides and Bifidiobacterium (Nava et al., 2012). These studies show the influence of 
the microbiome on potential energy harvest from our diets (depending on what is available).  
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1.3.2. DEVELOPMENT FROM BIRTH  
The gut is quickly colonised from birth by microorganisms; at first, the newborn gastrointestinal tract 
is an aerobic environment where only facultative anaerobes are able to live (Arrieta et al., 2015). 
Over time, larger numbers of anaerobic species establish in the infant gut and drive out the 
facultative bacteria through competition for nutrients. Early infant microbiome has a dominance of 
Bifidiobacterium, Clostridium and Bacteroides; this community develops through the first few 
months of life (Matamoros et al., 2012, Collado et al., 2012, Nicholson et al., 2012). It is believed 
that gestational age, the mode of delivery, nutrition (maternal or formula milk), clinical interventions 
(e.g antibiotics), environmental exposures as well as maternal microbiota can affect the composition 
of the early gut microbiome.  
However, it has recently been postulated that the foetus is not exclusively sterile as previously 
thought; bacteria has been isolated in the umbilical cord blood and the meconium of healthy full 
term babies (Jimenez et al., 2007). Furthermore, bacteria have also been isolated in the amniotic 
fluid and placentas of full term infants, where it would have usually been associated with preterm 
birth (Staokari et al., 2008; Aagaard et al., 2014). This suggests that gut colonisation starts before 
birth and could affect the in utero development in a number of different ways; whether this is 
beneficially or detrimentally, is still unknown.  
Eventually, the microbiota is established and stabilised by the end of the third year of an infant’s life. 
This composition is unique to the individual and will not change dramatically throughout life, 
although it is continuously fluctuating (Palmer et al., 2007). There is a reported familial similarity, 
and it is thought that genetic makeup, as well as environmental factors are contributors to the 
determination of the composition (Leser and Molbak, 2009).   It has also been reported that with an 
increase in age, the diversity of bacterial species in the gut decreases, meaning the composition is 
very variable throughout life (Ottman et al., 2012). 
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1.3.3. MODE OF DELIVERY 
The mode of delivery, vaginally delivered versus caesarean section, has a strong influence on the 
early gut microbiome colonisation in infants. It has been well documented that infants who have 
been delivered through the birth canal, have a bacterial community which is similar to that of a 
typical vaginal community and the mother’s gut microbiome; this includes Lactobacilli, Prevotella 
and Sneathia (Dominguez-Bello et al., 2010).  Furthermore, vaginally delivered infants are primarily 
colonised by different Bifidiobacterium species within the first couple of days, the most prevalent 
species being B.catenulatum group and B.longum (Biasucci et al., 2008; Biasucci et al., 2010).  
Caesarean section (CS) infants are influenced by the exposure to the mother’s skin and the clinical 
environment they first experience. Therefore, these infants are associated to different bacterial 
species compared to vaginally delivered; including Staphylococcus, Corynebacterium and 
Propionibacterium (Dominguez-Bello et al., 2010).  
Some studies have found that infants born by caesarean section have a lower diversity of bacterium 
and so their acquisition of Bacteriodes, Bifidobacteria and Escherichia coli is delayed compared to 
infants born by vaginal delivery (Azad et al., 2013; Dominguez-Bello et al., 2010). However, there is 
still much to learn, as there are many contradictory results currently in the literature, especially in 
terms of diversity and presence of pathogenic bacterium (Rotimi et al.,. 1985, Hallstrom et al., 2004; 
Rutayisire et al., 2016).  
Furthermore, these infants are more likely to be colonised by Clostridium difficile compared to 
vaginally delivered infants (Penders et al., 2006). This bacterium is a toxin producing bacteria, which 
mostly causes diarrhoea and food poisoning (Schutze et al., 2013). A study of the gut microbiome 
composition related to mode of delivery in children at age 7 showed that Clostridium species were 
higher in children born by CS (Salimen et al., 2004).  However, other studies found no significant 
associated between mode of delivery and the prevalence of Clostridium difficile (Azad et al., 2013).  
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1.3.4. GESTATIONAL AGE 
Preterm infants generally have a lower diversity of gut microbiota during the first few weeks of life 
compared to full term babies (Cong et al., 2016). Initially, preterm infants have difficulty digesting 
nutrients as some specialised cells are not fully functional, and this may affect the composition of 
the microbiota.  Since preterm infants are generally underdeveloped, they may contribute to gut 
dysbiosis as a result of immature peristaltic ability, which is used to control the microbiota 
community (La Rosa et al., 2014). Furthermore, preterm infants are subject to more antibiotic 
treatments and different early nutrition than full term infants, and so it is difficult to form 
conclusions from these studies.   
Recently, Cong et al., (2016) discovered that preterm infants had a high proportion of Proteobacteria 
and there was a significant difference between male and female infant gut community. There are 
not many studies comparing preterm and term infants gut microbiome composition, due to the 
Figure 1- 2. Schematic to illustrate the influence of external factors on the developing gut microbiome 
from birth to infancy. Adapted from Matamoros et al., 2013. (Collado et al., 2012, Voreades et al., 
2014, Rodriguez et al., 2013) 
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different experiences that these two groups of infants go through in early life. On a species level 
however, it has been found that preterm infants have a higher diversity of facultative anaerobes and 
less strict anaerobes compared to full term infants (Arboleya et al., 2012; Stark et al., 1982). Stark et 
al., (1982) found that preterm infants had a delayed colonisation of Bifidobacterium species 
compared to term infants.  
1.3.5. NUTRITIONAL IMPACT ON THE INFANT GUT MICROBIOME COMPOSITION 
It is universally accepted that feeding by breast milk for the first 6 months is very beneficial and even 
to 1 year with the introduction of solid foods is ideal practice (Bertino et al., 2013). In the first few 
days after birth, a specific type of milk is produced called colostrum. This milk is low in fat and high 
in carbohydrates, proteins and antibodies; it also acts as a laxative to remove the meconium from 
the intestines.  
Babies who are exclusively fed breast milk have a more stable, lower diversity bacterial composition 
compared with formula feed infants; breast fed infants have a much higher abundance of 
Bifidobacterium and Lactobacillus species (Penders et al., 2006; Matamoros et al., 2013; Harmsen et 
al., 2000; Roger et al., 2010). These infants also have other microbes present, including 
Staphylococcus and Propionibacterium which are transferred from the skin and nipple of the mother 
(Collado et al., 2012). Formula fed infants have a higher diversity of bacteria in their gut, mainly 
Bacteroides, Clostridium and Enterobacteriaeae species (Penders et al., 2006; Fallani et al., 2010; 
Gomez-Llorente et al., 2013).  
Breast feeding is believed to be more functionally beneficial and better protected against infection 
of the GI, respiratory and urinary tracts as well as other diseases compared with those who are 
formula fed. Salminen and co-workers have attributed this effect, at least partly, to differences in 
microbial composition (Salminen et al., 2005). Furthermore, this beneficial protection can be 
attributed to many different aspects of breast milk as well including antimicrobial enzymes (e.g. 
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lysozyme) found in breast milk which helps to inhibit the growth of certain bacteria (Kau et al., 
2011). Human milk oligosaccharides (HMO) are unique complex carbohydrates and cannot be 
digested by human intestinal enzymes. Therefore, they reach the large intestine and colon intact, 
where they can promote the proliferation of certain types of bacterial species (Arrieta et al., 2015). 
Breast milk also contains IgA antibodies which are similar to bacterial antigens to prime the immune 
system against common pathogens (Kelly et al., 2000).  
Feeding with parenteral feed is sometimes quite necessary for preterm or very sick infants, however 
this can cause a lower diversity in the gut microbiome as well as a delayed colonisation (Blakey et al., 
1982; Jacquot et al., 2011). These infants are also more associated to the bacterial species 
Pseudomonas and E. coli. 
When the infant starts weaning, usually around six months, the gut microbiome changes again and 
starts to resemble an adult gut microbiome (Harmsen et al., 2000). In general, the Bifidobacterium 
community gradually decreases and a more complex composition establishes itself, with the main 
species being Bacteroides, Clostridium and Eubacterium (Roger et al., 2010). It is difficult to know 
exactly how the gut microbiome will change at this stage as it is very dependent on the more 
complex diet becoming available, supporting a more diverse bacterial community.  
1.3.6. MEDICAL AND ANTIBIOTICS INFLUENCE 
In neonatal intensive care units, antibiotic treatment is a common occurrence to reduce bacterial 
infections that could be fatal; this is especially true for infants born extremely premature. Antibiotic 
over use in this setting is a cause for concern as antibiotic induced microbial dysbiosis could affect 
early life development (Jernburg et al., 2010; Arrieta et al., 2015).  
 Overall, total count and diversity of the gut microbiome is decreased with antibiotic use (Koenig et 
al., 2011; Blakey et al., 1982; Butel et al., 2007; Tanaka et al., 2009). Broad spectrum antibiotics can 
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significantly disrupt the composition of the microbiome, potentially causing the susceptibility of 
pathogenic bacteria to colonise the gut (Collado et al., 2012; Arrieta et al., 2015).  
Infants have a decreased colonisation of Lactobaccillus and Bifidobacterium; common beneficial 
bacterial species found in infants (Blakey et al., 1982; Penders et al., 2006; Butel et al., 2007). These 
infants are commonly colonised by Enterobacteraceae, Klebsiella and Clostridium which dominate 
the community; this is due to these microorganisms being highly resistant to broad-spectrum 
antibiotics (Alderberth et al., 2006; Penders et al., 2006; Tanaka et al., 2009; Collado et al., 2012).  
Even though antibiotics have been proven to affect gut microbiome composition which could further 
affect health in later life, many studies are researching different types of antibiotics which can affect 
different bacterial species. Furthermore, these infants are extremely unwell, and therefore dysbiosis 
of the gut microbiome is probably occurring; this adds to the complex nature of the interaction, 
making it difficult to study.  
1.3.7. DEVELOPMENT OF THE IMMUNE SYSTEM 
The colonisation of the gut induces immune development through immune homeostasis as well as 
promoting the host-microbial mutualistic relationship (Geuking et al., 2014).  Host-microbe 
interactions occur mainly along the mucosal surface and the gut microbiota has a vital role in 
immune system development. This includes both food and bacterial antigens from the environment 
which are harmless and allow regulation of inflammatory responses (Bischoff et al., 2011). In the 
large intestine, the mucosal layer is the main means by which bacterial overgrowth and penetration 
via the epithelial cell surface occurs. The mucosa is split into two layers, the outer layer is colonised 
with bacteria and the inner layer has antimicrobial lectins, which are expressed by epithelial cells, 
constantly being secreted (Hooper et al., 2012). This diverse community of microbes causes an 
abundance of foreign antigens interacting with both the mucosal immune system as well as the 
systemic immune system. This interaction shapes the development of the immune system and 
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causes a ‘cross-talk’ between the gut microbiota and the immune system (Nicholson et al., 2012).  
The interaction is still not fully understood as the immune system must find a balance between 
allowing the growth of bacteria and discouraging overgrowth.   
Furthermore, breast milk contains antibodies from the mother which facilitates the adaptive 
immune system whilst the infant is fed. If the infant is formula fed, they rely on their own white 
blood cells to fight any pathogenic antigens. During weaning, the infant’s immune system is further 
developed through the introduction of new foreign antigens, and their bodies rapidly produce their 
own antibodies (Hooper, 2004).   
1.3.8. NEUROLOGICAL DEVELOPMENT ASSOCIATED TO THE GUT MICROBIOME  
Sudo et al., (2004) postulated that the gut microbiota has a role in the development of 
hypothalamic-pituitary-adrenal (HPA) function during the first weeks of life and can therefore have 
an impact on the enteric nervous system (ENS) (Sudo et al.,. 2004; Nicholson et al., 2012).  There has 
been increasing interest in the gut-brain axis and whether the gut microbiota and diet can affect 
brain development and function, including behavioural changes (Collins et al., 2009).        
For example, autistic spectrum disorders (ASD) are a group of developmental disabilities that are 
associated with impaired social skills, communicative skills and repetitive behaviours. (Parracho et 
al., 2005). Recent research has shown that ASD is linked not only to the neurological system but also 
to the dysregulation of the immune and digestive system. Some autistic children have a range of 
different gastrointestinal disorders which can be associated with an abnormal gut microbiota. This 
may be attributed to ASD children receiving antibiotic therapies during infancy, which has been 
documented to lead to gut dysbiosis (Adams et al., 2011). It has been hypothesised that the toxins 
produced by the gut microbiota may play a role in the etiology of ASD, in particular, 
lipopolysaccharides (LPS) (Gondalia et al., 2010). 
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1.3.9. GUT MICROBIOME INFLUENCE IN HEALTH LATER IN LIFE  
Colonisation of the gastrointestinal tract by microbes is an essential process, as the interaction 
between host and microbiota have an important influence on human health and disease. Digestive 
function and health is dependent on the composition of the microbiota, which if disrupted can lead 
to ‘dysbiosis’. This can lead to complex diseases including inflammatory bowel disease, celiac disease 
and colorectal cancer. It is becoming increasingly important that this relationship and the impact of 
molecular interactions in nutrition and digestive health is understood. 
Each part of the GI tract differs greatly in function and environment, especially referring to pH levels, 
and this affects the species which live there. However, it is known that over 99% of these bacteria 
are from the bacterial divisions; Bacteroides and Firmicutes (Gill et al., 2006). This complex 
community of bacteria and some archaea, fungi and protozoa can help to keep our guts healthy by 
protecting us from the overgrowth of pathogenic bacteria.  It is known that Bifidobacterium and 
Lactobacillus species are the most common genera in the human colon and are important in 
promoting the health of the host (Kim et al., 2004). 
1.3.9.1. Obesity 
This condition is an imbalance of higher intake of energy compared to the expenditure of energy. It 
is believed that certain exposures early in life can play an important role in the long term risk of 
obesity (Biro et al., 2010; Lifschitz, 2015). Studies on germ free mice have provided evidence for an 
association between gut microbiome and body weight (Let et al., 2005). Transfer of the gut 
microbiome from obese mice that are genetically prone to the disorder, to germ free mice, 
increased the fat deposits in these animals regardless of an increase in food intake (Ley et al., 2006).  
Furthermore, studies in humans have revealed that patients suffering from obesity have a higher 
number of Firmicutes living in their gut (Ley et al., 2006). These bacteria are more adapted to 
breaking down food, which the body cannot breakdown normally and from which it cannot gain 
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nutrients. However, when these obese individuals were put on a reduced fat diet over the course of 
a year, it was found that the Firmicutes numbers slowly decreased and Bacteroides increased in 
abundance (Frank and Race, 2008). Therefore, it has been postulated that the bacterial community 
of the human gut is dramatically influenced by the host’s diet. 
1.4. OMICS TECHNOLOGIES 
Metabolic phenotyping is the study of low molecular-weight endogenous metabolites present in 
biological fluids including urine, plasma and faecal water (Nicholson et al 2005). This analytical 
technique generates a unique metabolic “fingerprint” from biological samples, and thus is an 
invaluable tool in learning more about the complexities of diseases (Nicholson et al., 1999).  
Metabolite profiles can be generated using different high resolution analytical platforms including 
nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Global profiling using 
NMR and Ultra Performance Liquid Chromatography – Mass spectrometry (UPLC-MS), allows high 
throughput analysis of samples, identifying the most significant and highly concentrated metabolites 
by statistical analysis, with no a priori knowledge. Targeted profiling requires knowledge of specific 
metabolites of interest and uses more sensitive analytical techniques including liquid 
chromatography (LC) and gas chromatography (GC) hyphenated MS approaches, which are able to 
discern specific groups of molecules such as bile acids and short chain fatty acids (SCFAs). 
Furthermore, gut microbial associated metabolites can be detected in human biofluids, particularly 
in urine and faeces.  
Combined ‘omic’ -approaches can be used to examine complex disease associations, and can be 
invaluable to investigate gut microbiota composition and the correlation to metabolic regulation. 
Metagenomic analysis can establish the composition of gut microbiota through surveying the 16S 
rRNA genes (Li et al., 2011). By combining metagenomics with metabonomics, it supports the 
identity of microbiome-based biomarkers of metabolic activity. This knowledge has the potential to 
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aide us in identifying new ways to manipulate the microbiome to optimise their function for 
individuals in health and disease.  
1.4.1. METABONOMIC ANALYSIS IN INFANTS  
The clinical potential of metabonomics in neonatology has become evident from the rapidly 
expanding literature reported related to this area, demonstrating how physiological foetal 
development or pathological conditions affect the perinatal and neonatal outcome (Martin et al., 
2014; Moco et al., 2013).  
The composition of urine mirrors many metabolic processes and therefore provides information on 
metabolic changes in different organs. Further understanding of this post-natal organ development 
will help indicate better care initiatives for infants or may help provide us with biomarkers for 
developmental disorders. This is especially true for preterm birth and development, as it is a 
significant and increasing burden on the healthcare system. 
Metabonomics is a promising approach to investigate the interaction between our bodies and the 
gut microbiome, using metabolic profiling to capture endogenous metabolites as well as co-
metabolites from microbial sources. These exogenous compounds, which originate from the diet 
and/or gut microbiota, can enter the host’s system where they can be further processed in the liver 
and other tissues before being excreted in the urine. Therefore, urine is an ideal matrix in infant 
research as it is non-invasive and can be influenced by the diet and gut microbiota activity. 
Furthermore, consecutive samples help us to understand the dynamic changes from the rapidly 
developing body over time.   
Additionally, human faeces are also an excellent source of biological information to interrelate the 
human microbiome and human metabolome. The metabolic profile of faecal water can provide a 
window for understanding the complex metabolic relationship between humans and the complex 
ecosystem residing in the gut. The normal metabolic trajectory of the healthy neonate and how the 
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development of the gut microbiome can influence the faecal metabolic profile, remains relatively 
unknown. The aim of this thesis is to further explore this area of research.  
1.4.1.1. Urine Metabolic Profiling 
Urine is usually the biofluid of choice for metabolic profiling analysis, as metabolites in the urine are 
known to have entered the body systemically. Additionally, neonatal urine is typically used to test 
for many different inborn errors of metabolism using different assays available (Constantinou et al., 
2005).  
Age is an important contributor to the metabolic profile with many studies looking at birth up until 
early childhood (Jackson et al., 2016).  In one study, urine from infants collected at birth until age 12, 
identified several metabolites correlated to age including creatinine, creatine, glycine, 
betaine/TMAO, citrate, succinate, and acetone (Gu et al., 2009). Martin et al., (2014) also 
investigated the metabolic profiles of urine samples taken from the same infant at different time 
points. They discovered that the metabolic profile changed over time with an increase in two ketone 
bodies, 3-d-hydroxybutyrate and acetoacetate; these metabolites contribute to energy metabolism 
(Martin et al., 2014). Furthermore, authors discovered that these metabolites were present at 
different concentrations in breast fed versus formula fed infants.  Recently, Chiu et al., (2016) also 
investigated the urinary metabolic profiles of healthy infants over time from six months to 4 years. 
They discovered that at 6 months of age, urinary excretion of betaine, trimethylamine-N-oxide, 
glutamine and glycine were higher compared to age 1; these samples had increased concentrations 
of creatine and creatinine by comparison (Chiu et al., 2016). Another group (Diaz et al., 2015) found 
metabolite changes in healthy new born infants dependant on gender and mode of delivery, these 
metabolites included betaine, 4-hydroxyphenylacetate and myo-inositol among others (Diaz et al., 
2015).  
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Metabolic profiling has given a better insight into kidney development outside of the womb and the 
risk of renal disorders later in life. Even though the kidneys are sufficient to maintain homeostasis in 
the infant, its filtration function is not optimum (Drukker et al., 2002). Foxall et al., (1995), found 
that osmolytes, including taurine, myo-insitol and trimethylamine-n-oxide in the urine helps to 
protect medullary cells found in the kidney. Furthermore, they also found betaine (which is 
synthesised from choline in the diet) increases throughout the neonatal period (Brown et al., 1989; 
Foxall et al., 1995; Trump et al., 2006).   
Gestational age has a strong effect on the urinary metabolic profile. In studies investigating preterm 
infants compared with full term infants, an altered urinary metabolome was discovered. 
Concentrations of urinary alanine, formate and citrate were found to be higher in preterm infants 
whilst creatinine, creatine and dimethylglycine were lower. This altered metabolome persisted until 
the preterm infants reached term-equivalent age and also when ex-preterm individuals were tested 
as young adults (Hyde et al., 2010; Parkinson et al., 2013). Another study showed an inverse 
correlation of urinary hippurate with weight in preterm infants and, therefore, may be related to 
elevated adiposity later in life (Thomas et al., 2011).  
Furthermore, infants born preterm had lower concentrations of tryptophan, phenylalanine, malate, 
tyrosine, hydroxyl-butyrate, N-acetyl-glutamate, 1-N-methylnicotinamide, and proline than term 
born infants, but similar concentrations of betaine (Atzori et al., 2011; Trump et al., 2006).  Preterm 
infants were shown to have higher concentrations of urinary bile acids, which was attributed to an 
overproduction or bile acid clearance (Yamato et al., 2001). Diaz et al., also found a range of 
metabolite differences in urine profiles from preterm infants when compared to infants with other 
disorders (e.g. respiratory distress, large for gestation age and malformation) (Diaz et al., 2016).  
Another interesting research area of infant metabolic profiling is in relation to neurological 
disorders, including ASD, and the gut microbiome. It is known that increased levels of urinary indolyl-
3-acryloylglycine (IAG) are seen in individuals with ASD, which is an indication of gut dysbiosis. It has 
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been theorised that an increased level of IAG causes a disruption in the gut membrane and increases 
the intestinal permeability (Shattock and Whiteley, 2002). This can then allow an unusual amount of 
undigested peptides or bacterial derived toxins to enter the blood stream and possibly cross the 
blood brain barrier (Wang et al., 2009). Yap et al., (2010), discovered that there was a significant 
difference in the metabolic composition of urine between ASD patients, their unaffected siblings and 
non-related controls. Urinary concentrations of hippurate and phenylacetylglutamine (PAG) were 
found to be lower in ASD children, as well as perturbations in urinary amino acid concentrations and 
metabolites linked to nicotinic acid metabolism (Yap et al., 2010). Furthermore, several autistic 
children have different levels of N-methyltryptamine, L-arabinose and 4-cresyl sulphate which also 
adds evidence of gut abnormalities in these individuals (Altieri et al., 2011).  
1.4.1.2. Faecal Metabolic Profiling 
Human faecal metabolic profiling is a relatively new research area compared to other biofluids, with 
many studies only utilising this biofluid in the last 10 years (Saric et al., 2008; Jacobs et al., 2008; 
Monleon et al., 2009). The application of faeces has shown to have great potential for non-invasive 
diagnosis of diseases and disorders. For example, Marchesi et al., (2007) showed that faecal 
metabolic profiling by 1H NMR can be used to diagnose inflammatory bowel disease (IBD). 
Furthermore, faecal metabolic profiling has shown to help understand the interaction and influence 
of microbiome co-metabolites on human health (Le Gall et al., 2011). Therefore, faecal 
metabonomics is becoming a useful tool for defining interactions among host, microbial 
communities and nutritional interventions (Nicholson et al., 2005; Jacobs et al., 2008; Martin et al., 
2010). 
From birth, the gut microbiome development and interaction also plays a crucial role in later health, 
especially in terms of early nutrition (Chow et al., 2014). The effect of breast feeding versus formula 
feeding is a common topic of interest in infant development. Recently, studies based on faecal 
metabolic profiling has been utilised to further expand this knowledge. It was found that protein 
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fermentation by the gut microbiome was seen at a higher rate in formula fed infants compared to 
breast fed infants (Chow et al., 2014; Martin et al., 2014). This is thought to be due to the higher 
concentration of proteins in formula feed to make up for the lack of human milk oligosaccharides.  
Little is known about the faecal metabolome in infants and how it changes from birth during such a 
rapidly developing period. Therefore, further investigation is needed into not only faecal metabolic 
profiling but infancy development.   
1.5. SCOPE OF THIS THESIS: Develop a metabonomic strategy to further 
understand early life metabolism in developing infants 
The first goal of this work was to optimise and standardise the use of infant biofluid samples for 
metabolic profiling. This included characterising any contaminants that can come from the collection 
materials used to collect, prepare and run infant biofluid samples by 1H NMR and UPLC-MS, as well 
as investigating the detection limits of different biofluids (urine, plasma and faeces) using 1H NMR. 
Furthermore, understanding the age variability of urine metabolic profiles was critical to interpreting 
results throughout this project (Jackson et al., 2016). Finally, this work produced and optimised a 
protocol for infant faecal water extraction for both 1H NMR and UPLC-MS. As previously mentioned, 
faecal metabolic profiling in humans is a relatively new method and so an optimised preparation for 
infant samples was lacking from the literature or within the department at the start of this project.  
After this investigation was completed, the developed faecal water extraction method was carried 
out on two different sample sets; a term vs preterm study and the Norwegian Microbial (NoMic) 
study. Faecal samples collected as part of a large non-clinical cohort study, called the Norwegian 
Microbial (NoMic) study, using 1H NMR spectroscopy. Samples were collected from 524 infants at 4, 
10, 120, 365 and 730 days postpartum, which for many metabolic profiling-based infant research 
studies, have not had this number of time points, or participant numbers on this scale. This 
longitudinal study facilitated the characterisation and understanding of the faecal metabolic profile 
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of developing infants using two different types of statistical analysis; including multivariate statistics 
and time series analysis.  
Based on current literature, there are few investigations which have compared term and preterm 
infants using metabolic profiling; especially using more than one biofluid. Thus, in this investigation 
the aim was to better understand the early life metabolism in term and preterm born infants. This 
sample set consisted of urine and faecal samples from both term and preterm born infants; 
longitudinal samples were taken from birth until three months postpartum. An investigation 
comparing metabolic profiles between term and preterm infants was conducted at different stages 
of life: at birth, term equivalent age and three months postpartum. Utilising 1H NMR, UPLC-MS for 
global metabolic profiling and metagenomics analysis, has given an in-depth understanding of the 
differences between these two groups from birth and through the first few months of life.  
To date, this critical period of development and how it impacts future health of the child has not 
been fully understood nor investigated using this analytical approach. By using metabolic profiling to 
explore the functionality of the developing gut microbiome, the role of microbial molecules in host 
physiology and health will be better understood.   
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CHAPTER 2 
 
ANALYTICAL METHODS 
 
 
 
Metabolic profiling techniques are applied to a wide range of complex samples such as biofluids and 
tissues. Profiles derived from urine and faeces give insight into specific metabolic changes and 
provide indirect information about gut microbial activity as urine contains specific metabolites 
produced by host-microbial interactions. It has been estimated that there are approximately 2000 
metabolites making up the human metabolome (Beecher, 2003). However 2651 compounds have 
been identified in human urine alone (Bouatra et al., 2013).  
Metabolite profiles can be generated using different high resolution analytical tools including 
Nuclear Magnetic Resonance (NMR) spectroscopy and Mass Spectrometry (MS) coupled with Liquid 
Chromatography (LC) (Nicholson et al., 2012). The advantages of using 1H NMR spectroscopy is that 
it is a non-destructive technique; therefore, it doesn’t destroy nor change the sample and can be 
used for further analysis. Furthermore, this technique is robust and more reproducible compared to 
mass spectrometry. The disadvantage of using 1H NMR is that it is not as sensitive as UPLC-MS. Mass 
spectrometry when coupled with liquid chromatography can be highly sensitive and selective for 
targeted metabolic analysis including bile acid and SCFA analysis. The disadvantage of mass 
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spectrometry is that it is destructive to the sample as well as harder identification of metabolites 
due to matrix effects. These techniques have advantages and disadvantages, but by utilising these 
complimentary techniques, the information recorded from as many metabolites as possible gives a 
more in depth picture of the metabolome.  
2.1. NUCLEAR MAGNETIC RESONANCE 
High resolution proton NMR spectroscopy is a quantitative and reproducible analytical method, 
which doesn’t destroy the sample. It is used to detect a wide range of low molecular weight 
compounds (<1000 Daltons) in a complex sample, such as biofluids (Beckonert et al 2007; Dona et al 
2014).  NMR-based metabolic profiling is a suitable tool for metabonomic applications as it provides 
a metabolic ‘snapshot’ representative of the sample at the time of the collection.  
NMR spectroscopy is a powerful and versatile techniques which has been successfully applied in 
analytical chemistry, biochemistry, physiology and medicine. NMR has had huge progress in the 
understanding of the theory and the technical implementation over the last century. Therefore, 
NMR techniques can now be used to analyse liquids and solids to understand their chemical 
composition, molecular structure, and potential biochemical pathway.  
2.1.1. FUNDAMENTAL PRINCIPLES OF NMR SPECTROSCOPY 
Nuclear Magnetic Resonance (NMR) spectroscopy is based on the fundamental properties of the 
atomic nucleus which is composed of protons and neutrons. NMR detects quantum shifts using 
electromagnetic radiation interacting with the spin of atomic nuclei; this can be characterised by a 
nuclear spin quantum number, I.  Some nuclei have integral spins (e.g. 1, 2, 3), others have fractional 
spins (e.g. 1/2, 3/2, 5/2) and some have no spin; all nuclei with a non-zero nuclear spin are able to be 
observed by NMR.  Furthermore, many atoms spins are paired against each other, resulting in the 
nucleus of the atom having no nett spin. However, for biological purposes the nuclei with 1/2 spin 
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are the most useful and 1H is best detected by NMR due to the high abundance of hydrogen nuclei in 
biological samples.   
When a magnetic field is applied to these protons, their nuclei move from being in a random 
orientation to an ordered one circulating around the direction of the applied magnetic field. This 
circulation, or precession, causes a small magnetic field at the nucleus which opposes the externally 
applied field. The rate of the precession is known as the Larmour frequency of the nucleus and may 
be clockwise or anticlockwise but always the same for any given nuclei.  
The external magnetic field causes the nuclei to separate into two different energy states, 
depending on their orientation and quantum spin number; in the case of the 1H protons this would 
be high and low energy levels.  The population of nuclei at each energy level can be calculated by the 
Boltzmann distribution.  
Where N and N represent the number of nuclei in different energy states and R is the gas constant 
and T is the temperature.  ∆E equals the difference or energy gap between the spin energy levels. 
This can be worked out using the equation below: 
         ∆E=γhB0/2π          
Where γ is the angular frequency (nuclear magnetic moment), h is the Plank’s constant and B0 is 
strength of the external magnetic field. Under the influence of the external magnetic field, nuclei at 
the lower energy level will leap to the higher enrgy level.  The transition of nuclei back into the  
energy level from the  state when the magnetic field is removed can be recorded and converted 
into an NMR signal. The difference between the energy levels is characterised by the resonance 
frequency. The energy difference represented by the intensity of the NMR signal is proportional to 
the total number of nuclei in the sample (Keeler, 2002; Ross et al 2007).  
N 
N 
 
= e∆E/RT 
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During an NMR experiment, a 90-degree radio frequency pulse is applied to excite the nuclei. The 
nuclei tip to the y axis and then when the radio frequency is turned off the nuclei will precess to the 
x axis; the preferred position (Figure 2-1). During this precession, an oscillating magnetisation 
voltage is released, called free induction decay (FID), and can be recorded. The FID represents the 
sum of the nuclei in the sample and can be transformed, using a Fourier transformation, to produce 
an NMR spectra with chemical shifts.  
 
Nuclei experiencing the same chemical environment are called equivalent. The differences in 
chemical environment are represented on the NMR spectrum as chemical shifts on a parts per 
million (ppm) scale. Those nuclei experiencing different environment or having different chemical 
shifts are non-equivalent and nuclei which are close to one another exert an influence on each 
other’s effective magnetic field. If the distance between non-equivalent nuclei is less than or equal 
to three bond lengths this effect can be observed; this effect is called spin-spin coupling. This 
coupling can cause the splitting of NMR peaks, and the shape of these peaks gives a further 
Figure 2-1. Representation of the 90-degree pulse effect on the nuclei. The nuclei at first are 
precessing around the external magnetic field (Z axis). When a 90-degree radio frequency pulse is 
applied and tips the nuclei to the XY plane instead. Once this radio frequency is turned off, the 
nuclei will precess back to the Z axis to reach equilibrium. This oscillating signal can be recorded 
and is known as the FID. (adapted from Keeler, 2002)  
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indication of the number of neighbouring protons; this is called multiplicity, where peaks can be 
represented as singlets, doublets, triplets and multiplets.   
One dimensional pulse sequences, with water pre-saturation, are typically used for metabonomic 
experiments on urine and faecal samples, as these samples are generally low in protein and lipid 
concentration (Beckonert et al., 2007). A standard ID experiment was used for all biofluids in this 
thesis and specific parameters can be found in the materials section of each results chapter; 
although other experiments including Carr-Purcell-Meiboom-Gill (CPMG) and diffusion edited 
experiments, which are typically used for plasma and tissue investigations.  
2.1.2. TWO DIMENSIONAL NMR SPECTROSCOPY 
Multi-dimensional NMR experiments are essential for additional structural information on molecules 
to help with identification, by plotting the data into two different domains. J-resolved (JRES) 1H NMR 
spectroscopy allows the separation of chemical shifts and homonuclear J-coupling into different 
frequency domains. This is very useful to initially elucidate peak structure, for example whether two 
peaks are part of a doublet or two separate singlets.  
Correlation spectroscopy (COSY) generates 2D NMR spectra in which signals of a normal single-pulse 
spectrum are correlated with each other; typically separated by two or three bonds. COSY 
experiments generate a spectrum that is presented by the chemical shifts from the nuclei as a 
diagonal line and the cross-peaks on either side of the diagonal that represent the coupling 
information between the nuclei.  
2.1.3. LIQUID CHROMATOGRAPHY - MASS SPECTROMETRY 
Mass Spectrometry (MS) is a very sensitive analytical technique which is typically coupled to 
upstream chromatographic platforms in metabonomic analyses. Unlike NMR, MS is a destructive 
technique since it requires the ionisation of the biological samples. Chromatography is used to 
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separate and fractionate the sample in order make the identification of metabolites easier. 
Metabonomic studies uses many different types of separation techniques, including liquid 
chromatography (LC), gas chromatography (GC) and capillary electrophoresis chromatography (CE). 
In this project, I will be focussing on LC-MS only, please refer to the literature for other separation 
techniques.  
2.1.3.1. Principles of Mass Spectrometry 
Mass spectrometry (MS) is an analytical tool in which molecules in ionised gaseous form are 
separated in space and time according to their mass to charge ratio (m/z) prior to detection. The MS 
is composed of the ionisation source, a mass analyser and an ion detector (Figure 2-2). 
 
There are different ionisation techniques used for organic analysis including electrospray ionisation 
(ESI), matrix-assisted laser desorption ionisation (MALDI), desorption electrospray ionization (DESI), 
chemical ionisation (CI) and electro impact ionisation (EI) (De Hoffman et al 1996). For biological 
Figure 2-2: Diagram of mass spectrometer – the ionisation source, a mass analyser and an ion 
detector producing a signal. UPLC: ultra-pressure liquid chromatography, gas chromatography, 
ESI: electrospray ionisation, MALDI: matrix-assisted laser desorption ionisation, DESI: Desorption 
electrospray ionization, EI/CI: electronic or chemical ionisation 
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investigations, ESI is commonly used as it is highly sensitive and it can directly convert ions from a 
liquid phase to a gas phase. ESI works by uses a capillary tip to produce a fine spray of charged 
particles, the solvent is evaporated by traveling through nitrogen gas and the charges enter the mass 
spectrometer (Pitt, 2009). ESI can produce positively or negatively ions and are analysed separately. 
By doing this, the number of molecules which can be identified can increase as some molecules will 
only be detectable in one polarity.   
Once the molecules are ionised, they are transported through a vacuum into the mass analyser. This 
analyser separates the ions based on their mass to charge ratio (m/z). The mass analyser can be a 
quadrupole (Q), time of flight (TOF), ion trap or Orbitrap system. The quadrupole analyser uses four 
rods placed in parallel and a voltage is passed through them causing an electric field to be produced. 
This in turn allows the control of certain ions to pass through to the detector without hitting the 
quadrupoles (Pitt, 2009). The time of flight (TOF) analyser uses the fact that ions with a larger mass 
to charge ratio will travel through space slower than ions with a smaller mass to charge ratio to its 
advantage (Wiley et al 1955). The TOF will accelerate the ions through a high voltage causing further 
separation of ion species depending on their m/z ratio and helps with detection.  The triple 
quadrupole (TQ) is typically used for MS/MS experiments to help with confident assignment of 
molecules using fragmentation. This fragmentation occurs in a collision cell placed between two 
quadrupole mass analysers (Pitt, 2009). Several analysers can be combined to approve ion 
separation and gain fragmentation information, including QTOF and the TQ. These are usually used 
in metabonomic studies to gain structural information through fragmentation patterns. 
Finally, the ion species reach the detector, and are recorded by a current being produced when they 
hit the detector. The ion intensity and the m/z ratio is converted to make a digital signal and 
recorded by a computer (De Hoffman et al 1996).   
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2.1.3.2. Principles of Liquid Chromatography (LC) 
Liquid chromatography (LC) is used to separate small molecules in a liquid mobile phase and passed 
through a column. These columns have different chemical compositions depending on the 
metabolite class of interest. Ultra-performance liquid chromatography (UPLC) uses smaller particles 
sizes (<2um) and operate at a higher pressure (>10,000 psi) to improve chromatographic 
performance compared to high performance liquid chromatography (HPLC); this includes peak 
resolution as well as increased sensitivity and speed (Wilson et al 2005).  
A frequently used technique in metabonomic studies is reversed phase (RP) chromatography to 
separate medium to non-polar molecules. However, in this project, hydrophilic interaction liquid 
chromatography (HILIC) was used. This chromatographic technique is used for the retention of very 
polar molecules such as amino acids and organic acids (Spagou et al 2010). HILIC uses silica or a 
derivative of silica column and water in the mobile phase to further retain the polar molecules on 
the column (Dettmer et al 2007). The retention time vary between the substances so it can be used 
as an aid for the separation of molecules and therefore the identification of certain molecules.  
2.2. MULTIVARIATE STATISTICAL ANALYSIS FOR METABONOMIC DATA 
NMR and UPLC-MS data from biofluids are very complicated due to the complex nature of the 
mixture of chemicals and the heavy overlap of metabolite signals. Therefore, multivariate data 
analysis methods have been developed in order to extract significant information from the large 
data sets from these techniques. These techniques can simplify data sets and make visualisation of 
the similarities and differences between the different observations possible within biological 
samples. 
An unsupervised multivariate technique commonly used is the principal component analysis (PCA), 
this establishes models with any a priori knowledge of class information in the dataset; thus, 
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indicating the intrinsic differences within the dataset. When focussing on group classification, 
supervised methods for data analysis can be used. These methods require prior knowledge of the 
class information and includes Partial Least Square (PLS) and Orthogonal Partial Least Squares - 
Discriminant Analysis (OPLS-DA). This class information means the data analysis optimises the 
separation between the different classes and requires subsequent validation via prediction of an 
independent test set to prevent over fitting of the data.  
2.2.1. UNSUPERVISED METHODS 
Principal components analysis (PCA) is a qualitative chemometric technique that reduces the 
number of variables that need to be considered into principal components that are linear 
combinations of the original variables (Wold et al 1987). This method is unsupervised, therefore no a 
priori knowledge of the sample classes is used and only the inherent variation in the data set is 
described. The data is firstly made into a 2D matrix of the different samples versus the number of 
variables or metabolic features.  
 
By substituting the variables with derived axes called principal components, these latent axes 
correspond to the maximum variance of the dataset.  The first principal component (PC) computed 
minimises the square of the distance of each data point to that vector. The first PC typically explains 
Figure 2-3: Representation of a PCA in 
three dimensions.   The first two 
principal components (PC) describe the 
largest variance in the data. They 
produce a new plane for the data to be 
projected; presented as a scores plot.   
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the greatest variance in the matrix and the second principal component, which is orthogonal and 
uncorrelated to the first, will explain the second greatest variance (Wold et al 1987). Therefore, PCA 
allows the reduced multivariate data to be projected onto two or three dimensions.  
This reduction in dimensions improves visualisation of the data as a whole and reveals patterns in 
the data; this visualisation is in the form of a scores and loadings plot. Scores illustrates the 
variability between the samples, whereas the loadings plot illustrates the weight of the variables 
causing this separation between samples.  PCA is a useful analytical technique for metabonomic data 
as many metabolites are correlated so this information can be explained in less dimensions rather 
than looking at them individually.  
2.2.2. SUPERVISED METHODS  
Supervised statistical tools, for example projections to latent structures by means of Partial Least 
Squares (PLS) analysis and orthogonal partial least squares (OPLS), when the difference between two 
or more groups want to be investigated.  The PLS method maximises the covariance between the 
metabolic data (X scores) and the thing we want to predict (Y scores); e.g. age, ethnicity or weight. 
This covariance is typically dominated by the X scores as this usually has a higher number of 
variables compared to the inner relationship of Y. Unlike PCA, this method maximises the covariance 
between the predictor of interest and response matrices rather than maximising the variance 
explained within the data. PLS can project the X- and Y-variables onto the same space within a 
scores plot to show the correlation between the co-ordinates of one observation on the X-plane to 
its corresponding co-ordinate on the Y-plane; this relationship is asymmetric (Tapp & Kemsley, 
2009).  
Orthogonal-PLS (OPLS) is an extension of PLS, which uses an orthogonal component to the model. 
Orthogonal variation means that the systematic variation in one block is not linearly related to the 
second block. This method can rotate the projection of a PLS plot to focus on the effect of interest 
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giving a better interpretation of the data. This is very useful for when you can’t control for some 
variation or effects, which is typically useful for human or biological studies.  
 
OPLS-DA is an extension of OPLS and is used to obtain maximum separation between classes of data 
that are categorical and can be used to predict class membership. For OPLS-DA models, the X matrix 
is the sample NMR data whereas the Y matrix is made up of binary variables that describe the class 
for each sample. Even though it is similar to PCA, which describes the maximum variation within the 
data, it doesn’t necessarily describe the maximum separation of classes in the PC scores plot.  
A seven-fold cross-validation was also used to assess the robustness of the models and to ensure 
that the models weren’t over-fitted. This test is done by removing a section (1/7th) of data at a time 
and this is used to train the model and it then uses this information to predict the other sections of 
data. This is repeated for each section of data until all the data has been predicted. In order to 
Figure 2-4 – Representation of PLS analysis. This is a regression extension of PCA and is used 
as a method to relate two data matrices together, in this case X = NMR variable and Y = 
clinical data (e.g. age or weight).  PX and PY represent the scores matrices for the model.  
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further test the validity of the model, permutation tests were performed. By assigning each sample 
with a random group and repeating the model 1000 times, a p-value can be produced by comparing 
Q2Y values from the permutated models against the non-permutated test; a 95 % significance 
threshold (p <0.05) was used for this project.  
A heat map presenting the Pearson correlation coefficient values of the identified discriminatory 
resonances from the urine and faecal NMR and HILIC-MS data were constructed. This information is 
super imposed onto a pseudo NMR-spectra, or loadings correlation coefficient plot, which highlights 
the specific peaks causing the separation between the two classes (Cloarec et al 2005). The direction 
in which each peak, positive or negative, reveals the relative difference between the two groups. 
2.3. METABOLITE IDENTIFICATION IN GLOBAL PROFILES 
2.3.1. 1H NMR DATA 
Metabolite identification is achieved by first visualising specific data points in the NMR spectra. The 
designation of an identification was performed by comparing this information with available 
literature and existing databases, including in-house databases and the Human Metabolome Data 
Base (HMDB) found online. However, many molecule signals overlap in the NMR spectra making it 
hard to distinguish and make a conclusive assignment.  
Therefore, statistical methods can be used to identify highly correlated data points in the NMR 
spectra to the variable in question and to extract structural information of the metabolite; this 
statistical method is called Statistical Total Correlation SpectroscopY (STOCSY) (Cloarec et al 2005).  
STOCSY is able to show highly correlated variables within in the whole NMR spectra and has the 
potential to highlight different molecules which are related to the same metabolic pathways. The 
correlation between NMR peaks to the selected variable of interest is indicated by a colour scale; 
ranging from low (blue) to high (red) correlation (Cloarec et al., 2005a). For this thesis, this method 
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was used as an aid to identify metabolites of interest within multivariate analysis as well as time 
series analysis.  
2.3.2. HILIC-MS DATA 
Using the correlation coefficient plots, the top 10 metabolites that caused the greatest separation in 
the groups was identified. The first step for identification was to search the chromatogram of the 
sample with the highest abundance of the molecule; using the median m/z value and retention time 
(RT) information. Once the exact m/z value, as well as information on adducts (if possible) was 
compiled from the sample. The designation of an identification was performed by comparing this 
information with available literature and existing databases, including METLIN from the Scripps 
Centre for Metabolomics and the Human Metabolome Data Base (HMDB) found online. MS/MS 
experiments were performed on QC samples only, therefore only molecules at a high abundance in 
these samples had fragmentation information available to aid identification of features.  
The level of identification was determined using the criteria found in Sumner et al (2007); level 4, an 
unknown compound that couldn’t be identified; level 3, a known compound class through the 
identification through database searching ; level 2, the mass to charge ratio for a particular molecule 
matches the databases; level 2+, the mass to charge ratio and MS/MS fragmentation data is 
matched to the databases; level 1, the compound has been identified and confirmed using chemical 
standards (Sumner et al 2007).    
2.4. TIME SERIES ANALYSIS FOR 1H NMR SPECTRAL DATA  
In this project, a time series analysis has been used to identify metabolites, which are different 
between groups through time using an in-house time series algorithm (Wolfer et al., In Press). This 
method of analysis was used to further understand specific metabolite trajectories in infant faecal 
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samples in the first two years of life. This technique relies on functional spline for short 
asynchronous time series analysis and functional data analysis (FDA) (Ramsay et al 1988).  
A variable of interest should differentiate groups through time (e.g. term vs. preterm born). This 
corresponds to a variable for which the time-trajectory of term samples if significantly different from 
the preterm samples. To evaluate the significance of the actual difference between these group 
trajectories, these group curves need to be compared (and out-perform) to randomly generated 
groups (i.e. term or preterm).  
For this method, 1H NMR data was binned into 1000 bins; variables represent 5 columns of NMR 
data summed and assigned a ppm region at a distinction of 0.01ppm. For each individual, each 
variable (binned 1H NMR data) is plotted onto a graph and a curve is used to best represent the data 
trajectory through the time points. The benefit of using curves to compare between different 
individuals rather than specific data points is that there can be missing values from individuals 
without affecting the curve.  The smoothness of this curve, using 4 degrees of freedom, corrects for 
the measurement of error but will not over fit the data (Figure 2-5(a)). Therefore, a curved line that 
doesn’t go through all data points is used to describe the average rather than a straight line (similar 
to a linear regression). 
For the different groups, an average or mean group curve is produced; in this project, this included 
term vs. preterm at birth, mode of delivery and BMI status at 1 and 2 years of age (low versus high). 
Group curves have 95% confidence bands, constructed from a bootstrapping technique; this 
technique randomly assigns individuals in a group and reruns the algorithm another 1000 times. An 
empirical p-value can be determined by comparing the actual value with the null distribution of the 
value which has been permuted. 
Furthermore, to evaluate the significance of the difference between the two mean group curves 
(e.g. term vs. preterm born) a permutation test is performed. This test assigns each individual with a 
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random group and reruns the algorithm 1000 times to calculate a p-value for the specific variable. 
The p-value is calculated by how many times the random assignment of groups is superior to the 
actual assignment of groups and then divided by the number of tests performed; in this case 1000 
times.  
 
As the p-value is obtained or each variable (ppm) a false discovery rate (FDR) correction can be 
applied across the resulting p-values. The algorithm applies a Benjamini-Holberg FDR correction to 
Figure 2-5: Representation of time series analysis. a) the curve (dotted line) is fitted for each 
variable for each individual, with arrows representing the measurement of error. b) curves from 
each individual for each variable is compared and compiled with individual variability accounted 
for (arrows). c) groups are represented by different colours, individual measurements by circles, 
individual trajectories by dashed lines, d) group mean curves by continuous lines and 95% 
pointwise confidence area on the group mean curve estimation is drawn as a coloured area. 
a b 
c d 
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the obtained p-values. As a p-value of zero should not be reported, the lowest p-value obtainable 
(with the present settings) when no random groups out-perform the actual groups is 0.000999. 
By examining the spline graphs, the bold lines represent the group mean curves and the 95% 
pointwise confidence area on the group mean curve is the shaded area in the same colour (Figure 2-
5(d)). This graph and the corresponding p-value informs the difference in group’s specific variables 
or metabolites at certain time points. Once these variables were identified, STOCSY (section 3.1) was 
used on the NMR spectral data to assign and identify specific variables to metabolites.  
2.5. GUT MICROBIAL PROFILING 
Microbiome-host interaction has been found to play a crucial role in mammalian health and disease 
development. Therefore, studying the microbial communities present in various locations of the 
human body has contributed to our knowledge of this interaction. Metagenomics is defined as the 
culture-independent study of sets of genomes from a microbial population or the exploration of the 
entire microbial genome; this field has expanded exponentially due to the growing interest in of the 
role of the microbiome in human health. As over 80% of the bacteria in the gut are uncultivable it 
means the improved DNA-sequencing technologies have enabled enhanced capabilities for 
sequencing large scale data sets. However, the complexity of the microbial communities makes this 
field very challenging. The genetic information of the metagenome can be up to 100 times greater 
than the human genome.  
2.5.1. 16S RIBOSOMAL RNA GENE SEQUENCING USING ILLUMINA MISEQ 
SEQUENCING 
The 16S ribosomal RNA (rRNA) gene codes the 16S rRNA, which is a part of small subunit (30S) of the 
prokaryotic ribosome (Woo et al., 2008). The ribosome is an organelle that performs translation or 
protein synthesis; it consists of a large and a small subunit. The small subunit binds to mRNA and the 
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large subunit catalyses protein bond formation between amino acids to produce peptides.  The 16S 
rRNA gene codes for the small subunit of a prokaryotic ribosome; this is homologous to the 
eukaryotic 18S rRNA. Therefore, this gene is useful for sequencing in different types of samples, 
especially human biofluids, as it is unique to prokaryotes.  
The 16S rRNA gene is very well conserved between different species due to its important function in 
the cell so it is an ideal gene for sequencing to differentiate between bacterial species. However, 
between the conserved regions, there are 9 variable (V) regions within the gene, which are different 
between species of bacteria; therefore, specific bacterial species can be identified. This technique 
was used for the creation of the first phylogenetic to understand evolutionary relationships between 
species (Fox et al 1977). Using this gene, different types of sequencing technologies have been 
produced including Sanger’s sequencing (Sanger, Nicklen, & Coulson, 1977), 454 Roche sequencing 
(pyrosequencing) (Margulies et al., 2005), and MiSeq (Illumina). For the purpose of this thesis, I will 
be discussing the MiSeq technology only, please refer to the literature for more information on 
other technologies.  
MiSeq by Illumina applies amplicon sequencing to analyse genetic material; in this case the 16S rRNA 
gene sequence. The forward and reverse universal primers, which target the conserved region of the 
gene, are used to make a template from the DNA strand for both strands separately. A single-strand 
of DNA is attached to the surface of a matrix using an adapter at both ends of the DNA fragment.  
Fluorescently-labelled nucleotides are added to the DNA strand one at a time, and as they attach to 
the daughter DNA strand a fluorescent signal is given off. The fluorescent signal omitted for each 
nucleotide is different and distinguishable so the signals can be determined by a fluorometer and 
recorded as a digital output (Clarridge, 2004; Mardis 2008).  
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2.5.2. PRE-PROCESSING 16S rRNA SEQUENCED DATA  
DNA was isolated from faecal pellets using PowerFaecal DNA Isolation kits (MoBio Laboratories Inc) 
in accordance to the manufacturer’s protocol and eluted in the 50 l of water. This was sent for 
sequencing using the V4 region of the bacterial 16S rRNA gene using Illumina by Research and 
Technology (USA).    
Using this method of sequencing produces two reads for each strand of DNA (forward and reverse) 
and needed to be put together. This was done using the Mothur programme and standard scripts 
associated to this programme (Schloss et al 2009). This data was aligned and clustered together 
depending on how similar to each other they are. The sequences are then classified according to the 
16S rRNA gene and only bacterial species data is kept; eurkaryotic and archaea data is removed. The 
sequences are then clustered into Operational Taxonomic Units (OTU) and the taxonomy for each 
OTU was matched. The data output is a list of bacteria species with Phylum, Class, Order, Family and 
Genus information for each OTU as well as the size or number of times each OTU was in a sample. In 
this project, 569 OTUs or different species of bacteria were recognised from the faecal samples.  
When processing, 12 samples which had less than 2000 sequences were excluded from the analysis. 
This was done because samples with low number of sequences would reduce the percentile of OTUs 
and therefore reduce how detailed the outcome could be.  
2.5.3. ANALYSIS OF MICROBIAL PROFILES 
The data, in the form of OTUs, taken from Mothur was then imported into the statistical analysis of 
taxonomic and functional profiles (STAMP) software, with the corresponding metadata for each 
sample, to analyse the microbial profiles (Parks et al 2014). This software was used to identify 
features that differ significantly between microbial profiles from different groups; in this project the 
difference between infants born term and preterm. As the data was not normally distributed, non-
parametric tests were used. For the two groups, the two sided White’s parametric t-test was 
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performed on all identified bacterial species in the sample. In order to avoid false positive results in 
the data analysis, the Benjamini-Hochberg correction was applied using this software. STAMP 
software produced extended error plots to show significantly different bacterial phyla, classes and 
genera in samples taken from infants born term or preterm at different time points. These extended 
error plots also include 95% confidence intervals. Only OTU differences between samples with a p-
value of less than 0.05 was used as a cut off for significance.  
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CHAPTER 3 
 
METHOD DEVELOPMENT OF INFANT BIOFLUID 
SAMPLE PREPARATION FOR METABOLIC 
PHENOTYPING 
 
 
 
3.1. INTRODUCTION 
Plasma, urine and faecal water metabolic fingerprints capture essential information associated with 
host energy metabolism and microbial-host co-metabolism (Nicholson et al 2012). The majority of 
biofluid sample preparation methods for metabolic phenotyping have been produced for adult 
studies, but pipelines created especially for new-born babies and infants are lacking (Jacobs et al 
2008; Monleon et al 2008; Pettersson et al 2008; Saude et al 2007). Infant biofluid samples are 
often challenging for metabolic phenotyping, mainly due to their smaller volumes compared to 
adults; 24 hour urine volume for new borns is 20-350mL in comparison to a normal adult, where the 
urine volume ranges from 750-2000mL. This is especially true for blood samples, where infants 
undergo a heel prick and blood is collected onto filter paper (Pitt 2010).  Whilst in hospital, urine 
samples can be collected using plastic collection bags attached with adhesive, but typically cotton 
balls are placed inside disposable nappies for collection. Faecal samples are collected in a similar 
manner to urine samples, through disposable nappies, which causes concern for cross 
contamination of urine and faeces. In early life, depending on the diet of the infant, faecal samples 
can be liquid in consistency, adding to the challenges of biofluid collection. Furthermore, 
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contamination introduced from disposable nappies and cotton wool is a major consideration, which 
may introduce biases in downstream ‘omic methods (Goodpaster et al 2011). 
It is thus clear that there is a critical need to optimise sample preparation and data acquisition 
protocols for the infant clinical samples. Firstly, the effect of dilution factor on biosamples 
(including, urine, plasma and faecal water; dilution series concentrations: 0, ½, ¼, ⅛) for metabolic 
phenotyping, using 1H NMR spectroscopy was investigated. Following this analysis a method for 
faecal water extraction was established and optimised, using a range of different extraction 
techniques and solvents, for metabolic phenotyping using 1H NMR spectroscopy. Finally, a database 
of contaminants associated with infant hygiene products including nappies and cotton wool was 
established using 1H NMR and UPLC-MS.  
3.2. AIM 
The aim of this work was to evaluate and optimise infant biofluid (urine, plasma and faecal) sample 
preparation methods for metabolic profiling using 1H NMR spectroscopy and UPLC-MS, combined 
with multivariate data analyses. I will be fully evaluating any contaminants coming from cotton wool 
and nappies during the collection of urine samples.  Furthermore, due to the large amounts of 
faecal samples being used in this project, the optimisation of faecal water preparation in infants 
was done.   
 
 
 
 
 
 66 
3.3. MATERIALS AND METHODS 
3.3.1. SAMPLE DONOR INFORMATION AND ETHICS 
Urine and faecal samples were collected from five term born infants, further information can be 
found in Table 3-1. A plasma sample was collected from five healthy adult donors (due to ethical 
considerations with respect to sampling of neonates). Ethical approval for the use of these samples 
was granted from the West London Research Ethics committee (REC reference number 12/LO/0203 
and 10/H0/7135). 
Table 3-1. Clinical information on infant urine and faecal samples used in method development 
for dilution series analysis.  (T: Term, P: Preterm, M: male, F: female, VD: vaginal delivery, CS: 
caesarean section) 
Clinical data Urine Stool 
1 2 3 4 5 1 2 3 4 5 
Term or Preterm T T T T T T T T T T 
Gestation age at 
birth (weeks) 
40.4 41.4 41.8 40.7 41.7 40.1 37.1 39.1 39.3 40.4 
Weight (kg) 3.75 3.34 3.93 3.96 3.6 3.69 2.8 3.24 2.7 4.07 
Sex F M M M M M F M M F 
Mode of delivery CS VD CS VD VD VD VD CS CS VD 
Sample week PP 1 1 0 0 1 0 1 0 2 1 
 
3.3.2. DILUTION FACTOR OF URINE, PLASMA AND FAECAL SAMPLES  
Urine and faecal samples were collected from five term born infants and a plasma sample was 
collected from five healthy adult donors (due to ethical considerations with respect to sampling of 
neonates). A dilution series was produced for each biofluid prior to profiling by 1H NMR 
spectroscopy. For each of the samples, a dilution series (0, ½, ¼, ⅛) was created (see supplementary 
data (S1) for further information). To compensate for the decrease in signal to noise in more dilute 
samples, the length of the acquisition was increased, acquisition scans quadrupled as the dilution 
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increased, which in turn increased the duration of the NMR experiment. Samples were also subject 
to the same number of NMR acquisitions (32 scans). 
3.3.2.1. Urine Preparation for Metabolic Profiling 
For the undiluted samples, 540µl of urine was mixed with 60µl phosphate buffer solution at pH 7.4  
(0.6M Potassium Dihydrogen Phosphate (KH2PO4,), 0.01% 3-Trimethylsilyl Propionic Acid-d4 Acid 
Sodium Salt (TSP), 3mM Sodium Azide (NaN3 ), and Potassium Hydroxide Solution KOH 45% w/w in 
80% D2O). After centrifugation at 16000 xg for 10 minutes at 4°C, samples were transferred to 5mm 
outer diameter NMR tubes. Depending on the dilution series, samples were mixed with water to 
make up the volume up to 600µl, the same amount of phosphate buffered solution with the 
internal standard, TSP, was added to each sample.  
3.3.2.2. Plasma Preparation for Metabolic Profiling 
For the undiluted sample, 300µl was mixed with 300µl of phosphate buffer solution. After 
centrifugation at 16000 xg for 10 minutes at 4°C, samples were transferred to 5mm diameter NMR 
tubes. Depending on the dilution series, samples were mixed with water to make up the volume up 
to 600µl; the same amount of phosphate buffer solution was added to each sample.  
3.3.2.3. Faecal Water Preparation for Metabolic Profiling 
From the native sample, 200mg of faecal sample was homogenised (vide infra section 3.4.2) with 
500µl of water using zirconium beads. The samples were centrifuged at 16000 xg for 10 minutes at 
4°C and faecal water (supernatant) was obtained. This suspension was mixed with 60µl of phosphate 
buffer solution and samples were transferred to 5mm outer diameter NMR tubes. To make this 
dilution series, different masses of faecal matter was mixed with the same amount of water (500µl) 
and the same amount of phosphate buffered solution was added to each sample. 
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3.3.3. ASSESSMENT OF AGE-RELATED VARIABILITY ON INFANT URINE PROFILES 
Infants develop rapidly from birth, due to interactions with their internal and external environments 
and as their gut microbiome starts to develop and this is likely to cause their metabolic profile to 
dramatically change in the first few weeks of life. Therefore, the assessment of age variability on 
infant profiles was investigated for metabolic phenotyping by 1H NMR spectroscopy. Urine samples 
taken for mother-infant comparison were obtained from a mother-infant matched samples using an 
infant born at term. Urine samples were taken from the infant at 0, 14 days, 8 weeks and 14 
months’ postpartum and a further maternal sample was taken at the time of birth for comparison. 
3.3.4. SAMPLE COLLECTION MATERIAL CONTAMINATION ASSESSMENT 
To assess contamination of infant urine metabolic profile introduced by collection protocols, 
different nappies and cotton wool brands were investigated. Three brands of nappies were 
assessed; Pampers, a UK hospital brand (Libero) and a UK store brand (Tesco). Four cotton wool 
brands were also assessed: three UK store brands (Tesco, Sainsbury’s and Boots) and a UK hospital 
brand (Robinson’s healthcare). Chemical profiles arising directly from these products were assessed 
using H2O as a blank sample, as well as a pooled infant urine sample from infants at postpartum 
ages from 0-19 weeks.  
A volume of 3 mL of urine was added to cotton wool and incubated for two hours at 37°C (to mimic 
the typical infant urine collection conditions); the cotton wool was either frozen overnight at -80°C 
prior to extracting urine or urine was extracted directly from the cotton wool immediately after 
collection.  
Extraction from the cotton wool was carried out in two ways to assess whether chemical 
contamination was from exposure to laboratory equipment: 1) squeezed by hand from the cotton 
wool into a falcon tube or 2) extracted by centrifugation at 16000xg for 5 minutes. Extraction by 
centrifugation involved adding the cotton wool to a falcon tube and positioning a microcentrifuge 
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tube underneath it to stop the cotton wool from moving to the bottom of the tube to ensure as 
much urine was extracted as possible (Supplementary – Figure S2).  
It was not possible to gain urine from nappies directly due to the absorbent core of the nappy. 
Therefore, nappies were also assessed using a similar method to the cotton wool; urine was added 
to cotton wool and this was inserted into the different nappies and incubated at 37°C for two hours. 
Urine was extracted from the cotton wool by manual squeezing.  
For 1H NMR analysis, 540l of urine and 60l of phosphate buffer was transferred to 5mm NMR 
tubes and acquired. The remaining urine was added to two well plates and run by both Reversed 
Phase (RP) and Hydrophilic Interaction Chromatography Mass Spectrometry (HILIC) in both 
electrospray ionisation positive and negative mode. In addition to urine, water was used to obtain 
an experimental blank sample from both cotton wool and nappies. These were treated in the same 
way as urine samples for preparation and analysis.  
3.3.5. FAECAL WATER EXTRACTION OPTIMISATION PROCEDURE 
The schematic representation for optimal faecal water extraction experimental design during this 
method development can be seen in Figure 3-1 below.  
3.3.5.1. Freeze-thaw cycle effects  
It has been previously postulated that by subjecting a sample to freeze thaw cycles, it will increase 
the concentration of metabolites released into the water (Wu et al 2010). Therefore, the influence 
of freeze thaw cycles was assessed using the same faecal sample with 200mg aliquots taken after 
being subject to different conditions. These conditions included: no thawing of the sample, 1, 2, and 
3 freeze-thaw cycles; for each freeze cycle, the samples were subject to freezing at -80°C for two 
hours. All aliquots were added to 600µl of water, vortexed for 15 seconds and sonicated for 30 
minutes. Samples were centrifuged for 20 mins at 13,000 xg and 540µl of supernatant was mixed 
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with 60µl of phosphate buffer and transferred into a 5mm NMR tube. 1H NMR spectra were 
acquired for all the aliquots via the method described in section 3.5 of this chapter. 
3.3.5.2. Homogenisation techniques 
Due to the nature of faecal samples, it is important to fully homogenise the sample to ensure that 
all metabolites are released into the faecal water. Four homogenisation techniques were assessed: 
1) bead beating, 2) vortexing, 3) homogenisation by pestle, and 4) homogenisation by liquid 
nitrogen. The experiment was conducted in duplicate and faecal samples were, firstly, weighed out 
(200mg).  
The samples that were homogenised with beads and vortexed, had 500µL of water added prior to 
homogenisation, whereas pestle and liquid nitrogen homogenisation samples were mixed with 
water and vortexed for 1 minute after the homogenisation technique. 1) For the bead beating 
technique, faecal samples were combined with 0.1mm of 1mm Zirconium beads and bead beat for 
30s using  the Biospec Mini Beadbeater 96, 2) for the vortexing technique, samples were vortexed 
for 1 min and sonicated for 5 minutes, 3) samples underwent homogenisation in microcentrifuge 
tubes using a plastic pestle and 4) samples were placed in a mortar and liquid nitrogen was poured 
into the mortar to deep freeze, and the a pestle was used to produce a dehydrated powder. All 
samples were centrifuged for 20 minutes at 13000 x g to obtain a supernatant of faecal water.  
Further to this, a raw sample that was not homogenised and only centrifuged to obtain as much 
natural faecal water as possible, and named the centrifuge only technique. This faecal water 
(400µL) was mixed with phosphate buffer (200µL) and transferred to 5mm NMR tubes; 1H NMR 
spectra were acquired using the experimental parameters described in section 3.5.  
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Figure 3-1: Schematic representation of the summary of experimental design for infant faecal 
water extraction optimisation.  
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3.3.5.3. Solvent extraction  
Use of the appropriate solvent is important for the full retrieval of information from the stool 
sample and to optimise the resolution of spectroscopic analysis (Jacobs et al 2008). Four different 
solvents were assessed: 1) deionised H2O, 2) heavy water - D2O, 3) PBS (1.9 mM Na2HPO4 , 8.1 mM 
NaH2 PO4 , 150 mM NaCl, pH 7.4) and 4) Phosphate buffer (KH2PO4, TSP, NaN3, and KOH 45% w/w, 
in D2O ).  
Faecal water was extracted in duplicate from each sample to assess the influence of different 
solvents on the metabolic profile of faecal water by 1H NMR spectroscopy. Three faecal samples 
were divided into four 200mg fractions each. Each fraction was mixed with 400µL of different 
solvent, homogenised by vortexing and sonication and centrifuged for 20mins at 13.000 × g. From 
the supernatant, 200µl of faecal water was mixed with 340µl of D2O and 60µl of phosphate buffer; 
this was transferred to a 5mm NMR tube; 1H NMR spectra were acquired using the experimental 
parameters described in section 3.5. 
3.3.5.4. Optimisation for UPLC-MS analysis 
Due to the small mass that is typically available from infants, an optimised technique for the 
preparation of faecal samples for both 1H NMR and UPLC-MS acquisition was needed for this 
project. Therefore, for UPLC-MS, an organic solvent is needed to precipitate proteins from the 
sample and improve the retrieval of metabolites, especially species of bile acids (Michopoulos et al 
2009; Sarafian et al 2015).    
Furthermore, UPLC-MS proposes to filter samples through 0.2 µm Costar’s Spin-x centrifuge tube 
filters (Sigma CLS8160) to ensure larger particles in the sample are removed and don’t block or 
damage the column.  
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Two aliquots from the same faecal sample (200mg) was added to acetonitrile (ACN) and UPLC-grade 
water (500l ) at a ratio of 1:3 (ACN:H2O). Another two aliquots of the same faecal sample was also 
extracted using UPLC- grade H2O only was compared with samples extracted using the ACN:H
2O 
mix. The samples were then homogenised using the bead beating technique and centrifuged 
following the protocol described in section 3.4.2. of this chapter.  
To compare filtering of samples, one sample from both solvent types had the supernatant 
transferred into the filters and centrifuged for a further 20 mins at 16000 xg. The other two faecal 
samples from the different solvent types, weren’t transferred into filters and just centrifuged for 
the same amount of time. Faecal water that had successfully passed through the filter was then 
aliquoted into two separate vials; for 1H NMR analysis and UPLC-MS analysis. As these samples were 
being acquired using  1H NMR analysis, the ACN was evaporated using speed vacuuming for 30 mins 
and re-suspended in 600l of phosphate buffer.  This was transferred to 5mm NMR tubes and 1H 
NMR spectra were acquired using the experimental parameters described in section 3.5. 
3.3.6. 1H NMR SPECTROSCOPY AND DATA PRE-PROCESSING 
1H NMR spectra were acquired on a Bruker DRX-600 spectrometer (Bruker Biospin, Karlsruhe, 
Germany) operating at 600.29MHz for proton observation using a standard one dimensional water 
pre-saturation pulse sequence [relaxation delay-90°-t1-90°-tm-90°-acquire free induction decay 
(FID)]. The relaxation delay was 4 seconds, with application of a 90° radio frequency pulse, t1, 
referring to the interpulse delay, which was set to 3µl, while tm is the mixing time of 100ms. The 
probe was matched and tuned automatically to the proton transmitter resonance frequency before 
acquisition for each sample and samples were run at a temperature of 27C (300K). 
Processing of 1H NMR spectra was carried out using TOPSPIN 3.1 software package (Bruker Biospin, 
Rheinstetten, Germany). The FIDs were transformed into a spectrum by Fourier transformation. The 
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spectra were manually phased, baseline corrected and calibrated to the TSP signal at δ0.0 for the 
urine and faecal samples and the glucose signal at δ5.25 for plasma samples.  
3.3.7. UPLC-MS GLOBAL PROFILING  
3.3.7.1. RP-UPLC-MS Analysis 
UPLC separation was conducted using an Acquity UPLC System (Waters Corp, USA) using an Acquity 
UPLC CSH C18 2.1 × 100 mm, 1.7 μm, column (Waters Corp, USA). Column temperature was set at 
45 °C and flow rate at 0.5 mL/min. Mobile phase A consisted of 0.1% formic acid in water and 
mobile phase B of 0.1% formic acid in ACN. The elution gradient was set as follows: 99% A (0.0−3.0 
min), 85% A (3.0−6.0 min), 50% A (6.0−9.0 min), 5% A (9.0−10.1 min; curve 1), 99% A (10.1−12 min). 
Injection volumes of 1 μL were used for both positive and negative ionization modes. The 
autosampler was set to 4 °C. Mass spectrometry was performed using a Xevo G2 QToF (Waters MS 
Technologies, U.K.) with an electrospray ionization (ESI) source. A Quality Control (QC) strategy was 
employed for the UPLC-MS analysis. This QC was produced from a pooled sample of all the urine 
extracts collected from the cotton wool balls and nappies. This sample was injected at least 10 
times before initiating the run, in order to condition the column. The QC was subsequently 
reinjected at the beginning of the run, every 5 sample injections, and finally at the end of the run to 
assess instrument stability and analyte reproducibility.  H2O experimental blanks as well as a pooled 
infant urine sample were injected at the very end of the run. 
3.3.7.2. HILIC-UPLC-MS Analysis  
Acquity UPLC BEH HILIC 2.1 × 100 mm, 1.8 μm, column (Waters Corp, USA) was also performed to 
maximise global profile coverage of metabolites. Column temperature was set at 40°C. Mobile 
phase A consisted of acetonitrile (ACN)/water (95:5) and mobile phase B ACN/water (50:50). In both 
solutions ammonium acetate was diluted to 10 mM final concentration (5%). The elution gradient 
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was set as follows: 99% A (0.0−2.0 min; 0.4 mL/min), 99−45% A (2.0−8.0 min; 0.4 mL/min), 45−1% A 
(8.0−9.0 min; 0.4 mL/min), 1% A (9.0−9.1 min; 0.4−0.6 mL/min), 1% A (9.1−11.1 min; 0.6 mL/min), 
1−99% A (11.1−11.2 min; 0.6 mL/min), 99% A (11.2−17.6 min; 0.65-0.9 mL/min), 99% A (17.6−17.7 
min; 0.7−0.5 mL/min), 99% A (17.7−20.0 min; 0.4 mL/min). An injection volume of 1 μL was used for 
both positive and negative ionization polarity modes. The autosampler was set to operate at 4°C. 
Mass spectrometry was performed using a Xevo G2 Q-TOF (Waters MS Technologies Ltd., UK) with 
an electrospray ionization (ESI) source. Finally, the same QC strategy was followed as for the RP-
UPLC-MS analysis with H2O experimental blanks and a pooled infant urine sample being injected at 
the end of the run. 
3.3.8. DATA PROCESSING AND MULTIVARIATE DATA ANALYSIS 
3.3.8.1. 1H NMR Data processing 
The spectral data (from δ0.5 to 9.5) were imported into Matlab software (version 2014a, the 
Mathworks Inc, MA, USA) and were transformed into 32K data points. Resonance of the water (δ4.7 
-5.05) was also removed from each spectra. Each 1H NMR spectrum was aligned using an in-house 
algorithm and normalised using Probalistic Quotient Normalisation (PQN) in order to remove 
variation in metabolite linked to osmolarity and dilution (Dieterle et al 2011).  
3.3.8.2. Data Extraction for UPLC-MS  
Data collected following HILIC and RP-UPLC-MS analysis (both positive and negative) were subjected 
to peak-picking and grouping using MarkerLynx XS (Waters Inc., v4.1) software. Samples were 
normalized to median fold change and filtered once again using coefficient of variation in the QC 
samples; this removed features with low repeatability within the QC samples run throughout the 
experiment. The remaining features were produced into a table and imported into SIMCA-P 14 
software (Umetrics, Umea, Sweden). The most relevant features or metabolites in pair-wise models 
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from MS data were flagged by using S plots; the top 10 significant features which cause the 
separation in the model was taken to be identified. 
3.3.8.3. 1H NMR and UPLC-MS metabolic data analysis 
Multivariate statistical models (PCA, OPLS, OPLS-DA) were performed in Matlab software (version 
R2014b, the mathworks Inc, MA USA) and SIMCA-P 14 software (Umetrics, Umea, Sweden) using UV 
scaling. The Q2Y value was determined by plotting the score against the cross validating scores to 
estimate the goodness of fit and level of over fitting of the OPLS and OPLS DA models. All models 
were validated by multiple permutation tests (permutation number =100). (see Methods Chapter 
for further details) 
  
 
 
 77 
3.4. RESULTS 
3.4.1. 1H NMR SPECTROSCOPY BIOFLUID METABOLIC PROFILES WITH DILUTION 
FACTORS   
3.4.1.1. Urine Dilution Series 
The urine 1H NMR spectra obtained from an individual infant, with each spectrum corresponding to 
a different dilution factor and run at the same number of acquisitions are shown in Figure 2a. 
Samples were both subject to the same number of NMR acquisitions as well as increasing the 
number of acquisitions to correspond with the dilution series. To adjust for this difference in 
acquisitions and therefore intensity of signals, the same amount of the internal standard, TSP, was 
added to all of the samples. By scaling the NMR spectra - which had increasing scan length- to the 
integral of the TSP peak at δ0.0, this correctly adjusted and calibrated the spectra of all of the 
samples to its relative intensity (supplementary - Figure S3) (Spagou et al 2010; Hoult et al 1976).   
These results indicate that after adjustment for the number of scans to account for differences in 
signal to noise, there was little visual effect of dilution on the NMR spectral signal intensities (Figure 
3-2b).  The main difference seen in samples is an increased peak at δ1.25, which has been identified 
as the contaminant tert-butanol. This molecule has been seen in a number of different cases within 
the department including from the nappy contamination, which is discussed later in section 4.3.1 of 
this chapter. It is believed that this molecule is present in the phosphate buffer, which is used to 
balance the pH in biofluids for NMR analysis. However, as all of the samples had the same amount 
of phosphate buffer added before analysis but variable amounts of distilled water, it can be 
concluded this contaminant is present in the water also.   
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The dilution factor was shown to affect the computational models derived from the spectral data 
when non-normalised spectra were used, suggesting that dilution has a physicochemical effect on 
the observation of certain metabolite signals. In the Principal Components Analysis (PCA) scores 
plot the dilution factor here, indicated by colour, the clustering of the samples from the five infants 
studied, which are indicated by different symbols, was affected (Figure 3-3a). There is a larger 
observable difference between individuals when the samples were more dilute as this was the 
biggest effect causing the separation in the model.  
Figure 3-2 a) 1D 1H NMR urinary dilution series spectra from one infant, with the same number of 
acquisitions (32 scans). b) 1D 1H NMR spectra from one infant with dilution series with increasing 
number of acquisitions as dilution increases. Key: Dilution series: i)68µl, ii) 135µl, iii)270 µl, iv) 
520 µl of urine 
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a) 
Figure 3-3 a) PCA of dilution series: R2X =0.985 (First component accounts for 84% of the total 
variance), Q2X(cum) =0.941, b) PCA of normalised diluted infant samples: R2X =0.5 (First 
component accounts for 32% of the total variance), Q2X(cum) =0.29 – colours represent 
dilution series, i) Blue, 520 µl, ii) Red, 270 µl, iii) Green, 135µl, iv) Purple, 68µl. Shapes 
represent different individual infants 
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Once normalisation was applied, the effect of dilution (Figure 3b) is reduced and clear inter-
individual differences between the infants become apparent at all dilution factors, with the 
exception of two infants whose profiles were largely superimposed in the first two components (as 
indicated by the squares and stars) showing that the effect of dilution on the spectroscopic profile 
can be largely resolved with spectral pre-processing. For one infant represented by diamond 
symbols, the effect of urinary dilution was still clearly visible. This particular infant had the lowest 
creatinine to noise ratio, suggesting that the urine sample from this individual was the most dilute 
to begin with (Figure 3-4). From Figure 3-3b, it is clear that if samples are already dilute, dilutions 
less than half the original volume would be the most appropriate dilution factor for the best 
recovery of metabolic data. It is critical that all samples in a sample set are treated to the same 
dilution factor to gain reliability in the data.   
 
3.4.1.2. Plasma Dilution Series 
When infants are born they are subject to a number of different screening tests using their blood 
(Pitt 2010). A small quantity of blood is obtained on a specific filter paper, and is tested for diseases 
including Sickle Cell Disease and Cystic Fibrosis. The spot of blood is punched out of the filter card 
and eluted in buffer for analysis; this is believed to be the equivalent of 3-5µl/500ml concentration 
(Mei et al 2001). It is necessary to limit the amount of blood drawn from babies, particularly in the 
Figure 3-4. 1H NMR 
spectra of creatinine 
(δ3.05) in urine from 5 
infants (different 
colours) to determine 
original concentration 
of urine samples.  
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case of preterm infants. To utilise this resource, investigation of detection limits of plasma was 
conducted to evaluate the use of limited amounts of plasma for metabolic profiling by 1H NMR 
spectroscopy.      
Plasma gives us a metabolic picture of the circulating metabolites from areas around the body for a 
given moment in time. The composition of plasma is very diverse and includes both low weight 
metabolites and macromolecules such as lipids (Beckonert et al 2007). It is intrinsically sparser, in 
terms of small molecules, compared to urine and faeces.  
The plasma 1H NMR spectra obtained from an individual sample, with each spectrum corresponding 
to a different dilution factor, is shown in Figure 3-5. Samples were subject to both the same number 
of NMR scans as well as an increasing number of scans to adjust for the dilution series. To adjust for 
this difference in scans and therefore intensity of signals, samples were scaled to glucose (δ5.23). As 
the number of scans increased this adjusted the spectrum of all of the samples.  
These results indicate that after adjustment for the number of scans, to account for differences in 
signal to noise, there was little visual effect of dilution on the NMR spectral signal intensities (Figure 
3-5b).  As mentioned previously in the urine limits results, a difference seen in the dilution samples 
is the peak at δ1.25, which we have identified as the contaminant tert-butanol, increases as 
dilutions increase. Further to this, there is a peak at 3.38, which increases as the samples become 
more dilute. This unknown metabolite is only present in plasma samples and suggest this 
metabolite could have been protein bound in the less dilute samples. 
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Figure 3-5 a) 1H NMR CPMG plasma spectra from one infant with dilution series in effect with 
the same number of scans. b) CPMG 1H NMR plasma spectra from one infant with dilution 
series with increasing number of scans as dilution increases. Dilution series: i)38µl, ii) 75µl, 
iii)150 µl, iv) 300 µl  
 
 
 
 83 
 
Figure 3-6 a) PCA of 1H NMR CPMG plasma dilution series: R2X=0.67, Q2X(cum) =0.578,  b) 
PCA of 1H NMR CPMG normalised plasma diluted infant samples: R2X =0.55, Q2X(cum) 
=0.326 – colours represent dilution series, i) Blue, 300 µl, ii) Red, 150 µl, iii) Green, 75µl, 
iv) Purple, 38µl. Shapes represent different individual infants 
 
a) 
b) 
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The PCA scores plot (Figure 3-6a) shows how the dilution series can affect the plasma samples, even 
after an increase of scans to accommodate the dilution effect are introduced. Similar to the urine, 
the largest observable cause of variation in the data was caused by the dilution of the samples. 
From the raw spectral data, we have confirmed that there are some contaminants within the 
samples, which are at a higher concentration in the more dilute samples. Furthermore, as the 
dilution series increased it was harder to suppress the water signal in the spectra; the difficulty of 
suppressing the water strongly in the more dilute samples influenced the model in this experiment 
greatly.  
By normalising the data, the effect of dilution on the model is greatly reduced (Figure 3-6b), and 
clear inter-individual differences can be recognised. This observed effect is not as strong in the 
plasma compared to the urine; four of the individuals have very similar plasma metabolic profiles 
where one individual (shown as triangles) separates in the model. When looking back at the raw 
data, this individual has higher relative concentration of lipids in their plasma when compared to 
the other participants, which explains this difference.  
3.4.1.3. Faecal Water Dilution Series 
Faecal water is extracted from faecal samples in a number of different ways and the optimisation of 
this technique will be discussed later in this chapter; section 4.4.  The first point of focus will be on 
chemical detection limits with respect to this biofluid. Faecal water gives us an insight into not only 
the metabolites from our diet and biochemical events, but also from the microbiome, residing 
within the gastrointestinal tract (Saric et al., 2007; Jacobs et al., 2008).  Thus, it enables us to study 
the interaction between the gut microbiome and host more closely (Nicholson et al., 2012).  It is 
increasingly apparent that this knowledge is especially important in early life as the gur microbiome 
are involved in infant development, including the immune system.  
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The faecal water 1H NMR spectra obtained from an individual sample defined by a dilution series, 
with each spectrum corresponding to a different dilution factor, is shown in Figure 3-7. Samples 
were subject to both the same number of NMR scans as well as increasing the number of scans to 
correspond to the adjustment factor necessary to accommodate the dilution series.   
 
As mentioned previously, a difference seen in the dilution samples is the peak at δ1.25, which was 
identified as the contaminant tert-butanol, which increased as the dilution factor increases. There is 
an increase signal at δ0.88, δ2.23 and δ8.46, which have been identified as iso-butanol, acetone and 
Figure 3-7 a) 1D 1H NMR faecal water spectra from one infant with dilution series in effect with 
the same number of scans. b) 1D 1H NMR faecal water spectra from one infant with dilution 
series with increasing number of scans as dilution increases. Dilution series: i)25mg, ii) 50mg, 
iii)100 mg, iv) 200 mg. Key: 1. Iso-butanol (δ0.88), 2. Tert-butanol (δ1.25), 3. Acetone (δ2.23) 
and 4. Formate (δ8.46)   
 
1 
2 
3 
4 
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formate respectively. These metabolites are also known to be contaminants of biofluids for 
metabolic phenotyping. Formate, which can be endogenous, is also known to be related to the gut 
microbiome, this co-metabolite may indicate that there was microbial activity during the NMR run; 
especially as the increase in scans causes the experiment to be much longer in length.  
The PCA scores plots (Figure 3-8a) shows how the dilution series can affect the faecal samples, even 
after an increase of scans are introduced. From what we can observe, similar to the urine, the 
largest observable variation in the data can be attributed to the dilution of the samples. From the 
raw spectral data, we have confirmed that there are some contaminants within the samples are at a 
higher concentration in the more dilute samples.  
By normalising the data, the effect of dilution on the model is greatly reduced (Figure 3-8b), and 
clear inter-individual differences between individuals can be recognised. Normalisation can clearly 
be seen in the individuals depicted as squares as their scores cluster together, indicating that their 
1H NMR spectra are extremely similar. Interestingly, individuals depicted as diamonds and stars 
have very similar faecal metabolic profiles to each other.  
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Figure 3-8 a) PCA of dilution series: R2X =0.78, Q2X(cum) =0.562, b) PCA of normalised diluted infant 
faecal samples: R2X =0.488, Q2X(cum) =0.31 – colours represent dilution series, i) Blue, 200mg, ii) 
Red, 100mg, iii) Green, 50mg, iv) Purple, 25mg. Shapes represent different individual infants 
 
  
 
b) 
a) 
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3.4.2. AGE VARIABILITY IN INFANT URINE PROFILES 
The urinary 1H NMR spectral profiles of infants at the time of birth are consequently very similar to 
urinary samples collected from the mother at the same time (Figure 3-9a). The similarities are 
particularly clear in the aromatic region of the NMR spectra, where there is higher relative 
concentration of hippurate (3.95) and phenylacetylglutamine (2.14, 2.46, 3.77, 7.35) in the 
infant sample obtained at birth than one would expect, given that many papers report an absence 
of signals in the spectral window of infant urine where phenolic and other aromatic molecules 
would be expected to arise. From the literature, microbiome colonisation of the infant gut largely 
begins at birth and that over a period of time as the symbiotic gut bacteria evolve, there is an 
increase in molecules such as hippurate, phenylacetylglutamine (PAG), indoles and methylamines 
(Holmes et al 2011). Here the urine sample obtained immediately at birth, hippurate (3.95), 4-
cresylsulfate (2.22) and PAG (2.14, 2.46, 3.77, 7.35) are found in the infant urine in similar 
concentrations to the maternal urine. However, some differences between maternal and infant 
urine composition are visible at this initial sampling point, including the presence of higher 
concentrations of trimethylamine (TMA- 2.28)  and formate (8.45) with lower concentrations of 
methylhistidine (6.93, 7.69). 
After two weeks (Figure 3-9(c)), the infant’s urine spectrum has become more dilute compared to 
the mother’s urine.  The most striking difference between these spectra is that there is much less 
creatinine and no hippurate with a reduction in the excretion of most aromatic compounds in the 
week two sample from the infant compared to the birth sample. This reinforces the observation of 
the close relationship between the mother and foetus exchange of nutrients and waste products 
during pregnancy and immediately postpartum which dissipates over the first few days. At this 
time, betaine (3.25, 3.89) is also found in higher concentrations in the neonatal urine compared 
to the maternal or infant urine samples taken later postpartum.  
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Figure 3-9: Mother – Baby Urine match 1D 1H NMR Spectra showing the age variability from birth 
until 14 months postpartum. a) Mother b) Birth c) 2 weeks d) 8 weeks and e)14 months. 1. Valine 
(δ0.99 –CH3; δ 1.04 –CH3); 2. Lactate (δ1.33 -CH3; 4.11 -CH); 3. Alanine (δ1.47 -CH3); 4. Acetate (δ 
1.92 –CH3); 5. Uromodulin (δ2.06 –CH2) 6. Succinate (δ2.42 -CH2); 7. Phenylacetylglutamine (PAG) 
(δ 2.14 –CH2; δ2.46 -CH2; δ3.77 -CH2; δ7.35 (–CH)3); 8. Citrate (δ2.55 -CH2; δ2.66 –CH); 9. Creatine 
(δ3.02 -CH3 (overlapped with creatinine); δ3.92 -CH2) 10. Proline betaine (δ3.11 -CH3; δ3.30 -CH3); 
11. Trimethylamine-N-oxide (δ3.25 -CH3); 12. Glycine (δ3.55 -CH2); 13. Hippurate (δ3.95 -CH); 14. 
N-methylnicotinamide (δ4.48 -CH); 15. Fumarate (δ6.53 -CH3); 16. Urocanic acid (δ6.65); 17. 
Formate (δ8.45 -CH); 18. Propylene glycol (δ1.14 -CH3); 19. Tert-butanol (δ1.25 -CH3); 20. Acetone 
(δ2.24 -CH3); 21. Methylguanidine* (δ2.23 -CH3); 22. Trimethylamine (δ2.28 -CH3); 23. Creatinine 
(δ3.05 -CH3; δ4.06 -CH2); 24. Betaine (δ3.25 (-CH3)3; δ3.89 -CH2); 25. 4-cresol sulphate (δ2.22 -
CH3; δ7.11 –CH; δ7.18 -CH); 26. 2-oxoglutarate (δ2.42 -CH); 27. Dimethylamine (δ2.72 -CH3); 28. 
Dimethylglycine (δ2.93 -CH3); 29. 3-methyl-histidine (δ6.93 -CH; δ7.69 -CH). *tentative 
assignment 
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At 8 weeks (Figure 3-9(d)), the infant’s urine spectrum is still dilute compared to the mother’s urine 
and very similar to the sample taken after two weeks. Creatinine (3.05, 4.06) levels have 
increased slightly and betaine (3.25, 3.89) is still high in this early sample. At this age, infants are 
being fed a milk based diet (whether it be breast milk or formula milk) and co-metabolites produced 
from gut microorganisms in the aromatic region are low except for formate (8.45). Glycine (3.55), 
an essential amino acid, is also elevated in this sample which could indicate an increased dietary 
consumption.  
At 14 months (Figure 3-9(e)), the infant will have grown considerably and be weaned onto solid 
foods as well as have a larger bacterial diversity in their gut microbiome, which may contribute to 
their metabolism and therefore their urine metabolic profile. The 1H NMR spectra taken at 14 
months postpartum shows a higher concentration of creatinine (3.05, 4.06), which is related to 
muscle mass, as well as other metabolites (e.g hippurate and PAG) found in the aromatic region, 
which are co-metabolites produced from gut microorganisms.   
3.5. NAPPY AND COTTON WOOL CONTAMINATION ON INFANT URINE METABOLIC 
PROFILES  
3.5.1. Cotton wool and nappy contamination 
Visual comparison of the 1H NMR spectra, obtained from blank water infused cotton wool samples, 
were assessed for chemical contaminants (Figure 3-10). From cotton wool, the major contaminants 
were identified as acetate (δ1.92 (-CH3)), acetone (δ2.23 (-CH3)), formate (δ 8.46 (-CH)), citrate 
(δ2.55(-CH2), δ2.66(-CH2)) and propylene glycol (δ1.14 (-CH3), δ3.4 (–CH), δ3.6 (–CH), δ3.9, (-CH2)), 
tert-butanol (δ1.25 (CH3)), iso-butanol (δ0.88 (-CH3)) as well as a peak at δ6.02 (currently 
unidentified).  Metabolite identification was assisted by our in-house database, together with the 
aid of 2-D 1H-1H COSY; a dotted line representing propylene glycol identification in Figure 3-10b.  
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Furthermore, despite the introduction of contaminants from the cotton wool, the urine profiles 
were highly similar and a change in citrate (2.55, 2.66) concentration was the only visual 
difference in endogenous compound concentration after urine had been extracted from the cotton 
wool, which suggests that citrate may be partially retained in the cotton wool. Furthermore, the 
citrate signals became broader after treatment with cotton wool which also suggests that there was 
binding of this metabolite (Figure 3-10(c)).   
Different cotton wool brands contained variable concentrations of these metabolites; for example, 
it can clearly be seen there is a lower concentration of formate in the ‘Boots’ own brand cotton 
wool compared to the other cotton wool brands (Figure 3-11). However, this brand has a much 
higher concentration of acetate compared to the cotton wool in other brands tested.  Whereas all 
cotton wool samples emitted the same amount of acetone into the urine, the ‘Sainsburys’ own 
brand cotton wool leached higher amounts of tert-butanol. However, overall, the qualitative 
presence of the metabolites was consistent between all the brands of cotton wool. 
Contaminants from nappies included propylene glycol (δ1.14 (-CH3), δ3.4 (–CH), δ3.6 (–CH), δ3.9     
(-CH2)), N, N-dimethylacetamide (δ2.1 (-CH3), 2.9 (-CH3), 3.1 (-CH3)) ethylene glycol (δ3.7 (-CH)), tert-
butanol (δ1.25 (-CH3)), isobutanol (δ0.88 (CH3)); as well as acrylic acid (δ5.76, δ6.02, δ6.11) and 
propionate (δ2.19 (-CH2), δ1.06 (-CH3) (Figure 3-10a).  Similar to what was observed with the 
different brands of cotton wool, different amounts of the contaminants were seen between the 
different brands; including higher concentrations of acetone in Libero nappies and higher amounts 
of tert-butanol in the Pampers brand (Figure 3-12). Furthermore, the Tesco nappy own brand, had 
higher amounts of the unknown metabolite at δ6.02. However, acrylic acid was only seen as a 
contaminant in the Pampers brand of nappy and not within the other two brands tested in this 
investigation. A nappy’s absorbent core is predominantly derived from a polymer made from very 
small particles of acrylic acid derivatives, giving its highly absorbent nature and seen in top market 
brands of nappy (e.g. Pampers).  
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Figure 3-10: a) 1D 1H NMR spectra from cotton wool (red spectrum) and diaper blanks (green 
spectrum), Key: 1. Isobutanol (δ0.88 -CH3); 2. Propylene glycol (δ1.14 -CH3; 3.43 -CH2; 3.53 -CH2; 
3.87 -CH); 3. Tert-butanol (δ1.25 -CH3); 4. Acetate (δ1.92 -CH3); 5. N, N-dimethylacetamide (δ2.1 -
CH3; δ2.9 -CH3; δ3.1 -CH3); 6. Acetone (δ2.23 -CH3); 7. Acrylic Acid (δ5.76 –CH; δ6.02 –CH; δ6.11 -
CH); 8. Unknown metabolite (δ6.02); 9. Formate (δ8.46 -CH); 10. Ethylene glycol (δ3.7 –CH); 11. 
Propionate (δ2.19 -CH2; δ1.06 -CH3); b) 2D COSY 
1H NMR spectra, dotted line depicting Propylene 
glycol (δ1.14 -CH3; 3.43 -CH2; 3.87 -CH); c) 1D 
1H NMR partial spectra (δ1.85 - δ2.75) from cotton 
wool which have been subject to freeze-thaw cycles; i) urine extracted from cotton wool and  
subject to one freeze thaw cycle; ii) urine extracted from cotton wool after one freeze thaw cycle; 
iii) urine extracted from cotton wool and acquired immediately; iv) control blank urine. Key: 1. 
Acetate (δ1.92), 2. Acetone (δ2.24), 3. Citrate (δ2.55, δ2.66), and 4. Dimethylamine (δ2.72).  
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Nappies are made of highly absorbent polymer structures including polypropylene and acrylic acid 
derivatives to ensure as much liquid is retained in them as possible. From Figure 3-12, the nappy 
and cotton wool profile are comparably different, with nappies leaching more polymer metabolites 
into the urine and causing higher amounts of contamination than cotton wool. The high 
concentration of PEG in these samples masks the urinary biological profile making analysis very 
difficult.  
 
 
Figure 3-11. 1D 1H NMR spectra of a QC urine sample and from the same urine subject to 
processing through five different cotton wool brands. a) Hospital brand – Robinson’s, b) 
Boots c) Tesco, d) Sainsburys, and e) original urine sample without cotton wool 
contamination. 1. Tert-butanol (δ1.25), 2. Acetate (δ1.92), 3. Acetone (δ2.23) and 4. Formate 
(δ8.46).  
 
e) 
d) 
c) 
b) 
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a) 
b) 
c) 
d) 
Figure 3-12. 1D 1H NMR spectra of a QC urine sample and from the same urine subject to processing through three different nappy brands. a) Pampers 
nappy, b) Libero nappy, c) Tesco nappy, d) blank urine.  
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Similar results were obtained for the UPLC-MS analysis, with the addition of high concentration of 
polyethyleneglycol (PEG) and other polymers (Figure 3-13). Cotton wool is a natural fibrous material 
and a high amount of PEG was observed in the sample, especially when running HILIC 
chromatography in positive ionisation mode.   
 
3.5.2. Contamination from cotton wool preparation  
To extract the urine from the cotton wool for analysis, the cotton wool was either squeezed 
manually or centrifuged using the apparatus depicted in supplementary material (Figure S2). The 
cotton wool, which had been squeezed to extract the urine, had a much higher concentration of 
acetone (δ2.24), tert-butanol (1.25), and iso-butanol (0.88) (Figure 3-14) than the urine obtained 
via centrifugation. This suggests that manually squeezing the cotton wool results in greater 
destruction of the cotton wool fibres and therefore releases more contaminants into the urine 
Figure 3-13 a) Base Peak intensity (BPI) chromatogram from RP UPLC-MS (ESI+) - cotton 
wool (red) and diaper blanks (green) 1. Polyethylene glycol (PEG) b) Base Peak intensity (BPI) 
chromatogram from HILIC UPLC-MS (ESI+) - cotton wool (red) and diaper blanks (green) 1. 
Polyethylene glycol (PEG) 
a) 
b) 
1 
1 
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sample.  This further underlines the need for better defined standard operating procedures and 
materials within this research area.  
The effect of freezing the urine sample in the cotton wool prior to extraction was further assessed 
and compared with obtaining urine fresh from the cotton wool ball. No obvious differences in the 
level of chemical contamination or endogenous profile were found. Therefore, freezing the cotton 
wool directly after collection at -80 °C is an acceptable practice when collecting urine from infants.  
 
 
 
 
 
Figure 3-14. Correlation coefficient plot by two groups; cotton wool squeezed 
(negative) vs centrifuged (positive) coloured by colour intensity. This plot highlights 
the discriminatory metabolites for these two groups. 1) isobutanol (0.88), 2) tert-
butanol (1.25), 3) acetone (2.23) 
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3.6. OPTIMISATION OF FAECAL WATER EXTRACTIONS FOR 1H NMR SPECTROSCOPY 
3.6.1. Freeze-thawing of faecal material 
Aliquots from a well-homogenised individual sample were taken and were subjected to different 
thawing cycles to establish the optimum method. By thawing the sample at least once, the 
concentration of metabolites increases and the highest concentration of metabolites can be seen 
after two freeze-thaw cycles (Figure 3-15). Interestingly, after three cycles of freeze thawing, the 
sample had a lower concentration of metabolites, which could be due to degradation of the sample 
in the last freeze thaw cycle.  
3.6.2. Homogenisation techniques 
In this investigation, four different extraction processes were used; 1) vortexing, 2) bead beating, 3) 
pestle homogenisation in microcentrifuge tube and 4) liquid nitrogen homogenisation using pestle 
and mortar. Other recommended extraction processes, including freeze drying and tissue lysing, 
were not included in this investigation, as they required excessive disruption of the sample 
including stabilising with acid and alkaline solutions and therefore not suitable for high throughput 
investigations.  
In Figure 3-16, the 1H NMR spectrum shows that the bead beating technique was able to extract the 
highest relative concentration of metabolites. For bead beating (Figure 3-16d), the added density to 
the sample in the form of the beads and the uniformity of the beating technique improves the 
homogenisation. Examination of acquired raw spectra revealed that the same biochemical 
information was obtained from each of the extraction processes.  The vortex technique produced a 
considerably lower concentration of metabolites (Figure 3-16e). Vortexing the sample to extract 
faecal water isn’t as strong a method at homogenising the sample compared to the other methods 
tested here.  
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No thaw 
1 x thaw 
3 x thaw 
2 x thaw 
a) 
b) c) 
Figure 3-15: 1D 1H NMR spectra of 
infant faecal water extractions 
after different freeze-thaw cycles. 
No thawing of sample, Freeze 
thawing cycles once, twice and 
three times. (a) Full spectra 
separate (b) overlaid full spectra 
and (c) lysine (δ3.02 (q)).  
 
ppm (δ) 
(ppm) (ppm) 
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Figure 3-16: 1D 1H NMR spectral data of infant faecal water extractions in buffer. Different extraction methods in Buffer at 250mg (a) 
Centrifuge only (b) Pestle Homogenisation (c) Liquid Nitrogen (d) Bead beating (e) Vortex 
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The most robust techniques for faecal water extraction are bead beating and liquid nitrogen 
homogenisation techniques. Spectra from the bead beating generally had a higher concentration of 
metabolites; this increase was especially true for carbohydrate metabolites (δ3-5). However, liquid 
nitrogen homogenisation spectra had higher concentrations of the metabolites butyrate (δ1.56), 
prolinebetaine (δ3.11) and a species of bile acid (δ0.73). There are also some shift differences in the 
spectra between the two techniques which could be an indication of a difference in pH. Both 
techniques use mechanical homogenisation, however bead beating has a higher throughput for 
screening processes potential.  
Additionally, to these extraction processes, investigation of the extraction of faecal water from the 
sample without any interference except for centrifuging was performed. In Figure 3-16a, the 1H 
NMR spectra show that by centrifuging only, information can still be gained from the sample, 
however the amount of signal recovery is much less in terms of concentration of metabolites 
compared to other extraction techniques. Therefore, a centrifugation only protocol may be an 
option if the sample is needed for further investigation using different analytical platforms and it 
would be beneficial to have no previous treatment of the sample. This, however, is not optimal and 
challenging for high throughput techniques. 
Acquired NMR spectral data were analysed using PCA scores plot (Figure 3-17), where the samples 
are coloured by extraction method and revealed separation between the different extraction 
processes. Pestle and liquid nitrogen homogenisation appeared to be very similar as their spectral 
profiles were closely clustered in the scores scatter plot, whereas bead beating and vortexing 
techniques have the highest separation from the rest of the sample, indicating that the spectral 
profile of faecal water extracted, following these two techniques, was different. Reviewing the raw 
individual spectra, the concentration of metabolites are different, but there are no additional 
metabolites from the different homogenisation techniques.  
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Interestingly, the centrifugation only method generated very similar information from the spectra 
to the rest of the extraction methods and suggests that this method does not loose information to 
cause it to lose reproducibility.  
 
Figure 3-17: Multivariate analysis of faecal water extraction samples using PCA. R2(X) =0.80, Q2(cum) 
=0.562. Different colours represent different faecal water extraction techniques; Green = Vortex, 
Blue=Beadbeating, Red=Liquid Nitrogen, Yellow=Pestle homogenisation, Purple=Centrifugation 
only. 
3.6.3. Solvent extraction  
Whilst investigating the extraction methods, extracting into different solvents was also investigated; 
including deionised water, D2O, phosphate buffer and phosphate buffered saline (PBS). Jacobs et al 
(2008) compared extracting faecal samples using water and methanol; they discovered that by 
extracting by methanol it optimised the extraction of lipids and water was optimal for extraction of 
Vortex 
Bead Beating 
Liquid Nitrogen 
Pestle h’genisation 
Centrifuge only 
 
Faecal water extraction (PCA) Different extraction methods
t[2
]
-100
-80
-60
-40
-20
0
20
40
60
80
-400 -300 -200 -100 0 100 200 300
t[1]
R2X[1] = 0.746                R2X[2] = 0.0491               Ellipse: Hotelling's T2 (95%) 
1
2
3
4
6
 
 
 102 
amino acids and sugars; as lipids are not the metabolite class of interest for this project methanol 
was not explored in this investigation.  
From the raw NMR spectra (Figure 3-18), it can be seen that by using different solvents, the 
concentration and resolution of peaks in the NMR spectra is varied. Interestingly, phosphate buffer, 
which is commonly used for metabolic profiling by NMR, recovered the lowest concentration of 
metabolites.  
Figure 3-18: Multivariate analysis of faecal water extraction samples using PCA. R2(X) 
=0.80, Q2(cum) =0.56. Different colours representing different solvent extractions for 
faecal water: Green =water (H2O), Blue = Phosphate buffer, Red = Deuterated water (D2O) 
and Yellow = Phosphate Buffered Saline (PBS) 
 
Water 
Buffer 
D2O 
PBS 
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Figure 3-19: 1D 1H NMR spectra of infant faecal water extractions using 
different solvents in bead beating extraction technique using 250mg mass; 
Phosphate buffer, Phosphate Buffered Saline (PBS), D2O and Water.  a) Full NMR 
spectra, b) partial NMR spectra δ3.0 - 4.0 - Extracted solvents: i) phosphate 
buffer, ii) Phosphate Buffered Saline (PBS), iii) deuterated water (D2O) and iv) 
water (H2O) 
i) a) 
ii) 
iii) 
iv) 
b) i) 
ii) 
iii) 
iv) 
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During the faecal water extractions, it was observed that when extracting into solvents that were 
deuterated, there were large particles present in the sample, which floated to the top over time. 
This suggests that may be some larger macromolecules, which are unable to dissolve in deuterated 
solvents and could cause some smaller molecules to bind to them. These are thus undiscoverable by 
metabolic profiling and can cause technical problems with the acquisition of 1H NMR data due to 
the lack of homogeneity of the sample; this is cause for concern when using 100% deuterated 
solvents for extraction purposes.  
Water extracted the highest concentration of metabolites and had the best resolution in the NMR 
spectra. However, for dilute samples an important instrumental challenge is optimal suppression of 
the water peak. If the correct position of the water peak has not been offset, the method may not 
be amenable to automation, which is not ideal for a large sample set and high throughput 
experiments.  However, by using a non-deuterated solvent such as water to perform the faecal 
water extraction, the sample is not compromised for analysis by other platforms including liquid 
chromatography-mass spectroscopy. 
In Figure 3-19, the PCA scores plot is coloured by the different solvents that the faecal sample was 
extracted into; the close clustering of samples reveals that there is not a significant difference in 
faecal water metabolic profile, following extraction using different solvents, although extraction 
into buffer gave the most variable results. 
3.6.4. Faecal water extraction for UPLC-MS techniques 
Infant samples are particularly valuable as samples volume can be difficult to predict especially for 
infants born preterm. As 1H NMR and UPLC-MS techniques are ideal for metabolic profiling of 
biofluids to gain complementary data from the same sample it was important to produce a protocol 
to extract faecal water for both analytical techniques using one faecal sample.  
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For UPLC-MS, the use of organic solvent is important in biofluid preparation to ensure the 
precipitation of proteins from the sample. From previous work into the optimisation of solvent 
extractions for faecal samples, H2O was found to extract the highest volume of metabolites and 
produce the best resolution 1H NMR spectra. Therefore, a sample that was extracted using ACN:H2O 
was compared to the same sample extracted using H2O only. From the results in Figure 3-20b & 3-
20e, there was no differences in the raw 1H NMR spectra in metabolite extraction or resolution.  
 
Also, as samples which contain organic solvent need to be evaporated and reconstituted before 
they can be analysed using NMR , the same aliquot extracted using H2O was compared using speed 
vacumning compared to the same sample which hadn’t been subject to speed vacumning. From the 
results shown in Figure 3-20c & 3-20d, there was no differences in the raw 1H NMR spectra in 
metabolite extraction or resolution. After this investigation, it was decided that evaporation under 
nitrogen gas would be more appropriate for high throughput studies.  
Figure 3-20: 1D 1H NMR spectra of infant faecal water extractions using a) Acetonitrile:H2O 
(1:3, ACN:H2O), filtered and speed vacuumed; b) a) Acetonitrile:H2O (1:3, ACN:H2O), non-
filtered and speed vacuumed; c) H2O, filtered and speed vacuumed; d) H2O, filtered; e) H2O, 
non-filtered. Key: 1. Methanol, δ3.36 
 
 
 
 106 
Furthermore, samples undergoing UPLC-MS analysis, need to be passed through a 0.2m filter. 
Therefore, the same faecal sample from both solvent extraction techniques were subject to filtering 
and not filtering before analysis.   From the results in Figure 3-20, the sample which had not been 
filtered or speed vacumned had retained the metabolite methanol (δ3.36). This metabolite is very 
volatile so this is not surprising but other volatile metabolites, including SCFAs weren’t affected. 
Therefore, this method was accepted for ease of high through put and minimal sample volume.  
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3.7. DISCUSSION 
This chapter has demonstrated the need for standardisation of biofluid collection and preparation 
in new-born and infant studies. Infant biofluids are a valuable resource to understand the 
development of the new-born infant after birth, therefore it is very important to prepare them 
correctly so that as much reliable information as possible can be obtained. 
3.7.1. EFFECTS OF DILUTION FACTORS AND NORMALISATION IN INFANT BIOFLUIDS 
METABOLIC PROFILES  
From these results, it is clear that metabolic information can be gathered from small amounts of 
sample volume for metabolic profiling using 1H NMR spectroscopy and UPLC-MS. However, as the 
sample volume decreases the amount of specific biochemical information from the sample also 
decreases. Also, from the different biofluids assessed in this chapter, it is apparent that 
contamination is still a very clear problem for metabolic profiling and by introducing solvents to 
biofluids this can easily introduce complications to a dataset. A more accurate way of controlling 
differential concentrations between samples would be to ensure that all samples were adjusted for 
osmolality prior to analysis. However, this would introduce an extra time constraint and potential 
for human error, especially with larger projects. 
Another factor to consider is that as the volume of sample decreases, the amount of FIDs acquired 
in each experiment increased, and therefore the length of the experiment increased, which reduces 
the efficiency of the metabolic screening process. This time was taken in consideration when the 
final protocol was produced, especially as longer experimental times are impractical for high 
throughput of samples and make huge demands on equipment resources.  
From the results, it was clear that metabolic profiles from urine samples at half the recommended 
volume could be used in studies if necessary. With the increased number of scans and the use of 
normalisation techniques, samples give useful metabolic data.  
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For this investigation plasma samples from infants was unfortunately too difficult to obtain and 
therefore adult plasma was used. Due to this, it is difficult to conclude if infant plasma samples are 
appropriate for metabolic profiling. Further investigation into the use of infant dried blood spots for 
1H NMR analysis for metabolic profiling would be very advantageous.  Furthermore, plasma samples 
in this investigation showed that water suppression issues and biological interactions attributed to 
protein binding make this biofluids more complicated when diluted.  
Faecal samples act similarly to urine samples when a smaller mass is used. It is clear that half the 
recommended amount of faecal sample can be used (100mg), combined with a higher number of 
scans, when acquiring using 1H NMR. Furthermore, from the results, good metabolite recovery is 
found in samples at a quarter the recommended amount of faeces for extraction also (50mg). 
Therefore, samples at very low volumes can be acquired using 1H NMR if necessary; this is promising 
for infant studies where this would be a common issue.  
3.7.2. AGE VARIABILITY AN IMPORTANT FACTOR WHEN ASSESSING INFANT 
METABOLIC PROFILES  
Throughout pregnancy the developing foetus relies on the mother for nutrient uptake, waste 
removal and gas exchange and therefore will demonstrate strong similarities in the metabolic 
profile (Tea et al 2012; Lager et al 2012). Regularly timed urine samples from infants, taken at birth 
through the neonatal period and onto infancy, highlights the high variability in urine composition in 
relation to age.  
Infant age is an important variable that contributes to the metabolic profile of biofluids and thus 
establishing the metabolic profiles linked to age needs to be a priority for future metabonomic 
studies. From birth, the infant metabolic profile can be related to their mothers and goes on to 
change dramatically after birth due to environmental factors. As the infant’s body develops and 
their gut microbiome quickly establishes, the metabolic profile reiterates this through changes in 
their metabolome. The knowledge of an age-related metabolic profile can make the interpretation 
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of data for other effects such as disease easier, which is important in biomarker discovery for 
disease diagnosis or prognosis. It shows that importance of obtaining samples from infants at the 
same time point, as even a few days or a week can completely change the metabolic profile and 
cause confounding results. In studies where age cannot be standardised, this should be appreciated 
and incorporated into the data modelling strategy. 
3.7.3. ASSESSMENT AND CHARACTERISATION OF CONTAMINATION FROM 
COLLECTION MATERIALS IN    INFANT URINE 
Clean catch urine is difficult to obtain from infants and thus typical collection means include placing 
adhesive sample collection bags on the infants or more practically relying on extracting urine from 
cotton wool balls placed inside the nappy. Both cotton wool and nappies contain chemical 
contaminants, which contribute to the urine metabolic profile and which can easily be detected by 
both 1H NMR and UPLC-MS techniques. It is necessary to recognise these contaminants before 
studying urine data so that their signals can be excluded from the statistical models.  
This issue of possible contaminants has been examined and further reported using complementary 
1H NMR and UPLC-MS-based metabonomics of three nappy brands using the ‘nappy plus cotton 
ball’ technique. It was found that the NMR spectra of the different cotton ball brands examined 
were identical in composition, thus only one brand of cotton ball was used for ‘nappy plus cotton 
ball’ samples analysis. It also indicated, that certain nappy brands are more likely to exhibit distinct 
contaminant profiles than others; for example Pampers contains acrylic acid. Therefore, it is advised 
that nappies and cotton balls are characterised using metabonomic methodologies prior to urine 
samples analysis. This way contaminants coming from any material would be manageable and 
unwanted variation introduced by contamination could be minimised.  
Although some of these contaminants have been previously reported, such as polyethylene glycol 
(PEG) from nappies and propylene glycol in infant urine which has been suggested to derive from 
babywipes, this is a more comprehensive assignment of exogenous chemicals deriving from 
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collection procedures (Goodpaster et al 2011; O’Sullivan et al 2013). A systematic analysis of the 
effect of different nappies on synthetic urine by Goodpaster and colleagues (2011) showed that 
multivariate analysis of either NMR or LC-MS spectra resulted in clustering of spectra according to 
the brand of nappy. In Goodpaster’s study, it was estimated that up to 59% of the NMR spectrum 
was influenced by chemical contamination from diapers. Thus, it is important that the brand of 
diaper is standardised across a study to prevent the introduction of extraneous variation.  
This chapter has demonstrated the importance of assessing materials associated with the collection 
and preparation of infant biofluids. It needs to be ensured that introduced contaminants are well 
characterised so that discriminant metabolites which are products of neonate’s metabolism, kidney 
function or gut microbiome co-metabolites can be recognised.  
3.7.4. OPTIMISATION OF INFANT FAECAL WATER EXTRACTION FOR METABOLIC 
PROFILING  
NMR-based faecal water metabolic profiling offers a great opportunity for understanding the 
complex interaction between humans, their diets and their gut microbiome (Saric et al 2008; 
Nicholson et al 2012). Furthermore, the extraction of faecal water for metabolic profiling has not 
previously been optimised for infant biofluids where volume of sample is limited. In this chapter, 
the optimisation for faecal water to be acquired by 1H NMR was produced to measure a broad 
range of different metabolites and obtain a global overview on diet and health of infants as well as 
interaction with the gut microbiome. It was also important to produce a protocol for high 
throughput and large dataset studies. 
To ensure a high recovery of metabolic information using NMR based metabolic profiling, stability 
of the sample and reproducibility of information is maintained, the selected method involves a 
number of different steps. Before homogenisation, it is recommended that faecal samples are 
subject to two freeze thaw cycle, this can release higher concentrations of all the metabolites, but 
more than two freeze thaw cycle can start to cause degradation of the metabolic profile.   
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To extract the water from the faecal sample, bead beating using zirconium beads should be used for 
the best results and for high throughput samples. For smaller sample sets, homogenising the 
samples using pestle and mortar whilst frozen under liquid nitrogen produces the best result for 
concentration of metabolites. 
For extraction, solvents should be added to the faecal samples before homogenisation to capture 
metabolites in the liquid for later analyses. In this investigation, a number of different solvents were 
tested and water is believed to be the best solvent for extraction. When using deuterated solvents, 
including phosphate buffer, metabolite concentration is considerably lower and loss of information 
is possible. This may be due to some macromolecules which don’t dissolve properly in the 
deuterated solutions bind to smaller molecules and therefore less information is available for 
metabolic profiling.  
 To ensure that infant faecal samples could undergo more than one analytical techniques, extraction 
of these samples were also tested for the possibility to extract for 1H NMR and UPLC-MS. By using an 
organic solvent and filtering when extracting, this was possible. Adding these elements to the 
protocol did not introduce any contaminants or affect the metabolic profile except for the loss of 
methanol. With this in consideration, the ease of the protocol for extraction for both platforms and 
the ability to extract for high through put studies meant that this was acceptable.  
3.8. CONCLUSION   
Currently most clinical tests available in neonatology rely on simple technologies that measure 
chemicals in blood, urine or other biofluids; including blood glucose, acid-base profile, lactate and 
ammonia. These tests can help to identify known groups of metabolic disorders; however, these 
tests are neither sensitive nor specific for any particular disease. The goal is for each condition or 
disease to acquire a discriminatory metabolic phenotype, derived essentially from small but 
significant differences in certain metabolites. Thus, scientists need to be sure that these 
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discriminant metabolites are products of a neonate’s metabolism and kidney function and not just 
contaminants of the cotton wool and nappies used to collect the biofluids. 
A reproducible and well established metabolic profiling protocol for infant biofluid sample collection 
and preparation needs to be introduced. The analysis of this data as well as integration of this data 
with other ‘omic’ analysis will make this technology valuable in the clinical setting for disease 
diagnosis. Metabonomic research in neonatology offers a great potential to improve the diagnosis 
and treatment of infant’s diseases, significantly decreasing the stress that newborns endure. 
Metabolic profiling of infants may deliver validated biomarkers which can be used for predicting 
individual predispositions and disease etiology or to the monitoring of disease’s progression and 
treatment management. 
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CHAPTER 4 
 
NORWEGIAN MICROBIAL STUDY (NoMic):  
A TIME SERIES INVESTIGATION OF INFANT 
DEVELOPMENT 
 
 
 
4.1. INTRODUCTION 
We provide the bacteria with a stable environment, and in return the bacterium produce 
metabolites and vitamins from our diet. The gut is quickly colonised after birth, and this microbial 
community develops through the first few months of life (Nicholson et al., 2012). It is believed that 
gestational age, the mode of delivery, nutrition (e.g. maternal or formula milk), clinical interventions 
(e.g antibiotics), environmental exposures as well as maternal microbiota can affect the composition 
of the gut microbiome (Mueller et al., 2015).  
Faecal metabolic profiling has become a useful tool for deepening our knowledge into the 
interactions between humans, nutrition and microbiome communities. A number of different 
studies have utilised faecal samples in adults to predict risk for diseases including inflammatory 
bowel disease and colon cancer (Marchesi et al., 2007; Weir et al., 2013; Le Gall et al., 2011). There 
are few studies on infant faecal metabolic profiling but recent reports have shown promise in using 
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this biofluid as a tool for further understanding interactions among diet, microbes, and host (Chow 
et al., 2014; Martin et al., 2014).  
The gut microbiota is made up of a complex society of microbes which impacts the body by nutrient 
processing, vitamin synthesis and playing a key role in the maturation of the immune system. In 
recent years, obesity at childhood has been on the rise (Biro et al., 2010) and the gut microbiota has 
been indicated in the development of obesity (Koleva et al., 2015). It has been observed that 
childhood obesity is an important predictor of adult obesity, morbidity and mortality and with the 
number of people developing obesity increasing exponentially worldwide it is very important to 
understand the early development of the disease.  
Studies on germ-free mice have provided evidence for the association of body weight and gut 
microbiota; including evidence for the existence of an ‘obese microbiome’ that has the ability to 
harvest increased amounts of energy from the diet (Ley et al., 2005, Ley et al., 2006).  Obesity alters 
the gut microbiome by reducing the diversity of the community as well as altering metabolic 
pathway and gene expressions (Turnbaugh et al., 2006).  This development is thought to be 
influenced by early life exposures, including nutrition and early rapid weight gain, that alters the 
composition of gut microbiota (Arenz et al., 2004, Koletzko et al., 2012). A study using metabolic 
profiling of children with obesity discovered that BCAA and hormones were associated with 
adiposity and cardiovascular risk during childhood (Perng et al., 2014); they went on to discover that 
maternal BMI status may also contribute to this profile. 
Metabolites are representative of the underlying biological development of obesity and therefore 
may have a major impact on outcome. By understanding the early development of the metabolic 
profile it will build up towards understanding early risk factors for obesity later in life.  
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4.2. AIM 
It is has become increasingly apparent of the importance to understanding metabolite composition 
in infancy and how influential the gut microbiota is during this developmental period. This study 
proposes to investigate the early development of the infant metabolism and the influence of the gut 
microbiome.  
To do this the Norwegian Microbial (NoMic) study focussed on infants from birth up until the age of 
two (Eggesbo et al., 2011). The NoMic study was funded by a grant from the South-Eastern Norwat 
Regional Health Authority and in part by the Intramural Research Program of the NIH, National 
Institute of Environmental Health Sciences. Ethics for this project was approved by the Regional 
Committee for Medical Research Ethics, south East Norway (2012/1259-19). The work conducted in 
this thesis was funded as a pilot study and therefore the costs incurred were covered by the author’s 
department. My role was to perform the metabolic phenotyping of the NoMic stool samples from 
the infants using 1H NMR; this work had two main objectives:  
1. Characterise the faecal metabolic profile’s time trajectory in infants to establish a 
foundation for future investigations into the early metabolome. 
2. Understand the influence of early life experiences on the metabolic profile to identify early 
risk factors and potential early biomarkers for the prevention of metabolic disorders 
including obesity in later life.  
For this project, the characterisation of the developmental trajectory of the faecal metabolic profile 
is key to understand the baseline metabolism in the early years of life. Therefore, time series 
analysis was necessary to examine this data as there are multiple samples taken from the same 
individual through time as well as a large cohort of samples. This analysis will be used to identify 
metabolic features significantly altered through time between different groups, including term 
versus preterm at birth, mode of delivery, and BMI status at 1 and 2 years of age.   
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4.3. MATERIALS AND METHOD 
4.3.1. NORWEGIAN MICROBIOME (NOMIC) STUDY SAMPLE SET INFORMATION  
Faecal samples were collected at six time points; 4 days, 10 days, 30 days, 120 days, 1 year, and 2 
years after birth; comprising of 1802 faecal samples used for this thesis. Five hundred and twenty-
four healthy infants were recruited to take part in this non-intervention clinical study. A faecal 
sample was taken on at least one time-point from each child, if not more, but not all individuals have 
provided a sample at all six time points. A detailed description of how many samples were collected 
from each time point can be found in table 4-1 as well as further clinical information infants and 
mothers.  
Relevant clinical data were collected for each infant at each time point and questionnaires on 
nutritional information were also obtained; including months that each child was exclusively fed 
breast milk. This included information on gestational age and weight at birth of the infant; including 
mode of delivery of the infant. Information on allergies, asthma and colic. Further to this, antibiotic 
treatments prescribed to the child and at year 1 and 2, the infant’s BMI status was recorded.    
Maternal information was also noted including smoking before or after the pregnancy, any antibiotic 
treatments during the pregnancy and during or after birth. Maternal age, ethnicity as well as BMI 
were also recorded at the time of the birth.   
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Table 4-1: Clinical data information for Norwegian Microbial (NoMic) sample set at each time point and all the time points together. Data is expressed as 
the median (IQR) or as a percentage of subjects.  
 Clinical data 
Sample time point  
All samples  4 10 30 120 365 730 
Number of samples  1802 287 291 272 239 405 308 
Number of infants  512             
Infants with samples at all 6 timepoints 56 (11.6%)             
Birth gestational age (range) 39.7 (23.3-44.5) 39.85 (27.3-44.5) 39.71 (27.3-44.6) 39.64 (27.3-44.6) 40.1 (27.5-43.9) 39.57 (23.3-44.5) 39.57 (25.3-44.6) 
Preterm samples (%) 26.47% 23.34% 28.50% 28.40% 17.15% 27.65% 30.50% 
SGA (%) 13.28% 12.50% 12.70% 14% 10.80% 13.30% 15,6% 
Weight median (g) 3370 (500-5050) 3400 (832-5050) 3365 (832-5050) 3352 (832-5050) 3540 (920-5050) 3370 (500-4695) 3290 (652-5050) 
Caesarean section (%) 31.96% 29.26% 33.30% 33.90% 33.47% 31.85% 29.80% 
Breast feeding exclusively (months) 4 (0-12) 4 (0-11) 4 (0-11) 4 (0-12) 4 (0-12) 4 (0-12) 4 (0-11) 
Gender (% male) 45.90% 45.64% 45.70% 43.75% 46.86% 50.10% 46.75% 
BMI 1 yr (% high) 19.72% 19.32% 20.37% 20.50% 20.60% 19.20% 19.65% 
BMI 2 yr (% high) 18.47% 20.15% 15.82% 16% 19% 18.26% 21.80% 
Allergies (%) 10.45% 8.70% 9.62% 8.80% 9.60% 12.10% 12.66% 
Asthma (%) 8.33% 8.01% 8.90% 9.20% 9.20% 6.66% 8.76% 
Colic (%) 14.65% 15.13% 13.85% 17.64% 14.07% 13.10% 15.60% 
Infant antibiotic prescribed in 1st 2 years 61.7%%             
Maternal age (yrs) 30 (20-40)             
Maternal pre pregnancy BMI 24.09 (16.45-47.89)             
Maternal post pregnancy BMI 29.4 (17-51.5)             
Maternal ethnicity (Norwegian) 88.42%             
Maternal smoking pre pregnancy 11.9%%             
Maternal smoking post pregnancy 8%             
Maternal antibiotic taken during pregancy 0.80%             
Maternal antibiotic taken during birth 6%             
Maternal antibiotic taken after birth 14.50%             
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4.3.2. FAECAL WATER PREPARATION  
Faecal samples were weighed out (100mg) and transferred to microvials which contained 0.1mm 
zirconium beads whilst frozen. They were then subject to two freeze thaw cycles before having 
250ul of ACN:H2O added to the microvials. These vials were homogenised using a bead beater for 10 
seconds and centrifuged at 16,000 xg for 10 minutes, at 4°C. The supernatant was taken from the 
vial and placed in pre-washed spin columns and again centrifuged for 20 minutes at 16,000 xg, at 
4°C. The faecal water was evaporated under nitrogen gas for 30 minutes to remove any organic 
solvent. Once evaporated, these samples were reconstituted into 540µl D2O and 60µl phosphate 
buffer, vortexed and sonicated for 5 minutes. The faecal water was then transferred into 5mm NMR 
tubes ready to be acquired using a 600MHz 1H NMR spectroscopy.  
4.3.3. 1H NMR SPECTROSCOPY OF FAECAL WATER 
1H NMR spectra were acquired on a Bruker DRX-600 spectrometer (Bruker Biospin, Karlsruhe, 
Germany) operating at 600.29MHz for proton observation using a standard one dimensional water 
pre-saturation pulse sequence [relaxation delay-90°-t1-90°-tm-90°-acquire free induction decay 
(FID)]. The relaxation delay was 4 seconds; with application of a 90° radio frequency pulse, t1, 
referring to the interpulse delay, which was set to 3µl, while tm is the mixing time of 100ms. The 
probe was matched and tuned automatically to the proton transmitter resonance frequency before 
acquisition for each sample and samples were run at a temperature of 300K. 
Processing of 1H NMR spectra was carried out using TOPSPIN 3.1 software package (Bruker Biospin, 
Rheinstetten, Germany). The FIDs were transformed into spectrum by Fourier transformation. The 
spectra were manually phased, baseline corrected and calibrated to the TSP signal at δ0.0 for faecal 
samples.  
 
 
 119 
4.3.4. MULTIVARIATE DATA ANALYSIS 
4.3.4.1. 1H NMR data pre-processing 
The spectral data (from δ0.5 to 9.5) were imported into Matlab software (version 2014a, the 
Mathworks Inc, MA, USA). The spectral region incorporating the water (δ4.6-5.05) was also removed 
from each spectrum. 1H NMR spectra were aligned using an in-house algorithm and normalised using 
a Probalistic Quotient normalisation (PQN) in order to remove variation in metabolite linked to 
osmolarity and dilution.  
4.3.4.2. 1H NMR metabolic data analysis 
Multivariate statistical models (PCA, OPLS, OPLS-DA) were performed in Matlab software (version 
R2014b, the mathworks Inc, MA USA) and SIMCA-P 14 software (Umetrics, Umea, Sweden) using 
univariate scaling. The Q2Y value was determined for each model by plotting the data against the 
cross validated scores to estimate the goodness of fit and level of over fitting for the OPLS and OPLS-
DA models. All models were subjected to a 7-fold cross validation and were validated by multiple 
permutation tests (permutation number =1000). (see methods Chapter) 
4.3.4.3. A Time Series Analysis of 1H NMR faecal metabolic data 
1H NMR spectral faecal data were binned into 1000 bins producing variables, which represented 
0.01ppm scale rather than 0.001ppm. An in-house time-series algorithm that relies on Functional 
Spline for Short Asynchronous Time-Series Analysis was used to identify faecal metabolic 
features that are significantly altered in time between groups (Ramsay et al., 1988). These groups 
included mode of delivery, term versus preterm and BMI status of infants at 1 and 2 years of age. 
Significant differences in variables between time points from the groups were identified using p-
values of less than 0.01 and trajectory of the variables were observed using spline graphs. Further 
explanation on this method can be found in the methods chapter section.  
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4.4. RESULTS  
4.4.1. 1H NMR spectroscopy metabolic profiling 
Information was collected from both infant and mother through questionnaires and recording 
medical records during the sampling of infants. Statistical analysis was performed on faecal samples 
as a whole data set as well as individual time points to accommodate the complexity that time adds 
to the data given that development of the microbiota is an ongoing process that doesn't necessarily 
co-evolve at the same rate in all children. Characterisation of the development of the infant faecal 
metabolic profile is the main aim of this project. Further to this, I investigated the effect of preterm 
birth, the mode of delivery, BMI status, as well as the time of exclusivity of breast feeding has on the 
faecal metabolic profile through this highly developmental stage.  
4.4.1.1. 1H NMR faecal metabolic profiling of developing infants from 4 days until 2 years 
postpartum.  
Using the faecal 1H NMR metabolic profiles, a principal component analysis (PCA) was performed 
(Figure 4-1), which demonstrated a clear separation of samples according to their assigned class; six 
time points from 10 days to 730 days postpartum. This model was comprised of all the time points 
and was formed of three principal components, which collectively explained 34% of the variability 
within the metabolic data. The optimal number of orthogonal components was determined by R2X 
(goodness of fit) and Q2Y (predictability of fit) statistics.  
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Figure 4-1: PCA of 1D 1H NMR faecal spectral data from all infants at all time points. Key: Purple = Day 4, Blue = Day 10, Green = Day 30, Yellow = Day 120, Red = 
Day 365, and Pink = Day 730; Component 1 explains 24.8% of variance whereas component 2 explains 5%. R2X (cumulative) = 0.34 and Q2X (cum)=0.33.  
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Figure 4-2: Correlation Coefficient plot from OPLS regression model (R2X= 0.32, Q2X=0.73, R2Y = 0.78) showing significant metabolites in faecal water 
separating between infants at different time points: 4, 10, 30, 120, 365 and 730 days postpartum. 1. Butyrate ( 0.89), Propionate ( 1.06), & Valine 
(1.02), 2. Alanine (1.48), 3. Butyrate (1.56), 4. Acetate (1.92), 5. Butyrate (2.17) & Propionate (2.18), 6. N-acetyl-glycoprotein fragments (2.02, 
2.06), 7. Sugars (3.54, 3.62, 3.75, 3.87, 3.94, 4.0), 8. Glucose (4.68), 9. Tyrosine (6.91, 7.2), 10. Phenylalanine (7.38, 7.43), 11. Uracil 
(7.55), 12. Adenine (8.2, 8.23) 
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Figure 4-3: Median 1D 1H NMR faecal spectral data from all infants at all time points. A) Day 4, b) Day 
10, c) Day 30, d) Day 120, e) Day 365, and f)Day 730; (Aromatic region (5.5-9.5ppm) of the spectra has 
been increase by x10) 
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However, from Figure 4-1, day 4 postpartum faecal samples aren’t as well separated within the data 
and are similar to samples taken at 30 days postpartum. Considering the median spectra in Figure 3, 
day 4 postpartum samples seem to have relatively lower concentration of metabolites compared to 
day 10, especially the aliphatic region of the spectrum where carbohydrates and sugar are found as 
well as N-acetylglycoproteins fragments found around 2.04 (data not shown). This higher 
concentration of metabolites could be the influx of enteral feeding in the first few days not being 
recognisable in the metabolic profile until after the first week of life. From the PCA scores plot 
(Figure 4-1), the most noticeable difference between the time points is the variation in the early 
samples is much higher compared to samples taken at 1 and 2 years of age.  
An Orthogonal Partial Least Squares (OPLS) regression model was performed on all faecal data using 
time points as a regression class. For this model the metabolites with the highest correlation 
coefficient were identified (Figure 4-2) and metabolite assignments are summarised in table 4-2. In 
particular, a metabolite profile high in carbohydrates, sugars (3.54, 3.62, 3.75, 3,87, 3.94, 4.0, 
4.68) and N-acetylglycoprotein fragments (2.02, 2.06, 4.45), including N-acetyl glutamate 
(4.16) can be observed in samples obtained at earlier time points, (e.g. days 4 and 10). Whereas, 
faecal water acquired at later time points (e.g year 1 and 2) are more strongly associated with 
organic acids including, amino acids (alanine (1.48), tyrosine (6.91, 7.2) and aspartate (2.79, 
2.83), phenylalanine (7.38, 7.43)), SCFAs (butyrate (0.89, 1.56, 2.17), propionate (1.06, 
2.18) and acetate (1.92)), and BCAAs (valine 1.02). Later samples are also associated with 
succinate (2.4), methylamine (2.6), uracil (5.8, 7.55) and adenine (8.2, 8.22).   
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Table 4-2 – List of discriminatory metabolites assigned from OPLS time point regression model 
(Figure 4-2).  (*overlapped resonances from glucose, other sugars and polyols, N-methylated 
compounds and amino acids) 
Metabolite name 1H NMR δ  (multiplicity group) Days postpartum 
N-acetyl glycoprotein fragments 2.02 (s), 2.06 (s) ≤30 days 
Sugars* 3.54 (m),  3.62 (m), 3.75 (m), 3.87 
(m), 3.94 (m), 4.0 (m) 
≤30 days 
N-acetylglutamate 4.15 (m) ≤30 days 
Glucose 4.68 (d) ≤30 days 
 
Butyrate 0.899 (t), 1.56 (m), 2.17 (t) ≥120 days 
Propionate 1.06 (t), 2.18 (q) ≥120 days 
Valine 1.02 (d) ≥120 days 
Alanine 1.48 (d) ≥120 days 
Unknown 1 1.87 (s) ≥120 days 
Acetate 1.92  (s) ≥120 days 
Succinate 2.4 (s) ≥120 days 
Methylamine 2.60 (s) ≥120 days 
Aspartate 2.83 (dd)  ≥120 days 
Unknown 2 2.63 (s) ≥120 days 
Uracil 5.8 (d), 7.55 (d) ≥120 days 
Tyrosine 6.91 (d), 7.2 (d) ≥120 days 
Phenylalanine 7.38 (m) 7.43 (m) ≥120 days 
Adenine 8.2 (s) 8.23 (s) ≥120 days 
 
The median spectrum from each time point reiterates this variability in faecal sample metabolic 
profiles clearly (Figure 4-3), with a dramatic change between faecal samples taken at 30 days 
postpartum compared to 120 days postpartum. The highest correlating metabolites in infant faecal 
samples at day 30 compared to day 120 using an OPLS-DA model are detailed in table 4-3. Faecal 
samples taken at 30 days are highly associated to metabolites found in the carbohydrate region of 
the NMR spectrum (3.51, 3.61, 3.87, 4.14, 5.11, 5.24) as well as N-acetyl glycoprotein 
fragments (2.02, 2.06, 4.45) and faecal samples taken at 120 days postpartum, are highly 
associated with bile acids  (0.68), methylamine (2.6) and 4-cresyl glucuronide (2.32) as well as an 
unidentified metabolite (1.65, 2.24).  
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4.4.1.2. 1H NMR faecal metabolic profiling of infants highlights differences 
between infants born term vs preterm 
Preterm infants are classed as born at less than 37 weeks gestation; however, there are different 
severities of prematurity depending on the gestational age (GA) at birth. Further categorising of 
preterm infants into their severity was established for this model; early preterm (GA ≤31 weeks, 
n=121), late preterm (32-36 weeks, n=355), and term (>37 weeks GA, n=1325). An OPLS model, using 
one orthogonal component, was produced from the whole dataset to assess the overall differences 
between the term and different severities of preterm infant samples. The discriminatory metabolites 
associated with term versus preterm born infant samples are summarised in table 4-4. The final R2Y 
and Q2Y values equalled 15% and 9% respectively. The Q2 value for this model is fairly low, which is 
due to the nature of the high variance of stool metabolic profiles.  
There is a positive correlation to butyrate (0.87, 1.59) in the early and late preterm born infant 
samples compared to the term born babies. These samples also related to an unknown metabolite 
(1.38). and a metabolite found at 1.31 which has been tentatively assigned as the signal coming 
from the fatty acid chain of a triacylglyceride and will be named lipid 1 (L1) for the remainder of this 
thesis.  
Table 4-3 – List of discriminatory metabolites assigned in the loadings plot of OPLS-DA model of 
infants at time points  30 day versus 120 day postpartum (*overlapped resonances from glucose, 
other sugars and polyols, N-methylated compounds and amino acids) 
Metabolite name 1H NMR δ  (multiplicity group) Time point 
N-acetyls of glycoprotein 
fragments 
2.02 (s), 2.06 (s) Day 30 
Sugar* 3.51 (m),  3.61 (m), 3.87 (m), 4.14 (m), 5.11 
(d), 5.24 (d) 
Day 30 
 
Bile acids 0.68 (s) Day 120 
Unknown 1 1.65 (m), 2.24 (dd) Day 120 
4-cresyl glucuronide 2.32 (s) Day 120 
Methylamine 2.6 (s) Day 120 
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Comparatively, term infants had relatively higher concentrations of sugars (3.46) and specifically 
glucose (4.59 and 5.27) compared to preterm samples. Furthermore, infants born at term were 
highly associated with choline (3.28, 3.53, 4.07) and N,N,N-trimethyllysine (3.207).  
Differences in metabolite composition between infants born term and early or late preterm was 
similar when the data was modelled separately for each time point compared to modelling the 
whole data set. This would suggest that these samples gave the largest variation in the data and may 
have been the drivers for the models when all samples were included. When separating the data set 
into specific time-points and modelling the data using OPLS, there were clear differences in faecal 
metabolic profile from day 4 postpartum through to 4 months of age; discriminatory metabolites are 
summarised in table 4-6. However, faecal samples taken at days 365 and 730 did not show any 
significant separation in samples taken from term versus preterm infants indicating that early life 
differences are reflected in metabolite profiles but over time these differences diminish.  
Faecal samples taken from early and late preterm infants at day 4 were highly associated with 3’-
fucosyllactose (1.18, 5.39, 5.47), which is a common breast milk oligosaccharide (Practico et al., 
2013). Whereas, infants born at term were more associated with various bile acids (0.728, 0.735) 
and a sugar found at 3.46.  
The meconium is the first stool of the infant and is the contents of the foetal gastrointestinal tract. 
At birth the intestine sheds its protective layer consisting of bile, epithelial cells and hair which 
makeup the meconium. However, the meconium is usually excreted within 24 hours in full term 
infants (Clarke, 1977), therefore, these samples taken at 4 days postpartum are not meconium but 
suggest that there are still elevated secretion concentrations of bile acid in the first few days in term 
compared to preterm infants.  
Discriminatory metabolites associated with the two classifying groups samples change by the time 
the infant is 10 days postpartum. Infants born preterm were highly associated with L1 (1.31) and 
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tyramine (7.23) in their faecal metabolic profile. However, term born infants were correlated with 
choline (3.28, 3.53, 4.07), glucose (4.59, 5.27) and N,N,N-trimethyl-lysine (3.207).  
At 30 days’ postpartum, infants born preterm had metabolic profiles correlated to butyrate (0.86, 
1.59) and two unidentified metabolites (1.38, 1.99). Infants born term, when compared at this 
time point, separated from preterm infants due to choline (3.28, 3.53, 4.07) and tyrosine (6.91, 
7.2).  
At 120 day’s postpartum, the faecal metabolic profiles from early and late preterm infants separated 
due to the higher association with sugars (3.85, 4.01). Term samples were correlated to a number 
of different metabolites including leucine (0.96), alanine (1.48) and succinate (2.41). 
Furthermore, term infant’s faecal metabolic profiles was highly associated to choline (3.28, 3.53, 
4.07), tyramine (7.23) and phenylalanine (7.43).  
  
 
 
 129 
Table 4-4: List of discriminatory metabolites assigned from multivariate models of infant 1H NMR spectral data; Early Preterm (<27wks GA), Late Preterm (23-36wks GA) 
and Term (>37wks GA) Infants, Birth gestational age (GA) & Birth weight (OPLS-regression) – High (H) vs Low (L) (*overlapped resonances from glucose, other sugars and 
polyols, N-methylated compounds and amino acids) 
Metabolite Name 1H NMR δ  (multiplicity)  Early Preterm, Late Preterm & 
Term Infant 
 Birth GA - High vs Low  Birth Weight - High vs Low 
Time point Time point Time point 
All 4 10 30 120 All 4 10 30 120 All 4 10 30 120 
Bile acids 0.728 (s), 0.735 (s)  T          H H   
Butyrate  0.866 (t), 1.59 (m) P   P  L   L     L  
Leucine 0.96 (t)     T     H      
Valine 0.99 (d)          H     H 
Propionate 1.07 (t)        L L    L L  
Lipid 1 (L1) 1.31 (bs) P  P   L  L L  L  L L  
    
3’-fucosyllactose  1.18 (m), 5.39 (d), 5.47 (d)   P     L L    L L L  
Unknown 1 1.38 (dd) P   P  L   L  H   L  
Alanine 1.48 (d)     T     H     H 
Unknown 2 1.99 (s)    P     L       
Succinate 2.41 (s)     T     H     H 
Unknown 3 2.967 (d)       L     L    
    
NNN-trimethyl-lysine 3.207 (s)  T  T   H  H H  H H H H  
Choline 3.28 (s), 3.53 (m), 4.07 (t) T  T T T H  H H  H  H H  
Sugar* 3.46 (d) T T    H H H H   H    
3.85 (s)     P     L     L 
4.01 (m)     P     L     L 
    
Ethylene glycol 3.71 (s)        L L L   L  L L  
Glucose 4.59 (d), 5.27 (d)  T  T   H  H   H     
Tyrosine 6.91 (d) 7.2 (d)    T T    H H    H H 
Tyramine 7.23 (d)   P     L      L  
Phenylalanine 7.43 (t)     T     H      
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4.4.1.3. Faecal metabolic profiles from infants with variable birth gestational ages 
and birth weights  
The OPLS model was calculated using four orthogonal components, which can indicate high 
variability between the samples; this is due to the orthogonal components required to remove the 
systematic differences caused by the natural variability, and not related to the class of interest. The 
final R2Y and Q2Y values equalled 44% and 22% respectively for birth gestational age. The final R2Y 
and Q2Y values equalled 34% and 13% respectively for birth weight. 
The discriminatory metabolites associated with the two classifying groups for both the both birth 
gestational age and birth weight, models are summarised in table 4-4. Infants born with low birth 
weight and at a lower gestational age were highly associated with L1 (1.31), butyrate (0.86, 1.59) 
and ethylene glycol (3.71). Infants born with a higher birth weight and a higher gestational age, 
their faecal profiles were positively correlated to choline (3.28, 3.53, 4.07), N,N,N-trimethyl-lysine 
(3.207) and sugars (3.46), specifically glucose (4.59, 5.27). 
Interestingly, an unidentified metabolite - with a resonance of δ1.38 - was seen to be correlated to 
infants whom were born at a higher birth weight but was also highly associated with infants born at 
a lower GA. Unfortunately, without a more accurate identification of this metabolite a reasonable 
explanation for this difference cannot be concluded.  
Samples taken at 4 and 10 days with a lower GA and birth weight were highly associated with 
ethylene glycol (3.71) and 3-fucosyllactose (1.18, 5.39, 5.47); whereas at 30 days postpartum 
this metabolite was only associated with a lower birth weight.  At 4 days postpartum only, infants 
with a lower GA and birth weight are associated with an unknown metabolite (1.38). Samples from 
lower GA and birth weight were associated with propionate (1.07) and L1 (1.31).  
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Conversely, infants born at a higher gestational age, were more associated with sugars (3.85, 
4.01); but at a higher birth weight, these infants metabolic profile correlated with choline (3.28, 
3.53, 4.07) and N,N,N-trimethyl-lysine (3.207).  
However, at 120 days’ postpartum, the panel of faecal metabolic profiles separating the two classes 
was different. In lower birth gestational age and weight, infants were differentiated mainly by a 
higher correlation to sugars (3.46, 3.85). In samples taken from infants at born at higher 
gestational age and birth weight, metabolic profiles were highly associated with the amino acids; 
alanine (1.48), valine (0.99) and leucine (0.96), as well as succinate (2.41) and tyrosine (6.91, 
7.2). Furthermore, infants that were born at later gestation age were more associated to 
phenylalanine (7.43).   
4.4.1.4. 1H NMR faecal metabolic profiling of infants highlights differences 
depend on the mode of delivery 
A OPLS-DA model was produced from the whole dataset to assess the overall differences between 
the infants born vaginally compared to caesarean section infant samples; the discriminatory faecal 
metabolites associated with the two classifying groups were identified and are summarised in table 
4-5. The O-PLS-DA model was build using 2 orthogonal components with the final R2Y and Q2Y values 
being 15% and 5% respectively.  
From modelling all the samples, vaginally delivered infants were highly correlated with sugars 
(3.25, 3.43, 3.46) as well as alanine (1.48) and tyrosine (7.2). Acetone (2.22) was also present 
in relatively higher concentrations in faecal water taken from infants which were delivered vaginally.   
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Table 4-5– List of discriminatory metabolites assigned in the loadings plot of OPLS-DA model of 
infants delivered via different modes, vaginally (VD) and caesarean section (CS). (*overlapped 
resonances from glucose, other sugars and polyols, N-methylated compounds and amino acids) 
Metabolite name 1H NMR δ  (multiplicity group) Time point 
 
All 4 10 30 
Alanine 1.48 (d) VD  VD VD 
Acetone 2.22 (s) VD    
Gamma-amino-N-butyrate 2.3 (t)   VD  
Dimethylamine 2.7 (s)   VD  
Trimethylamine-N-oxide 3.27 (s)   VD VD 
Sugar* 3.25 (m), 3.43 (m), 3.46 (d) VD VD VD VD 
Tyrosine 7.2 (d)   VD VD 
Tyramine 7.23 (d)   CS CS 
Adenine 8.2 (s)   VD  
 
Faecal metabolic profiles from infants were then compared at each time point by using OPLS-DA 
models and it was discovered that the faecal samples differed significantly between vaginally 
delivered and caesarean section infants up until day 30 and after which there was no significant 
difference.  
At the earliest sample taken (4 days) infant faecal samples separated due to sugars (3.25, 3.43, 
3.46) which were correlated more strongly with infants delivered vaginally. Samples from 
caesarean section delivered infants had a stronger association with the metabolite tyramine (7.23). 
Vaginally delivered infants’ faecal profile, were highly associated with alanine (1.48), TMAO (3.27), 
adenine (8.2) and dimethylamine (2.7). Tyrosine (7.2) and gamma-amino-N-butyrate (2.3) were 
also related to being delivered vaginally.    
4.4.1.5. Nutrition from birth: the effect of breast feeding exclusively on the 1H NMR 
faecal metabolic profile  
An OPLS-regression model of the exclusivity of breast feeding in months was produced on faecal 
samples taken at 120 days postpartum. The longest period that an infant was exclusively fed breast 
milk in this study was 12 months but with many infants started to be weaned off milk around 4-6 
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months this added another confounding factor. Therefore, modelling the data at 4 months gives a 
better insight to the effect of the exclusivity of breastfeeding in the first few months.  This statistical 
modelling was performed on 138 faecal samples. Individuals which were born at less than 37 weeks 
gestation age (i.e. preterm infants) and samples with missing nutritional information were not 
included in the model; discriminatory metabolites associated are summarised in table 6. This model 
was build using 1 orthogonal component with the final R2Y and Q2Y values being 54% and 27% 
respectively; a relatively robust model. 
Faecal metabolic profiles from infants which were fed exclusively breast milk for less time were 
highly associated with amino acids including butyrate (0.91, 1.57, 2.16), lysine (1.47, 1.75, 
3.03), propionate (1.07, 2.18), and acetate (1.92). These samples were also associated with an 
unknown metabolite at 7.16.  
Samples from infants which were exclusively fed breast milk for more time were highly associated to 
3-hydroxybutyrate (1.19), choline (3.53, 4.06) and N-acetylglycoprotein fragments (2.06).  
 
Table 4-6– List of metabolites assigned in the loadings plot of OPLS regression model of infant’s 
exclusivity to breast fed in months from samples taken at 120 days only.    
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Butyrate 0.91 (m), 1.57 (m), 2.16 (m) Less exclusivity  
Lysine 1.47 (m) 1.75 (m), 3.03 (t) Less exclusivity  
Propionate 1.07 (t), 2.18(m) Less exclusivity  
Acetate 1.92 (s) Less exclusivity 
Unknown 1 7.16 (s) Less exclusivity  
 
3-hydroxybutyrate 1.19 (d) More exclusivity 
N-acetyl glycoprotein 2.06 (s) More exclusivity 
Choline 3.53 (m), 4.06 (m) More exclusivity 
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4.4.1.6. Understanding the effects of early life experiences on the development of 
the faecal metabolic profile: negative results 
Relevant clinical data were collected for each infant at each time point and questionnaires on 
nutritional was obtained from mothers. This included information on gestational age and weight at 
birth of the infant; including mode of delivery of the infant and nutritional information: these data 
have been reported in the literature. Further information on allergies, asthma, colic as well as the 
developmental condition of the child at two years was also collected. Modelling of faecal water data 
showed no differences in profile between samples from these classes. (Further information on the 
model statistical outputs can be found in the supplementary data- Figure S8).  
This project is interested in the effect of early life exposures to the correlation to infant BMI status; 
BMI data were therefore recorded at 1 and 2 years of age. In recent years, the gut microbiota has 
been indicated in the development of obesity. This development of the gut microbiota community is 
thought to be influenced by early life exposures including milk composition and the use of antibiotics 
in early life. The functionality of the complex microbial communities can be further investigated by 
studying the faecal metabolic profile. Interestingly, modelling the faecal water data showed no 
significant difference between samples from low and high BMI infants at 1 and 2 years of age. This 
would suggest that the functionality of the gut microbiome is similar regardless of BMI status of the 
infants.  
Additional information from the mothers was available, including mothers BMI, age, ethnicity, 
smoking habits as well as antibiotic use during pregnancy and after birth.  From the previous work in 
this thesis, it was notable that urine metabolic profiles at birth from infants can be related to 
mother’s metabolic profile. Therefore, infant faecal metabolic profiles were modelled using 
maternal classification data to investigate the effect of early life exposures. After modelling these 
data, no differentiations in metabolic profiles dependant on these classifications were found; this 
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suggests that faecal samples may not largely be affected by these factors and there are stronger 
factors that influence the composition of the faecal metabolic profiles.  
4.4.2. A TIME SERIES ANALYSIS OF 1H NMR SPECTROSCOPY FAECAL METABOLIC SPECTRA 
FROM DEVELOPING INFANTS – 4 DAYS POSTPARTUM UNTIL 2 YEARS OF AGE.  
After performing multivariate statistics analysis on this data, a time series analysis on the data was 
also performed on the same data set. As this data set has six time points, it was appropriate to 
execute this type of analysis to get a better idea of the development of the infant faecal metabolic 
profile.  
4.4.2.1. Investigation of the effect of infants born term vs. preterm on the faecal 
metabolic profile 
Time series analysis showed that there were statistically robust differences in faecal metabolite 
profiles from infants in the first four time points. Spline graphs from the discriminatory features 
illustrate at which time point these features differentiate between the two groups and displayed 
broad trends in behaviour of metabolites over time; infants born term versus preterm (Figure 4-4). 
Discriminatory metabolites associated with the two classifying groups samples are summarised in 
table 4-7. These differences include a higher correlation to butyrate (0.865, 0.875, 0.855; 1.59, 
1.602, 1.612) and L1 (1.309) in preterm infants at day 4, 10 and 30 time points. At days 10, 30 
and 120 days postpartum, preterm infants has elevated relative concentrations of tyramine (7.239).   
Term infants were correlated with higher concentrations of glucose (5.275, 5.281), tyrosine and 
choline at days 10, 30 as well as 120 days postpartum. Term infants were highly associated with 
faecal bile acids (0.673, 0.683) and betaine (3.287, 3.277) at days 10 and 30 postpartum. 
Interestingly, at day 10, preterm infants correlated highly to an unknown metabolite (2.368) but by 
the time the infants were 120 days old this metabolite was more affiliated with term infants.  
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Table 4-7: List of discriminatory variables assigned from time series analysis from faecal infants 
born term (T) versus preterm (P) (*overlapped resonances from glucose, other sugars and poly-
ols, N-methylated compounds and amino acids). P-value on the significance of time trajectory of 
term vs preterm infant samples for variable x. Empirical p-value obtained by estimation of the 
null distribution (no difference) using 1000 permuted random groups, with Benjamini Hochberg 
FDR correction applied (see page 62).  
Variable  -  
(observed multiplicity) 
p-value Potential ID  
 
Time point 
4 10 30 120 
0.673, 0.683 (s) 0.000999 Bile acid  T T T 
0.865, 0.875, 0.855 (t) 0.000999 Butyrate P P P  
1.309 (s) 0.000999 Lipid 1 (L1)  P P P  
1.592, 1.602, 1.612 (m) 0.000999 Butyrate   P P P 
1.985 (s) 0.000999 Unknown 1   P P  
2.369 (m) 0.000999 Unknown 2   P  T 
3.287, 3.277 (s) 0.000999 Betaine  T T T 
3.469 (m) 0.000999 Sugar*  T T  
5.271, 5.281 (d) 0.000999 Glucose  T T T 
7.208 (d) 0.000999 Tyrosine   T T 
7.239 (d) 0.000999 Tyramine  P P  
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Figure 4-4: Spline graphs of variables taken from 1H NMR spectral binned faecal data from infants 
born term versus preterm. Line represents the group mean of the feature through time and 
shaded area represents the 95% confidence interval. Red=Term born infant samples, Blue = 
Preterm born infant samples. X-axis = time point of which the sample was taken – 1 = Day 4, 2= 
Day 10, 3 = Day 30, 4 = Day 120, 5 = Day 365, and 6 = Day 730. Y-axis = feature intensity. a) 
Variable 0.68ppm: Bile Acid, b) variable 0.85ppm: Butyrate, c) variable 1.309ppm: L1, d) variable 
1.592ppm: Butyrate, e) variable 1.98ppm: Unknown1, f) variable 2.36ppm: Unknown2, g) 
variable 3.287ppm:Betaine, h) variable 3.469ppm:Sugar, i) variable 5.27ppm:Glucose, j) variable 
7.208ppm: Tyrosine, k) variable 7.238ppm: Tyramine.  
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4.4.2.2. The effect of the mode of delivery on the faecal metabolic profile in 
developing infants.  
The characterization of the differences in metabolic profiles between infants born vaginally 
compared to those born by caesarean section using time series analysis was performed. This analysis 
shows that the main differences between the two groups can be seen at 4, 10 and 30 days’ 
postpartum samples and discriminatory metabolites associated with the two classifying groups 
samples are summarised in table 4-8. All samples were used in this investigation from all infants, 
regardless of their gestational age.  
Spline graphs from the discriminatory features indicate at which time point these features 
differentiate between the two groups; infants born caesarean section vs vaginally delivered (Figure 
4-5). These differences included a higher correlation to sugars/carbohydrates  (3.246, 3.408, 
3.418, 3.428, 3.438, 3.458) and dimethylamine (2.712) at these time points in vaginally 
delivered infants.  
 
Table 4-8: List of discriminatory variables assigned from time series analysis from faecal infants 
delivered via different modes; vaginally delivered (VD) and caesarean section (CS) (*overlapped 
resonances from glucose, other sugars and poly-ols, N-methylated compounds and amino acids).  P-
value on the significance of time trajectory of samples from infants with different modes of delivery 
for variable x. Empirical p-value obtained by estimation of the null distribution (no difference) using 
1000 permuted random groups, with Benjamini Hochberg FDR correction applied (see page 62). 
Variable p-value Metabolite ID  Higher association at 
time point   
4 10 30 120 
1.48 (d) 0.0009 Alanine  VD VD VD 
2.005 (s) 0.0009 Unknown 1   CS  
2.712 (s) 0.0009 Dimethylamine VD VD   
3.257 (s) 0.0009 Trimethylamine-N-oxide VD VD VD  
3.246 (m), 3.408 (m), 3.418 (m),  
3.428 (m), 3.438 (m), 3.458 (m) 
0.0009 Sugar* VD VD VD  
7.198 (d) 0.0009 Tyrosine  VD VD VD 
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At day 10, 30 and 120 days postpartum the metabolites alanine (1.48) and tyrosine (7.198) were 
also associated with vaginally delivered infants. At day 30 postpartum, infants born via caesarean 
section were highly associated with the metabolite found at 2.005, which I have been unable to be 
identify to date but which has a chemical shift and multiplicity similar to acetamide.  
 
 
Figure 4-5: Spline graphs of variables taken from 1H NMR spectral binned faecal data from 
infants born vaginally delivered versus caesarean section. Line represents the group mean of 
the feature through time and shaded area represents the 95% confidence interval 
Red=vaginally delivered samples, Blue = caesarean section samples. X-axis = time point of 
which the sample was taken – 1 = Day 4, 2= Day 10, 3 = Day 30, 4 = Day 120, 5 = Day 365, and 
6 = Day 730. a) Variable 1.48ppm: Alanine, b) variable 2.005ppm: Unknown1, c) variable 
2.712ppm: Dimethylamine, d) variable 3.24ppm: Sugar, e) variable 3.25ppm: TMA, f) variable 
7.198ppm: Tyrosine.    
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4.4.2.3. The consequence of infant BMI status at 1 and 2 years on the metabolic 
profile 
Unlike the multivariate data analysis, time series analysis demonstrates that there is a difference 
between infants of different BMI status at 1 year of age. Spline graphs from the discriminatory 
features displays the time points where these features differentiate between the two groups; high vs 
low BMI status of the infant at 1 year (Figure 4-7); information gained was categorical of high and 
low BMI and not the actual BMI number. Discriminatory metabolites associated with the two 
classifying groups samples are summarised in table 4-9. Infants with a high BMI status at 1 years old, 
have a relatively higher concentration of trimethylamine (2.884) and an unknown metabolite 
(7.925) at 1 years of age and 4-hydroxyphenylacetate (7.158) at 2 years old.  
 
Table 4-9: List of discriminatory variables assigned from time series analysis 
from faecal samples comparing infants BMI status at 1 years of age. P-value on 
the significance of time trajectory of infant with a BMI high vs low for variable x. 
Empirical p-value obtained by estimation of the null distribution (no difference) 
using 1000 permuted random groups, with Benjamini Hochberg FDR correction 
applied (see page 62). 
Variable p-value Metabolite ID Time point 
365 730 
2.884 0.00999 Trimethylamine H  
7.158 0.01198 4-Hydroxyphenylacetate (4HPA)  H 
7.925 0.04595 Unknown 1 H  
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Time series analysis showed that there was a difference between infants of different BMI status’ at 2 
years of age. Spline graphs from the discriminatory features display at which time point these 
features differentiate between the two groups; high vs low BMI status of the infant at 2 years 
postpartum (Figure 4-8).  Discriminatory metabolites associated with the two classifying groups 
samples are summarised in table 4-10.  
 
Figure 4-6: Spline graphs of variables taken from 1H NMR spectral binned faecal data 
comparing BMI status at 1 year – low vs high BMI. Line represents the group mean of the 
feature through time and shaded area represents the 95% confidence interval. Red=Low BMI 
infant samples, Blue = High BMI infant samples. X-axis = time point of which the sample was 
taken – 1 = Day 4, 2= Day 10, 3 = Day 30, 4 = Day 120, 5 = Day 365, and 6 = Day 730. a) Variable 
2.88ppm: TMA, b) variable 7.158ppm: 4HPA, c) variable 7.925ppm: Unknown1.  
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Figure 4-7: Spline graphs of variables taken from 1H NMR spectral binned faecal data comparing 
BMI status at 2 years of age – low vs high BMI. Line represents the group mean of the feature 
through time and shaded area represents the 95% confidence interval. Red=Low BMI infant 
samples, Blue = High BMI infant samples. X-axis = time point of which the sample was taken – 1 
= Day 4, 2= Day 10, 3 = Day 30, 4 = Day 120, 5 = Day 365, and 6 = Day 730. a) Variable 1.138ppm: 
propylene glycol, b) variable 2.439ppm: Glutamine, c) variable 2.81ppm: Aspartate, d) variable 
2.823ppm: Aspartate, e) variable 2.904ppm: Unknown1, f) variable 7.158ppm: 4-HPA  
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Infants with a high BMI status at 2 years old, have a relatively higher concentration of propylene 
glycol (1.138) and 4-hydroxyphenylacetate (7.158) compared to infants with a low BMI status at 
the age of 2 years. Also, an unknown metabolite at 2.904 was also seen at 10 days postpartum that 
is associated to a high BMI status at 2 years. When STOCSY was performed on this metabolite it is 
highly correlated to glutamine at 2.47.  
The metabolite aspartate (2.803, 2.813, 2.823) was correlated to a low BMI status at three 
different time points; days 10, 30 and 120 postpartum. Furthermore, samples taken at 120 days 
have relatively higher concentrations of glutamine (2.44) in infants with a lower BMI status at 2 
years of age.  
 
 
 
 
  
Table 4-10: List of discriminatory variables assigned from time series analysis from 
faecal samples comparing infants BMI status at 2 years of age. P-value on the 
significance of time trajectory of infants with high vs low BMI for variable x. 
Empirical p-value obtained by estimation of the null distribution (no difference) 
using 1000 permuted random groups, with Benjamini Hochberg FDR correction 
applied (see page 62). 
Variable ID () p-value Metabolite ID Time point 
10 30 120 
1.138 (d) 0.04795 Propylene glycol L   
2.44 (m) 0.02797 Glutamine   L 
2.803 (dd) 0.04195 Aspartate L   
2.813 (dd) 0.01098 Aspartate   L 
2.823 (dd) 0.00399 Aspartate  L  
2.904 (t) 0.03796 Unknown 1 L   
7.158 (d) 0.03296 4-Hydroxyphenylacetate (4HPA) L   
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4.5. DISCUSSION  
Using faecal samples is a relatively novel approach to metabonomic studies; especially for infant 
studies which are rare. This project has not only been able to provide a comprehensive 
characterisation of the development of the faecal metabolic profile but also further understand the 
effect that environmental exposures has.  Furthermore, the large scale of this cohort has not 
previously been performed in infant studies so this gives us an insight into the baseline metabolic 
profile from birth.  
This study has shown that the metabolic profile of infant faecal samples changes rapidly in the first 
few months of life. In this highly active developmental period, environmental interactions can affect 
the metabolic profile and potentially health in later life, especially in terms of gestational age at 
birth, mode of delivery and early nutrition (Malina et al., 2004; Dominguez-Bello et al., 2010; Howie 
et al 1990; Quigley et al., 2016). Characterisation of the faecal metabolic profile in this sample set 
has also given further insight into the gut microbiome development and functionality in the first few 
months of life (Chow et al., 2014). Choline metabolism has been recognised as an important part of 
development in infants, especially in terms of nutritional changes at 4 months postpartum (Trump et 
al., 2006).  
4.5.1. CHARACTERISATION OF METABOLIC PROFILE FROM FAECES IN DEVELOPING 
INFANTS OVER TIME FROM BIRTH UNTIL 2 YEARS OF AGE 
Infants develop rapidly from birth with consequential adaptation of physiology, which is likely to 
cause their metabolic profile to dramatically change in the first few months of life. In Chapter 3, it 
was discovered that urinary metabolic profiles changes dramatically in the first few weeks from birth 
and can be related to the mother’s metabolic profile at the time of birth. In this chapter, faecal 
metabolic profiles also follow an age-related trajectory. Therefore, this reiterates the importance of 
standardising age in infant studies, especially when interpreting data for other effects, such as 
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diseases and co-morbidities. It was observed that carbohydrates, sugars and N-acetyl-glycoprotein 
fragments highly correlated with samples taken at the earlier time points. Breast milk composition 
consists primarily of sugars (e.g. lactose), carbohydrates (e.g. oligosaccharides), proteins (e.g. 
casein), lipids (e.g. triglycerides) as well as minerals (e.g. magnesium) (Ballard and Marrow 2013; 
Andreas et al., 2015).  
In the first four to six months of life, the infants in this study were primarily fed milk (breast or 
formula milk), after which time introduction of solid foods was generally implemented; diet highly 
contributes to the faecal metabolic profile. Through this period the gut is rabidly establishing a 
community of bacteria which plays an important role in nutrition by digesting sugars into other 
products. As the gut microbiome is still being established and stabilising, the sugars from milk aren’t 
being fully broken down, therefore they are excreted in the faeces.  
Whereas, faecal water acquired at after 4 months’ postpartum correlated with organic acids 
including, amino acids (alanine, tyrosine, aspartate, phenylalanine), SCFAs (butyrate, propionate and 
acetate), and BCAAs (valine). Amino acids are important in energy metabolism as they are regularly 
used in the TCA cycle and intermediates for the synthesis of glucose (Moltu et al 2014). As 
mentioned previously, the gut microbiome is becoming well-established and many of the bacteria 
produce short chain fatty acids, essential amino acids and vitamins from the infant’s diet and 
therefore are contributing to the metabolome further (Miller et al., 1996, Louis et al., 2014, 
Tremaroli et al., 2012).  
The greatest change in the faecal metabolic profile can be seen between samples taken at 30 days 
compared to 120 days postpartum. Infants start to be weaned off breast/formula milk onto solid 
foods from 4-6 months so this could be the main reason for the dramatic change in faecal profile 
between these two time points. Furthermore, the gut microbiome can change very quickly during 
this period and start to become similar to an adult composition (Koenig et al., 2011).  
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As seen with the previous model, it was observed that sugars and N-acetyl-glycoprotein 
fragments highly correlated with samples taken at 30 days postpartum. However, faecal metabolic 
profiles at 120 days were correlated to bile acids, 4-cresyl glucuronide, methylamine and an 
unknown metabolite. This unknown metabolite has two signals at 1.65 (m) and 2.24 (t) which is a 
very similar chemical shift patterns to alpha-aminoadipate; an intermediate of the breakdown of 
lysine. Further investigation using spike-in experiments would be needed to confirm this ID.  
Bile acids have a role in digestion as they emulsify and solubilises fats for intestinal absorption 
(Houten et al., 2006) as well as repress the growth of microbiome.  Furthermore, previous 
investigations have found that bile acids excreted in the faeces are correlated to the weight of the 
child; these results are in agreement to these findings as infants at 120 days will have gained a 
significant amount of weight from 30 days postpartum (Murphy and Signer, 1974).  
The metabolite 4-cresyl-glucuronide is a product of protein degradation by the gut microbiome and 
usually absorbed by the colon. Furthermore, this metabolite is strongly correlated with the transit 
time of faeces through the gastrointestinal system from urine samples (Roager et al., 2016). From 
this faecal data, it can be concluded that infants at 120 days postpartum have a higher concentration 
of protein in their diet but don't fully absorb the by-products from protein breakdown by the gut 
microbiome (Musso et al., 2010, Dumas et al., 2006). Furthermore, there was no distinguishable 
difference between 1 and 2 years of age samples, suggesting that at this stage nutrition and the gut 
microbiome’s contribution to metabolism is stable.   
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4.5.2. CHANGES IN INFANT FAECAL METABOLIC PROFILES RELATED TO EARLY LIFE 
EXPOSURES  
4.5.2.1. Full-term versus preterm (early and late) at birth 
Infants born after 37 weeks of gestation are regarded as born at term, whereas infants born earlier 
are regarded as born preterm; this characterisation can be split again into early (<27 weeks gestation 
age at birth) and late preterm (32-36 weeks gestation age at birth). From this dataset, I anticipated 
to gain an insight into the effect of gestational age at birth longitudinally. The difference in early life 
was further investigated in the subsequent chapter of this thesis (Chapter 5). Furthermore, the 
model was also modelled at each time point because the faecal metabolic profiles rapidly change 
over time so it was essential to take away the confounding factor of the data set in terms of time 
points.  From the 1H NMR data through multivariate statistics as well as time series analysis, similar 
metabolites which are discriminatory between the two groups have been established. From the time 
series data, the specific trajectory of the metabolites can also be examined thoroughly using Spline 
graphs. 
Butyrate is a principal SCFA that is produced by bacterial fermentation from the breakdown from 
lactose and recognised here as discriminatory in preterm infant samples. From the time series 
analysis spline graphs, it is evident that this metabolite has similar time trajectories in term and 
preterm but at relatively different concentrations. SCFAs are well known to act as a protective agent 
against infant diarrhoea. However, this metabolite has been implicated in NEC cases in animal 
models (Pourcyrous et al., 2014, Waligora-Dupriet et al., 2009, Wang et al., 2009). NEC is a serious 
disease related to preterm infants and the colonisation of pathogenic bacteria in the gut. 
Unfortunately, there was no data from this project as to whether any of these infants suffered from 
this disorder during this study.  
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A lipid (named here as L1 (1.3)) in NMR spectra is also highly associated with preterm infants 
samples (Musacchio et al., 2009). Preterm infants are typically fed high fat parenteral nutrition at 
the start of life and therefore higher lipid contents in their faeces are expected through 
malabsorption; preterm infants are more prone to malabsorption due to the immaturity of their 
gastrointestinal system and the low concentration of bile acids found in preterm infants (Fanaro, 
2013). Further evidence for the higher association of L1 in preterm infants can be seen in the spline 
graphs from the time series analysis as L1 is very high in preterm infants and gradually decreases 
over time as the infant develops and are subject to less parenteral nutrition.  
 
Term infants are highly associated with choline as well as betaine (choline breakdown product 
metabolite) from the time series analysis. The human body cannot synthesis choline and relies on 
exogenous sources from the diet; typically, choline is in high abundance in meat, animal products as 
well as human breast milk. Choline is broken down by choline oxidase to make betaine aldehyde and 
broken down further to make betaine by betaine aldehyde dehydrogenase. Betaine is then further 
metabolised into dimethylglycine (DMG) in another enzymatic reaction when choline is being 
Figure 4-8: Schematic to represent dietary choline biochemical pathway in the human 
body (Adapted from Cheng et al., 1996) 
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converted to glycine. TMA is produced from the conversion of choline by the gut microbiome 
enzymatic activity. TMA is then absorbed by the body and transported to the liver where TMAO is 
formed exclusively from the N-oxidation of TMA in the presence of liver FMO enzymes; TMA can also 
be broken down into DMA by the liver.  
Human breast milk provides large amounts of choline, especially in mature milk (220-300mol/L) 
compared to colostrum (~130mol/L), whereas formula feed and TPN choline concentrations can 
vary (~50-700mol/L)  (Ilcol et al., 2005; Caudill 2010; Cheng et al., 1996). Choline is a precursor for 
the biosynthesis of phosphatidylcholine which is essential to make cell membranes and therefore, 
neonates need large amounts of choline to sustain growth (Holmes-McNary et al., 1996). Term 
infants are also highly associated with N,N,N-trimethyl-lysine; this metabolite is a methylated 
derivative of the amino acid lysine. It is an integral part of carnitine biosynthesis and essential for 
energy metabolism (Vaz et al., 2002; Servillo et al., 2014).  
Separating the data set and modelling the data by time point independently, gives a better insight 
into the changing development of the faecal metabolic profile. Faecal water NMR profiles of preterm 
infants are highly associated with 3’-fucosyllactose, a common breast milk oligosaccharide and a 
substrate that the infant doesn’t digest in the stomach (Practico et al., 2013). This metabolite 
reaches the large intestine where the gut microbiome utilises it as a source of nutrition. Therefore, 
this could suggest the term infants’ gut microbiome have a larger diversity than the preterm infants 
and fully utilising this source of nutrition and therefore not being excreted by the term infants too 
(Cong et al., 2016).  
Using time series analysis, the spline graph for tyramine is very interesting. With similar relative 
concentrations of tyramine at birth for both term and preterm born infants, this metabolite 
decreases in term samples in the first few days of life and then rapidly increases after 10 days 
postpartum. Whereas in preterm infant samples tyramine stays relatively stable throughout the time 
points. This metabolite is a derivative of the common amino acid, tyrosine; the conversion of this 
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metabolite is linked to lactic acid bacteria, a common bacterial species found in the neonatal gut 
(Marcobal et al., 2013). It would be interesting to correlate this information to bacterial profiles and 
know the abundance of lactic bacteria (Johansson et al., 2005). 
Term infants have higher concentrations of faecal bile acids than preterm infants from 4 to 120 days 
postpartum, which has been seen previously (Moltu et al., 2014). This result reiterates the baseline 
characteristics seen in term infant faecal profiles compared to preterm. From the spline graph for 
this variable, the increase of bile acid at 120 days postpartum could be related to the shift in diet 
that infants start to experience when they are weaned off milk and fed solid foods.  
In term infant samples at 120 days postpartum, the metabolic profile has changed considerably 
compared to 30 days postpartum, which is most likely to do with the weaning of the infant.  Term 
infants at 120 days postpartum are still associated with choline however. Also at this time point, 
term infants had a higher correlation to amino acids, including alanine, tyrosine, phenylalanine and 
leucine, which is likely to be related to their change in diet and the increase production of energy for 
growth.  
Term infants were related also to succinate at this time point which is involved in the citric acid cycle 
to produces energy for cells. This metabolite has previously been found to be related to age in urine, 
with stronger correlations in infants less than one years of age compared to toddlers (Gu et al., 
2009), therefore this metabolite may be higher in term infants due to their relative size at this time 
point compared to preterm infants. Furthermore, succinate can be broken down from glucose by the 
gut microbiome, further suggesting that the gut microbiome community is more diverse in term 
infants (Jurtskuk et al., 1996).  
Faecal samples taken at days 365 and 730 postpartum, do not show any separation in samples from 
infants born term or preterm. This suggests that being born term or preterm on the metabolic 
profile doesn’t carry on once the infant is older.   
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4.5.2.2. Birth gestational age (GA) and birth weight  
As previously discussed, birth weight and birth gestational age (GA) could be related, and from this 
data this correlation is reflected in the similarity of the metabolites associated with each class.  
Modelling the data using a regression analysis was performed to gain a greater insight into the 
potential subtle differences in the faecal metabolic profile, which may be lost from a discriminatory 
analysis (term vs preterm). Faecal metabolic profiles were analysed as a whole data set which 
included all time points, as well as analysing the time points individually, using a regression model 
(OPLS).  
When modelling all the time points, infants born at a lower birth GA and weight had relatively higher 
concentrations of ethylene glycol. As described in chapter 3, this metabolite has been recognised as 
a contaminant from nappies, however it can also come from other sources including drug excipients. 
Infants who are born at a lower GA or weight are more likely to have complications, related to being 
underdeveloped from birth, and consequently are more likely to be treated with a variety of drugs.  
Furthermore, infants born at a lower birth GA and weight are related L1 (1.31); a tentatively 
assigned fatty acid chain of a triacylglyceride. Infants born at a lower GA are more likely to be being 
fed a diet rich in fatty acids (including linoleic acid) as well as other nutrients (amino acids, glucose, 
vitamins and minerals) (Gutcher et al., 1991, Meyers et al., 2013).  
Whereas, only infants with a lower birth GA and not birth weight were positively correlated to 
butyrate (0.86); this metabolite was also correlated to infants born preterm. Butyrate is a common 
source of energy for colonic epithelial cells and has a role in the proliferation of these cells as well as 
the maintenance of the intestinal barrier function (Neu et al., 2007, Hague et al., 1996). Formula fed 
infants produce more butyrate compared to breast fed infants and as these infants are more likely to 
be preterm this result is not unusual (Sanderson and Naik, 2000; Lee et al., 1972). As mentioned 
before, this metabolite has been implicated in NEC (Pourcyrous et al., 2014; Waligora-Dupriet et al., 
2009) and these results suggest that infants with a higher birth weight irrespective of their 
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gestational age may not be as likely to contract NEC (Gephart et al., 2013). This information could be 
useful for the management of preterm infants and further understanding the aetiology of NEC.  
Conversely, choline and N,N,N-trimethyl-lysine was at a relatively higher concentration in samples 
from infants born with a higher GA and birth weight as well as glucose and other sugars. These 
discriminatory metabolites are the same as those seen in term infants, when modelling infants as 
the two discriminatory classes; term or preterm.  
By modelling the data from each time point separately, samples taken at 4, 10 and 30 days with a 
lower gestational age and a lower birth weight were positively correlated to 3’-fucosyllactose, a 
common breast milk oligosaccharide. It is believed that oligosaccharides are resistant to enzyme 
hydrolysis in the stomach so that they are able to reach the large intestine where they serve as 
substrates for bacterial metabolism (Marcobal et al., 2012). This would suggest that the gut 
microbiome from this group are not utilising this compound fully so it is being excreted. Recently, 
Andreas et al., (2016) investigated the role of specific oligosaccharides species on Streptococcus B 
(GBS) infection in infants. This is important as GBS infection is the leading cause of infection in the 
first month of age. This study concluded that the 3’-fucosyllatose is inversely correlated to the 
abundance of GBS in breast milk as well as infant gut microbiome (Andreas et al., 2016); this is due 
to HMOs stopping the adherence of pathogenic bacteria to the intestinal epithelium as well as 
promoting commensal bacteria by acting as a nutritional source.   
Infants born at a higher birth weight are related to bile acids at 4 and 10 days postpartum, as 
previously been described these samples are related to weight rather than the GA of the infant at 
birth (Murphy and Signer 1974).  
When analysing the data as a whole it was apparent that at 120 days postpartum the metabolic 
profile changes significantly compared to samples taken during the neonatal period (≤30 days 
postpartum). When regressing birth weight and birth GA at 120 days postpartum, samples from 
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lower birth GA and weight separate due to higher correlation to sugars and carbohydrates; however, 
this does not include the milk oligosaccharide, 3’-fucosyllactose. These infants typically won’t be fed 
as much breast milk at this stage and are either on formula feed or weaned onto solid foods. 
Samples from higher birth GA and weight separate due to amino acids including alanine, valine, 
tyrosine and leucine as well as succinate. These discriminatory metabolites are comparable in term 
infants, when modelling infants as the two discriminatory classes (term vs preterm) rather than a 
regression.   
Comparable to the previous model, faecal samples taken at days 365 and 730 postpartum, do not 
show any separation in samples from infants at any birth weight or gestational age. This suggests 
that the differential effect of birth weight and gestational age on the metabolic profile doesn’t carry 
on once the infant is older.   
4.5.2.3. Mode of delivery – Vaginally Delivered (VD) vs. Caesarean Section (CS) 
From the 1H NMR data through multivariate statistics as well as time series analysis, similar 
metabolites which were discriminatory between the two groups have been established. From the 
time series data, the differential trajectories of the metabolite profiles associated with mode of birth 
can also be examined. 
Infants can be delivered through the vaginal canal (VD) or by caesarean section (CS); these actions 
are different mechanically as well as biologically. One very important difference between these 
infants is that they are thought to have different microbiota colonising their guts initially depending 
on the mode of delivery. Vaginally born infants are colonised by bacteria which are typically found in 
the vaginal canal (e.g. lactobacillus), whereas infants which are born through caesarean section are 
colonised by bacteria typically found on skin or within the hospital environment (e.g. 
Staphylococcus) (Dominguez-Bello et al., 2010, Matamoros et al., 2013). Furthermore, in the first 
few days after birth, the gastrointestinal system is becoming increasingly more anaerobic, thus 
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rapidly affecting the community (Solis et al., 2010).  By analysing faecal metabolic profiles, it gives an 
insight into the functionality of the gut microbiome and whether differences can also be seen in 
infants born through different modes.  
Infants which were delivered vaginally (VD) have relatively elevated concentrations of alanine when 
all the time points were modelled as well as at 10 and 30 days postpartum. This metabolite is a 
common amino acid; mainly used to produce energy from protein degradation (Rodwell, 2012). 
Acetone was also associated with this group; this is a ketone body, which is broken down in the liver 
to make energy for muscles, kidneys and brain (Bronk, 1999; Raman et al., 2013). This would suggest 
that energy production is more efficient in VD infants compared to CS.  
By modelling the data separately by time point, samples at day 10 and 30 postpartum from infants 
born through different modes of delivery separated clearly. Infants born through caesarean section 
correlate highly with tyramine. As previously mentions in the term versus preterm analysis, this 
metabolite is related to blood pressure. It has been found that delivery through CS causes a higher 
risk to high blood pressure in later life (Horta et al., 2013); therefore, this metabolite may be a factor 
towards this risk. Furthermore, tyramine is a derivative of the common amino acid, tyrosine; this 
conversion is linked to lactic acid bacteria (Pessione, 2012,). Lactic acid bacteria are commonly found 
in the infant gut microbiome as breast milk is a significant source for these bacteria to colonise the 
gut (Martin et al., 2003). Infants born vaginally already have an abundance of Lactobacillus in their 
guts whereas CS infants are typically colonised by Staphylococcus bacteria (Dominguez-Bello et al., 
2010). This result suggests that infants born through CS aren’t introduced to lactic acid bacteria until 
they are breast fed and this influx of bacteria can then utilise tyrosine and convert it into tyramine. 
Interestingly, infants born vaginally positively correlated to tyrosine at this time; the amino acid 
precursor to tyramine. Schulpis et al., (2008) investigated the plasma from mothers and umbilical 
blood who delivered their babies through VD and CS. They concluded that VD increased tyramine 
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found in plasma from mothers as well as umbilical cord blood and attributed it to the stress of 
delivery (Schulpis et al., 2008).  
Dimethylamine (DMA) and trimethylamine-N-oxide (TMAO) are related to the degradation of choline 
from the diet by the gut microbiome (Zeisel et al., 1989). The bacteria in our gut break down choline 
into trimethylamine (TMA) and DMA. TMA is absorbed and transported to our livers where it is 
further metabolised into TMAO (Romano et al., 2015).  The association of these metabolites with VD 
infants may be due to the excess of choline from breast milk of these infants. Interestingly, from the 
time series analysis, the spline graph for dimethylamine is high at the beginning of life, then drops 
off at 4 months before increasing again at 1-2 years; this result is similar to previous findings (Foxall 
et al., 1995). The increase of choline concentration in breast milk over the first few days and then 
the introduction of solid foods further changes the composition of the gut microbiome and therefore 
the functionality which can be recognised in the faecal profiles (Holmes et al., 2000).   
At 10 days postpartum infants VD had relatively higher amounts of -aminobutyrate (GABA), this 
compound is the product from glutamate break down by the Lactobacilli and Bifidiobacteria (Barrett 
et al., 2012; Li et al., 2010). These species of bacteria have been shown to be present at higher levels 
in infants born via VD so this result is not surprising (Dominguez-Bello et al., 2010). Although, GABA 
is a well-known neurotransmitter and elevated levels have been implicated in neurological disorders 
including autism spectrum disorders (Dhossche et al., 2002).  
4.5.3. Differences in metabolic profiles of stool associated to nutrition in infants 
exclusively breast fed for different periods of time  
Breastfeeding infants is recommended due to the complex mixture human oligosaccharides present 
in the milk as well as the immunological benefit for the child; breast milk is rich with immunoglobulin 
to protect the infant as well as help to mature their immune system (Andreas et al., 2015). Both of 
these functions are difficult to replicate in infant formula feed. To investigate the specific metabolic 
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signature associated with diet-induced development, faecal metabolic profiles were studied at 
samples taken at 120 days postpartum. Information was collected from mothers how long, in 
months, were infants exclusively breast fed (maximum exclusive breastfeeding for 12 months) but 
with many infants started to be weaned off milk around 4-6 months this added another confounding 
factor. Therefore, modelling the data at 4 months gives a better insight to the effect of the 
exclusivity of breastfeeding in the first few months.     
Breast milk differs from infant formula feed as it contains sialylated and fucosylated oligosaccharides 
(human milk oligosaccharides), which acts as prebiotics for the gut microbiome (Marcobel 2012; 
Tannock 2013; Smilowitz 2014). It therefore contains N-acetyl glycoproteins and choline, which 
corresponds to the results seen from infants exclusively breast fed for 4 months. Choline has been 
found to be critical during fetal development and is important for normal growth and neuro-
development in neonates (Zeisel 2006; Ozarda 2014; Ilcol 2005).  This reiterates the need to feed 
infants breast milk from birth, especially if infants being formula fed are not gaining enough choline 
for normal development, which these results may be reflecting.  
Infants that weren’t exclusively fed breast milk were positively correlated to SCFAs including 
butyrate, acetate and propionate. These fatty acids are bacterially generated by the fermentation of 
polysaccharides and infants who are formula fed have a more diverse bacterial community including 
Bacteroides and Clostridium species, compared to breast fed infants, who predominantly contain 
Bifidiobacterium (Knol et al., 2005). In agreement with previous findings, it has been found that 
butyrate and propionate are found at a higher concentration in formula fed infants compared to 
breast fed infants (Edwards et al., 1994; Edwards et al., 2002). Additionally, acetate is usually 
associated to breast fed infants (Knol et al., 2004). However, as this project is investigating the faecal 
metabolic profile it would indicate that these molecules are not being absorbed by the infant and so 
not introduced into the body systemically. Therefore, it could be postulated that acetate may be 
being produced by breast fed infants but they may be fully absorbing it and excreting less readily in 
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their faeces.  If we would be able to profile urine samples from the same infants this would give an 
indication of the metabolites which have entered the body systemically and potentially have 
interactions with their own metabolism.  
Furthermore, formula feed contains an excess of protein compared to breast milk to make up the 
amino acid differences and therefore these molecules are in excess for the formula feed infant 
(Chow et al., 2014). In animal models, it has been suggested that this excessive protein intake could 
compromise the intestinal barrier function, alter the colonic microbiota as well as affect early 
immune development (Boudry et al., 2013). Additionally, high protein infant formula feeds also 
contribute to obesity risk later in life (Lifschitz et al., 2015).  
4.5.4. Time series analysis of 1H NMR faecal metabolic profiles from infants classed as 
high BMI at 1 year and 2 years old.  
Obesity is among the major current health problems, which are increasing rapidly worldwide. 
Obesity is associated with a heightened risk of Western lifestyle diseases such as type 2 diabetes, 
cardiovascular disease risk, and sleep apnoea, as well as also increases the mortality risk (Jess, 2015; 
Musso et al., 2011). Excessive weight increments during the first months of life have been associated 
with a high risk of obesity development at 3 years of age as well as in later life (Rodriguez et al., 
2015; Druet et al., 2011; Monterio and Victoria 2004). This project is interested in the effect of early 
life exposures to the correlation with infant BMI status; BMI data were therefore recorded at 1 and 2 
years of age.  
From the 1H NMR data, the multivariate model (OPLS-DA) indicated that there was no significant 
difference in faecal metabolic profiles from infants with a high versus a low BMI. However, from the 
time series analysis on the same 1H NMR data, there is a significant difference between metabolite 
profiles between infants with high versus low BMI status. However, the difference between the 
different BMI status’ was very small as can be seen in Figures 4-7 and 4-8.  
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At 1 year of age, infants with a high BMI status at this age were associated with the metabolite, 
trimethylamine (TMA). TMA is a product of choline metabolism by the gut microbiome, where it is 
usually absorbed by the body to convert it into trimethylamine-N-oxide (TMAO) in the liver (Figure 
9). From the spline graph, it is evident that this metabolite is increasing as the infant ages, showing 
the increased efficiency of the gut microbiome metabolising choline products.  TMA and TMAO in 
urine and plasma have been connected to a higher risk of cardiovascular disease and related to the 
development of diabetes and obesity (Wang et al., 2011). Furthermore, Zhang et al., (2015) noted a 
decrease in TMA in urine from obese children on a non-digestible carbohydrate intervention diet 
indicating that this metabolite is a factor towards developing obesity in infants (Zhang et al., 2015).  
4-Hydroxyphenylacetate is a microbial catabolism product of tyrosine and was associated with 
infants with a high BMI status at 1 year of age (Holmes et al., 2011). From the spline graph, this 
metabolite increased rapidly after the first month of life until 2 years compared to infants with a low 
BMI status where it has a relatively stable trajectory through time. 4-Hydroxyphenylacetate has 
previously been noted to be elevated in biofluids associated with GI conditions in children, including 
small bowel disease (Chalmers et al., 1979). Protein degradation products suggest that the gut 
microbiome from these infants is has become distinct after the first month of life and is utilising 
tyrosine for energy thus producing 4-hydroxyphenylacetate. Interestingly, this metabolite is present 
in samples taken at 10 days postpartum, and is at a higher concentration in infant with a low BMI 
status at 2 years of age. When observing the spline graph, it shows that this metabolite is at a low 
concentration at birth and increases exponentially over time in infants with a high BMI whereas 
remained relatively stable for infants with a low BMI status at two years. This implies that high BM 
status infants at 2 years of age may have a distinctive gut microbiome altering their metabolic 
profiles. Further investigation into which bacterial species associated to this metabolite would be 
very interesting.  
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Infants with a low BMI status at 2 years of age are connected to aspartate at 10, 30 and 120 days 
postpartum with the spline graphs indicating that the trajectory is similar for each group but 
increased in these infants. Aspartate is a non-essential amino acid that is generated in the urea cycle 
by citrulline and ornithine (Rodwell, 2012). From the time series analysis, aspartate was also 
significantly different with a p value of 0.04 from samples taken at 30 days postpartum indicating it 
was not highly significantly different between the two groups at this time point.  
Furthermore, at 120 days postpartum, samples from infants at a low BMI status at 2 years of age are 
positively correlated to glutamine. Glutamine an amino acid found at high concentrations in human 
breast milk and increases in concentration in breast milk with time (Agostoni et al., 2000). This may 
indicate that infants that were still being fed breast milk at 120 days postpartum were more likely to 
have a lower BMI once they reach two years of age. This result has previously been observed in 
infants who are breastfed for longer are found to be leaner than those who are weaned earlier 
(Burke et al., 2005, Weng et al., 2012).  
4.6. CONCLUSION 
There is a clear age related variability in faecal metabolic profile which has been characterised in this 
project. Faecal metabonomics is fast becoming a tool to help us understand interactions between 
human health, nutrition and the mutualistic relationship of the gut microbiome. This interaction is 
especially important throughout the infant developmental period as it could have an impact on later 
life health.  
Changes in nutrition dramatically alters the faecal metabolic profile at 4 months postpartum and 
choline metabolism has been recognised as an important function in infant metabolism. 
Furthermore, the gut microbiome functionality in energy metabolism and metabolic pathways is 
very interesting and opens up new ideas for targeted investigation in infant development.  
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Gestational age at birth is recognised as a contributor the metabolic profile as well as the mode of 
delivery; especially the potential altered functionality of the gut microbiome in these infants.  
This cohort of infants has progressed the understanding of the development of the faecal metabolic 
profile. This foundation will help to determine the relative strengths in future studies especially in 
terms of gestational age at birth, early nutrition, mode of delivery, the role of the gut microbiome 
and the risk of obesity later in life.  
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CHAPTER 5  
 
METABOLIC AND MICROBIOMIC PROFILING OF 
INFANTS BORN TERM VERSUS PRETERM 
 
 
 
5.1 . INTRODUCTION  
Preterm infants are generally born immature as different systems develop at different times of the 
gestational period. Preterm and low birth weight (LBW) babies that survive through the neonatal 
period face the possibility of a lifetime of different disorders and disabilities (Howson et al., 2012; 
Moster et al., 2008). Preterm birth may predispose children to the development of the symptom 
complex referred to as metabolic syndrome in later life. Metabolic syndrome can be defined as a 
group of risk factors that raise the possibility of heart disease, stroke and other health problems that 
affect the blood vessels (Alberti et al., 2005; Despres et al., 2006; Reaven, 1988).   Metabolic 
syndrome starts with early insulin resistance, with the consequent development of type II diabetes, 
abdominal obesity, and hypertension (Abitbol et al., 2012).  
Furthermore, early life environmental influences, including gestational age, the mode of delivery, 
nutrition (e.g. maternal or formula milk), clinical interventions (e.g. antibiotics), environmental 
exposures can affect development of infant development as well as the composition of the gut 
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microbiome (Nicholson et al., 2012; Penders et al., 2006). For many preterm infants, they have a 
perturbed development of the gut microbiome due to these different factors (Cong et al., 2016).  
In studies investigating preterm infants compared with full term infants, an altered urinary 
metabolome has been discovered in preterm infants, with increased relative concentrations of 
citrate found in preterm and creatinine in term infants (Hyde et al., 2010). Furthermore, metabolites 
related to renal function during the neonatal period have been recognised as different in preterm 
infants, including 1-N-methylnicotinamide and myo-inositol (Foxall et al., 1995; Trump et al., 2006). 
 As previously noted in chapter 4, faecal metabolic profiling is still a novel application for 
metabonomic studies. Using this biofluid will help us to further understand the relationship between 
human health, nutrition and the developing gut microbiome. Currently there is limited knowledge 
and research in the infant faecal metabolome (Chow et al., 2014). This study complements the 
previous chapter by specifically looking at term and preterm infants metabolic profiles but at specific 
time points; at birth, term equivalent age and 3 months postpartum.  
Postnatal age is highly related to the changes in the metabolic profiles as well as the gut 
microbiome, due to the rapid development of the body after birth.  Exposures to different 
environmental factors add to the importance of the neonatal period for development and health in 
later life. Therefore, the understanding of different exposures in early life can help to predict or 
prevent later disorders.  
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5.2. AIM 
The aims of this chapter are to: 
 Characterise the dynamic perturbations of urinary and faecal metabolites in infants born 
preterm or term by 1H NMR spectroscopy and UPLC-MS in conjunction with multivariate data 
analyses.  
 Understand the variation in urine and faecal water metabolic profiles in infants through the 
first few weeks of life by 1H NMR and UPLC-MS. 
 To observe changes in the gut microbiota community during the course of development from 
birth in infants born term or preterm.  
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5.3. MATERIALS AND METHODS 
5.3.1. SAMPLE SET INFORMATION  
Samples of biofluids were taken from infants shortly after birth and during the first few weeks of life. 
The infants in this study were born at either term (gestational age (GA) 37-41 weeks) or preterm (GA 
24-36 weeks). This study includes urine (n=278) and stool (n=308) samples from about 150 infants 
(Figure 5-1 and Table 5-1). Biofluid samples taken from preterm infants were taken from birth and 
subsequently at weekly intervals until they were discharged from the neonatal unit. Whereas, urine 
and stool samples from term infants were collected predominantly at birth or in the first two weeks 
of life, and over the first 3 months of life, with the majority taken around 3 months postpartum. 
Information corresponding to birth gestational age, day of sample postpartum and type of feeding 
was also recorded at the time of sampling.  
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Figure 5-1: Schematic representation of urine and faecal samples analysed in chapter 5 for 
metabolic phenotyping and metagenomic analysis. Showing gestational age as well as date at 
which sample was taken in weeks postpartum 
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Table 5-1: Clinical data information for Term vs. Preterm sample set. Urine and Stool samples 
analysed using 1H NMR and LC-MS. Smaller batch of stool sampled for 16S MiSeq analysis due to 
sample volume. Data is expressed as the median (IQR) or as a percentage of subjects. 
Clinical data Urine Stool 16S MiSeq 
Number of samples 278 308 296 
Number of infants 109 151 147 
Time points range (days) 37 (0-123) 21 (0-134) 21 (0-134) 
Birth samples (%) 11.10% 7.48% 6% 
Gender (% male) 49.10% 47.90% 47.47% 
Birth gestational age (range) 30.7 (24.1-42) 38.3 (24.1-42) 38.5 (24.1-42.2) 
Preterm samples (%) 54.50% 44.48% 43.77% 
Weight median (g) 2770 (590-4720) 3050 (590-5820) 
3050 (590-
5820) 
Caesarean section (%) 19.30% 23.40% 23.90% 
Breast fed infants 46.60% 26.30% 26.60% 
 
Urine and stool samples were collected from infants born at term and preterm as part of an on-
going study at the Chelsea and Westminster Hospital (Ethics number: REC10H07135). Urine and 
stool was stored in Chelsea and Westminster hospital in -80C freezers and transferred to the South 
Kensington Campus using dry ice to keep them frozen. Samples were then stored in -80C freezers in 
the Sir Alexander Fleming building until preparation for metabolic profiling was conducted.  
5.3.2. URINE PREPARATION FOR METABOLIC PROFILING (1H NMR AND UPLC-MS) 
Urine samples were thawed and centrifuged at 16000 xg for 10 minutes at 4°C. A volume of 540µl of 
urine was mixed with 60µl of phosphate buffer solution at pH 7.4 (Potassium Dihydrogen Phosphate 
(KH2PO4), 3-Trimethylsilyl Propionic Acid-d4 Acid Sodium Salt (TSP), Sodium Azide (NaN3)), containing 
TSP (0.5mM) and sodium azide (3mM). Samples were transferred to 5mm NMR tubes and spectra 
acquired using a 600MHz 1H NMR spectroscopy.  
For UPLC-MS metabolic profiling, urine samples were thawed and centrifuged at 16000 xg for 10 
minutes at 4°C. Samples were transferred to 96 well plates for analysis by UPLC-MS.  A pooled 
sample from all urine extracts were created for quality control (QC) purposes. 
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5.3.3. FAECAL WATER PREPARATION FOR METABOLIC PROFILING (1H NMR & UPLC-MS) 
Faecal samples were weighed out (100mg) and transferred to micro-vials, which contained 0.1mm 
zirconium beads whilst frozen. They were subject to two freeze thaw cycles before having 250µl of 
ACN:H2O added to the micro-vials. These vials were homogenised using a bead beater for 10 seconds 
and centrifuged at 16,000 xg for 10 mins, at 4°C. The supernatant was taken from the vial and placed 
in pre-washed spin columns and again centrifuged for 20 mins at 16,000 xg, at 4°C. The faecal water 
was separated into two aliquots; one for NMR analysis and one for UPLC-MS analysis. The NMR 
aliquot was evaporated under nitrogen gas for 30 mins to remove the organic solvent. Once 
evaporated, these samples were reconstituted into 540µl D2O and 60µl phosphate buffer, vortexed 
and sonicated for 5 minutes. The faecal water samples were transferred into 5mm NMR tubes for 
spectra to be acquired using a 600MHz 1H NMR spectroscopy.  
The second aliquot was used for targeted bile acid profiling using UPLC-MS analysis; the faecal water 
samples were diluted 1:1 sample to isopropanol (IPA) respectively. It was vortexed for 1 minute, 
frozen for one hour and centrifuged for one hour at 16,000 xg, and the supernatant was transferred 
into glass vials.   
The faecal pellet obtained after the first centrifugation step during faecal water extraction, were 
subject to DNA extractions for gut microbiome investigation; this process is further explained in 
section 3.6 of this chapter.  
5.3.4. NMR SPECTROSCOPY OF BIOFLUIDS  
Please refer to Chapter 3, section 3.3.5 for details (Materials and Methods).  
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5.3.5. ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (UPLC-
MS) 
5.3.6. Hydrophilic Interaction Chromatography – Mass Spectrometry (HILIC-MS) 
Please refer to Chapter 3, section 3.3.6.2 for details (Materials and Methods).  
5.3.7. Targeted Bile Acid Profiling using UPLC-MS 
An acquity UPLC BEH C8 (2.1 × 100 mm, 1.7 μm) column (Waters Corp, USA) was used with the 
column temperature set at 60 °C. Mobile phase A consisted of water acetonitrile (ACN)/ (90:10) and 
mobile phase B ACN/IPA (50:50). In mobile phase A solution ammonium acetate was diluted to 1 
mM final concentration and 0.35 mM acetic acid. The elution gradient was set as follows: 90% A 
(0.0−9.25 min; 0.6 mL/min), 90−65% A (9.25−11.5 min; 0.6 mL/min), 65−15% A (11.5−11.8 min; 0.65 
mL/min), 15--0% A (11.8—12.4min; 0.8−1 mL/min), 0 - 45% A (12.45-12.5 min; 0.85 mL/min), 45 - 
90% A (12.5-12.6 min; 0.85 mL/min), 90% A (12.6−12.7 min; 0.8 mL/min), 90% A (12.7−12.8 min; 0.7 
mL/min), 90% A (12.7-15 min; 0.6 mL/min). An injection volume of 1 μL was used for both positive 
and negative ionization polarity modes. The auto-sampler was set to operate at 4°C. Mass 
spectrometry was performed using a Xevo G2 Q-TOF (Waters MS Technologies Ltd., UK) with an 
electrospray ionization (ESI) source. Finally, the same QC strategy was followed as for this analysis 
with H2O experimental blanks and a pooled infant faecal water sample being injected at the 
beginning and end of the acquisition. Furthermore, bile acid standards mixes were also acquired for 
reference.  
5.3.8. GUT MICROBIOME ANALYSIS FROM FAECAL SAMPLES USING 16S rRNA GENE 
SEQUENCING 
Pellets taken from faecal samples, obtained from faecal water samples extracted previously, were 
subject to DNA extraction. Isolation and purification of DNA from faecal samples was performed by 
 168 
 
PowerFecal® DNA Isolation Kit (MO-BIO Laboratories, California USA). This process involves the 
breakdown of cells using bead homogenisation as well as chemical disruption to cell walls, to ensure 
all DNA is extracted from cells. DNA is isolated through binding to a silica spin column and further 
washing to remove any substances that may interfere with PCR before eventually being eluted from 
the column. This eluted DNA was used for next generation sequencing.  
After DNA extraction of faecal samples, Polymerase Chain Reaction (PCR) was performed. The PCR 
mixture included 0.25 µl of Taq polymerase, 2.5 µl 10X buffer, 0.25 µl BSA, 0.5 µl of the universal set 
of primers for the variable region V3 (515F, 806R), 0.2 µl of dNTPs, 1 µl of the extracted DNA sample 
and making up the mixture to 25 µl with nuclease free water. PCR methods were performed by an 
initial denaturation step at 95°C for 3 minutes, followed by 30 cycles each consisting of a 
denaturation step at 90°C for 30 seconds, an annealing step at 58 to 65°C for 30 seconds and an 
extension step at 72°C for 45 seconds. A final extension step of 10 minutes at 72°C was performed to 
ensure complete amplification of all the DNA fragments. PCR products were analysed by 
electrophoresis in agarose gels containing ethidium bromide at a concentration of 2% w/v. 
To sequence the purified DNA samples, they were sent to Research and Testing Laboratory (USA) 
where sequencing was performed on Illumina MiSeq. More details of this technique can be found in 
the Methods section (chapter 2). 
5.3.9. MULTIVARIATE DATA ANALYSIS 
5.3.9.1. 1H NMR data processing 
Please refer to Chapter 3, section 3.3.7.1 for details (Materials and Methods) Urine and faecal water 
data sets were treated separately for processing. 
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5.3.9.2. Data Extraction for global and targeted UPLC-MS  
Data collected following HILIC-MS analysis (both positive and negative) were subjected to peak-
picking, grouping and alignment using MarkerLynx XCMS (Waters Inc., v4.1) software. Raw data 
were filtered using the dilution series samples, features which didn’t respond linearly to dilution 
were removed from the dataset. Samples were normalized to median fold change and filtered once 
again using coefficient of variation in the QC samples; this removed features with low repeatability 
within the QC samples run throughout the experiment. The remaining features were produced into a 
table and imported into SIMCA-P 14 software (Umetrics, Umea, Sweden). The most relevant features 
or metabolites in pair-wise models from MS data were identified using S plots; the 10 most 
significant features, which cause the separation in the model, were taken forward for identification.  
Targeted bile acid MS data were integrated using MassLynx 4.1 and TargetLynx software (Waters Inc. 
v4.1). Raw Bile Acid MS data (negative ionisation mode only) were imported into TargetLynx and an 
in house method was used to integrate the bile acid peaks. There were 57 different bile acids 
integrated using this method and was optimised for this experiment using bile acid standards mixes, 
which were run at the end of the experiment. Integrated values for each bile acid were exported into 
an excel spreadsheet where uni-variate analysis was performed (including student’s T-test).  
5.3.9.3. 1H NMR and UPLC-MS metabolic data analysis 
Please refer to Chapter 3, section 3.3.7.3 for details.  
5.3.9.4. 16S rRNA gene data analysis 
The 16S rRNA sequencing results were pre-processed and analysed using the Mothur program 
(Schloss et al., 2009) and analysed using the program STAMP. More details of this method have been 
provided in the Methods section (Chapter 2).   
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5.4. RESULTS 
5.4.1. 1H NMR SPECTROSCOPY DATA PROCESSING 
5.4.1.1. Urine metabolic profiling data processing 
From the raw data, multivariate statistical models showed that the primary metabolite causing a 
separation between term and preterm infants in the urinary 1H NMR profiles was creatinine; this 
metabolite has been shown to be correlated with muscle mass in humans (Baxmann et al., 2008). 
Babies that are born preterm usually have a lower birth weight and generally have less muscle mass.  
Since it was evident that this was overshadowing any other difference in the metabolic profile 
(Figure 5-2), subsequently, the spectral regions corresponding to creatinine (3.04, 4.05) were 
removed and the dataset was remodelled (Figure 5-3).   
-100 -50 0 50 100 150 200
-400
-300
-200
-100
0
100
200
300
Figure 5-2: PCA model scores plot of global urinary metabolic profiles for each group (Term = 
blue versus Preterm = red) before the removal of the resonances for the metabolite creatinine 
(δ3.05 -CH3; δ4.06 -CH2), there is a clear separation between groups due to creatinine. Two 
predictive components, R2X = 0.25, Q2=0.221 
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5.4.1.2. Faecal water metabolic profiling data processing 
A proportion (28%) of samples collected for this study were comprised of less than 100mg of stool. 
From the method development (chapter 3) carried out for this project, the optimum amount of stool 
needed to conduct metabolic profiling was 100mg but a further the minimum amount of 50mg could 
be used if necessary. Samples which had a mass of less than 50mg were excluded from analysis 
(n=57) and samples which were less than 100mg but over 50mg were extracted and acquired.  To 
compensate for the decrease in signal to noise in more dilute samples, the number of scans used to 
acquire NMR spectral profiles were increased compared with normal acquisition protocols.  Samples 
with 75mg of stool were analysed using double the standard number of scans than 100g samples, 
and samples with 50mg were analysed with a four-fold increase in the number of scans.  
A principal component analysis (PCA) was performed to evaluate whether the number of data 
acquisition scans had an influence on the variation in the dataset (supplementary Figure S4).  
Samples with 75mg and 50mg of faecal matter that were analysed using 128 and 256 scans 
respectively, are interspersed with 100mg samples analysed using the standard 64 scans, indicating 
no technical bias of this approach after normalisation and no separation between the different 
groups in the model.  
5.4.2. METABOLIC PROFILING OF INFANT URINE AND FAECAL SAMPLES USING 1H NMR 
SPECTROSCOPY 
5.4.2.1. Differences in metabolic signatures of biofluids of infants born term versus 
preterm 
After the removal of creatinine from the urine raw data, principal component analysis (PCA) was 
used to remodel the urine sample data (Figure 5-3), which demonstrated a clear separation of 
samples according to their class; born term or preterm. This model includes all time points that 
contributed to the three component model, explaining 25% of the total variance within the data.  
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A supervised model (OPLS-DA) was built with two orthogonal components resulting in a R2Y value of 
85% and a Q2Y value of 82% from the urine data; it was looking at the difference between term and 
preterm infant samples. For this model the metabolites with the highest correlation coefficient 
(Figure 5-4) were identified and the assignments have been summarised in table 5-1. In particular, a 
specific metabolite signature including betaine (3.27, 3.9) as well as dimethylamine (2.72) and 
dimethylglycine (2.93) was positively correlated to infants born term as well as trimethylamine 
(TMA) (2.91). Term infants were also associated with pseudouridine (7.68) and malonate (3.12).  
 
Figure 5-3: Global urinary metabolic profiles for each group, Term =blue, Preterm 
= red using 1D 1H NMR spectral data. PCA model scores plot, with three predictive 
components, R2X = 0.25 and Q2X=0.22.  
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 The infants born preterm are positively correlated to N-1-methylnicotinamide (NMN) (4.48, 8.19,  
8.91, 8.97, 9.27) and myo-inositol (3.53) in their urine as well as lysine (1.73). Generally, 
preterm infant’s urine also has a higher amounts of sugars within their urine, including mannitol 
(3.69), fructose (3.82) as well as unidentifiable sugars (3.84, 4.14, 3.78).   
Table 5-2 – List of urinary metabolites assigned in the loadings plot of OPLS-DA 
models (shown in Figure 4)  
Metabolite name 1H NMR δ (multiplicity group) Group observed 
Dimethylamine 2.72(s) Term 
Dimethylglycine 2.93(s) Term 
Betaine 3.27(s), 3.9(s) Term 
Pseudouridine 7.68(s) Term 
Malonate 3.12(s) Term 
Trimethylamine (TMA) 2.91(s) Term 
Unknown 1 2.78(s) Term 
1-N-methylnicotinamide 4.48 (s), 8.19(t),  8.91 (d), 
8.97(d), 9.27(d)  
Preterm 
Lysine 1.73 (q) Preterm 
Fructose  3.82 (s) Preterm 
Myo-inositol 3.53 (s) Preterm 
Mannitol 3.69 (s) Preterm 
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Figure 5-4: Correlation Coefficient plot from OPLS-DA model (R2X= 0.13, R2Y=0.85 and Q2Y=0.82) showing significant metabolites in 
urine separating between infants born term (positive) versus infants born preterm (negative). Metabolite ID: 1. Lysine (1.73), 2. 
Dimethylamine (2.72) 3. Dimethylglycine (2.93), 4. Malonate (3.12), 5. Betaine (3.27, 3.9), 6. Sugar (3.84), Fructose (3.82), 
Mannitol (3.69) and Myo-inositol (3.53)  7. 1-N-methylnicotinamide (4.48, 8.19, 8.91, 8.97, 9.27), 8. Pseudouridine (7.68). 
9 8 
1 
2 
3 
4 5 
6 
7 
8 
7 7 
 175 
 
 
Figure 5-5: PCA scores plot of global faecal water metabolic profile using 1D 1H NMR spectral data, R2X= 0.27, Q2X= 0.262 a) scores plot coloured 
blue = term samples, red = preterm samples. b) scores plot coloured by postpartum age that samples were taken. Colours = Birth sample (blue) 
through to Week 19 sample (red).   
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Unsupervised statistical modelling (PCA) was performed on faecal samples (Figure 5-5a); there was 
some separation of samples according to class (term vs. preterm), but much less so compared with 
urine samples run by the same analysis. By colouring the samples in the PCA scores plot in the same 
model by sample time point (Figure 5-5b), it can be seen that the separation is dominated by 
samples collected in the first week postpartum compared to those collected at a later stage. From 
this plot, there is a clear indication of metabolic profile similarity at birth, as these samples cluster 
together, but as the infant ages the metabolic profile becomes more variable and distinctive 
compared to these birth samples.  
 
  
 
 
Table 5-3 – List of faecal water metabolites assigned in the loadings plot of OPLS-DA 
models (shown in Figure 6)  
Metabolite name 1H NMR δ (multiplicity group) Group observed 
Bile acids 0.73 (s) Term 
Cholate 1.12 (s) Term 
Thiamine 2.57 (s) Preterm 
Glycerol 3.66 (m) Preterm 
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Term Samples 
Preterm samples 
Figure 5-6: Correlation Coefficient plot from OPLS-DA model (R2X= 0.26, and Q2Y=0.5) showing significant metabolites in faecal water 
separating between infants born term (positive) versus infants born preterm (negative).  Metabolite ID: 1. Bile acids (0.73), 2. Cholate 
(1.12), 3. Thiamine (2.57), 4. Glycerol (3.66).  
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A supervised model (O-PLS-DA) was built with two orthogonal components resulting in a R2X value of 
26% and a Q2Y value of 50% on the faecal data when looking at the difference between term and 
preterm infant samples; this model is not as strong as the urine spectral data when classifying 
samples by these groups. The correlation coefficient loadings plot (Figure 5-6) shows the 
discriminatory metabolites associated with the two classifying group samples, which are summarised 
in table 5-2. From the plot, there is a higher correlation of bile acids (δ0.73) and cholate (1.12) in 
the term born infant samples compared to the preterm born babies. The loadings plot shows that 
preterm infants have a higher concentration of glycerol (3.66) compared to term infants. 
Furthermore, preterm infants’ faecal water metabolic profile is related to thiamine (2.57), also 
known as vitamin B1.  
5.4.2.2. Differences in metabolic signatures from infants born term versus preterm at 
birth 
Preterm infants are born at a gestational age lower than 37 weeks and much of their development 
happens outside of the womb; this includes organ development. Therefore, the baseline urinary 
metabolic profile at birth from infants born at term versus preterm is very interesting to investigate 
further. However, due to the nature of infants born preterm, they are typically born smaller and may 
have a number of different disorders, thus their first substantial urine samples that could be 
acquired by NMR was typically obtained a few days from birth rather that immediately. Therefore, 
for this model preterm infant’s urine, which was collected within two weeks from birth, is regarded 
as a birth sample and compared to infants born at term where their samples were taken at birth 
(typically within the first 24 hours of life).   
 
 
 
Preterm samples 
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A PCA model was produced using the urine samples (Figure 5-7), which demonstrated a clear 
separation of samples according to their class; term (n=29) or preterm samples (n=26) taken at birth. 
From the plot, there are two term samples which are clustered with the preterm samples, these 
samples are from two infants born at 38 and 39 weeks of gestation. Comparisons of 1H NMR urinary 
spectra between term and preterm infants at birth was also performed using the supervised 
method; OPLS-DA. Results from this model are summarised in table 5-3 and the correlation 
coefficient (Figure 5-8) shows the metabolites that cause the separation of these two classes. 
Figure 5-7: PCA of 1D 1H NMR spectra urinary spectral data from infants born term vs 
preterm taken at birth: blue = term samples, red = preterm samples. R2X = 0.31 and 
Q2X=0.2.  
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Term Samples 
Figure 5-8: Correlation Coefficient plot from OPLS-DA model (R2X= 0.21, and Q2Y=0.06) showing significant metabolites in urine separating between 
infants born term (positive) versus infants born preterm (negative) taken at birth. Metabolite ID: 1. Alpha-aminoisobutyrate (δ1.49), 2. Unknown 
(δ2.31), 3. Methylguanine (δ2.83), 4. Trimethylamine (TMA) (δ2.91), 5. Threonine (δ3.59), 6. Myo-inositol (δ3.65), 7. Pseudouridine (δ7.68).   
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Similarly to the results from the previous model, urine samples taken at birth from term born infants  
were positively correlated with methylguanidine (2.83), trimethylamine (TMA) (2.905), and 
pseudouridine (7.68) as well as an unknown metabolite (2.31).  This may suggest that birth 
samples are again dissimilar from samples taken after a few days of life.  Urine from preterm infants 
at birth is related to threonine (δ3.59), 1-N-methylnicotinamide (δ4.48) and myo-inositiol (δ3.65) as 
well as an unknown metabolite, which was tentatively assigned as -aminoisobutyrate based on its 
chemical shift (δ 1.49) and signal multiplicity.  
Table 5-4 – List of urinary metabolites assigned in the loadings plot of OPLS-DA models (shown in 
Figure 5-8) 
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Pseudouridine 7.68 (s) Term 
Methylguanidine 2.83 (s) Term 
Trimethylamine 2.91 (d) Term 
Unknown 1 2.31 (s) Term 
Alpha-aminoisobutyrate 1.49 (s) Preterm 
Threonine 3.59 (d) Preterm 
1-N-Methylnicotinamide 4.48 (s) Preterm 
Myo inositol 3.65 (m) Preterm 
 
A PCA model of faecal samples was calculated for samples taken at birth from infants born term and 
preterm (Figure 5-9); there was separation according to class and explains 37% of the variability 
within the data.  This model has better predictability compared to the urine model which can be 
recognised from the Q2X values; 0. 2 = urine vs faecal = 0.31. In this scores scatter plot, there is a 
clear indication of metabolic profile similarity for the term infants compared to the preterm infant’s 
samples, which were highly variable in composition.    
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Table 5-5 –  List of faecal water discriminatory metabolites assigned in the correlation 
coefficient plot of OPLS-DA models (shown in Figure 5-10) 
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Bile Acid 0.68 (s), 0.73 (s), 0.83 (s)  Term 
Unknown 3.09 (t) Term 
Sugars* 3.61 (m), 3.76 (m), 4.14 (d), 4.67 (m),  
5.27 (d) 
Preterm 
Alanine  1.48 (d) Preterm 
Phenylalanine 7.34 (m) Preterm 
Figure 5-9: PCA of 1D 1H NMR spectra faecal water spectral data from infants born term 
vs preterm taken at birth: blue = term samples, red = preterm samples. R2X = 0.37 and 
Q2X=0.31. 
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The pairwise OPLS-DA model was performed on this stool data to assess the differences between 
the term and preterm samples taken at birth (figure 5-10); the discriminatory metabolites associated 
with the two classifying group samples are summarised in table 5-4. From the plot, there was a 
higher correlation of bile acids (δ0.68, δ0.73, δ0.83) in the term baby samples compared to the 
preterm babies, which was also seen when modelling the whole data set. Term infants also 
correlated with an unidentifiable metabolite (δ3.09).  When using STOCSY to determine the identity 
of this metabolite, it correlates to the bile acids at δ0.68, δ0.73 and δ0.83, suggesting that it could be 
a bile acid conjugated to taurine (Duarte et al., 2009).  
Comparatively, there was a higher amount of sugars (δ3.61, δ3.76, δ4.14, δ4.67, δ5.27) in preterm 
infant’s faecal samples compared to term infants. Further to this, preterm infant’s faecal samples 
were related to two amino acids; alanine (δ1.48) and phenylalanine (δ7.34).  
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Preterm samples 
Figure 5-10: Correlation Coefficient plot from OPLS-DA model (R2X= 0.35, and Q2Y=0.67) showing significant metabolites in faecal water separating 
between infants born term (positive) versus infants born preterm (negative) taken at birth. Metabolite ID. 1. Bile acids (δ0.68, δ0.73, δ0.82), 2. 
Unknown (δ3.09), 3. Alanine (δ1.48), 4. Sugars (δ3.61, δ3.76, δ4.14, δ4.67, δ5.27), 5. Phenylalanine (δ7.34).  
Term Samples 1 2 
3 
4 
5 
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5.4.2.3. Differences in metabolic signatures from term birth samples versus preterm 
samples at term equivalent age 
Infants which are born preterm are deemed term equivalent age when they have reached the 37 
week of gestation in the weeks spent postpartum. For example, if an infant was born at the 32nd 
week of gestation, 5 weeks after birth they would be termed a preterm infant at term equivalent 
age. By comparing term infants birth samples and samples taken from preterm infants when they 
reach term equivalent age (37-41 gestation week), it gives a clearer idea as to how the preterm 
infants have developed differently, if at all, compared to infants which are born at term. 
 
 
From the urinary NMR data, there was no significant difference in urinary metabolic profiles 
between term infants’ samples taken at birth compared to preterm infant samples taken at term 
equivalent age (Supplementary Figure S5).  However, there was significant separation of stool 
metabolic profiles according to this class definition (Figure 5-11). In this scores scatter plot, there 
seemed to be a clear indication of metabolic profile similarity, as term birth samples cluster very 
closely in this plot whereas preterm samples were highly variable in comparison. When looking at 
Figure 5-11: PCA of 1D 1H 
NMR spectra faecal water 
spectral data from infants 
born term at birth vs 
preterm at term equivalent 
age: blue = term samples, 
red = preterm samples. R2X = 
0.3 and Q2X=0.23.  
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the variance from this model using the loadings plot (data not shown); in the first principal 
component, there is a high concentration of sugars in preterm infant faecal samples compared to 
term samples and in the second principal component, preterm infant samples have higher amounts 
of alanine (1.48) in their faecal samples. 
OPLS-DA was performed on the stool data; to further investigate the differences between the term 
at birth and preterm samples taken at term equivalent age.  The correlation coefficient loadings plot 
(Figure 5-12) shows the discriminatory metabolites associated with the two classifying group 
samples, which are summarised in table 5-5. From the plot, there is a higher correlation of bile acids 
(δ0.68, δ0.73, δ0.83) in the term baby samples compared to the preterm babies, which was seen in 
the previous model when comparing term versus preterm at birth.  
Table 5-6 –  List of metabolites assigned in the loadings plot of OPLS-DA models (shown 
in Figure 5-12) 
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Bile Acid 0.68 (s), 0.73 (s), 0.83 (s)  Term 
Leucine 0.97 (m) Preterm 
Alanine 1.48 (d) Preterm 
Lysine 3.03 (m) Preterm 
Tyramine 6.92 (m), 2.93 (t) Preterm 
 
The loadings plot indicates a stronger correlation of amino acids - including alanine (δ1.48), leucine 
(δ0.97), lysine (δ3.03) - and tyramine (δ6.92, δ2.93) in preterm infant’s faecal samples compared to 
term infants.  
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Preterm samples 
Term Samples 
Figure 5-12: Correlation Coefficient plot from OPLS-DA model (R2X= 0.27, and Q2Y=0.8) showing significant metabolites in faecal 
water separating between infants born term taken at birth (positive) versus infants born preterm (negative) taken at term 
equivalent age. Metabolite ID: 1. Bile acid (δ0.68, δ0.73, δ0.83), 2. Leucine (δ0.97), 3. Alanine (δ1.48), 4. Lysine (δ3.03), 5. 
Tyramine (δ6.92).  
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Due to birth or meconium samples being very distinctive compared to faecal samples taken later in 
life - even a few days later – and causing the most amount of discrimination in the profiles, term 
samples which were taken at one week postpartum were modelled against preterm samples taken 
at term equivalent age using PCA (Figure 5-13).  
 
A supervised statistical method was performed (OPLS-DA); the correlation coefficient plot (Figure 5-
14) showing the discriminatory metabolites associated with each of the two classes and are further 
summarised in table 5-6.  
 
 
Table 5-7 –  List of metabolites assigned in the loadings plot of OPLS-DA models 
(shown in Figure 5-14)  
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Tyramine 3.23 (s), 2.95 (m), 7.23 (d) Term 
N-acetyl-glycoproteins 2.03 (s) 2.06 (s) Preterm 
Figure 5-13: PCA of 1D 1H NMR spectra faecal water spectral data from infants born 
term at one week vs preterm at term equivalent age: blue = term samples, red = 
preterm samples. R2X = 0.3 and Q2X=0.23.  
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Preterm samples 
Figure 5-14: Correlation Coefficient plot from OPLS-DA model (R2X= 0.27, and Q2Y=0.8) showing significant metabolites in faecal water 
separating between infants born term taken at one week (negative) versus infants born preterm (positive) taken at term equivalent age. 
Metabolite ID: 1. N-acetyl-glycoprotein (δ2.03, δ2.06), 2. Tyramine (δ2.95).  
Preterm Samples 
Term Samples 
ppm (δ) 
1 
2 
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In the previous model, term birth samples were modelled against preterm samples, the preterm 
samples were associated with tyramine (δ3.23, δ2.95, δ7.23). However, in this updated model, term 
samples were taken at one week postpartum and modelled against preterm samples taken at term 
equivalent age, tyramine was associated with term infants.  Preterm samples taken at term 
equivalent age were related to N-acetyl glycoproteins (δ 2.03, 2.04) when modelling against term 
faecal samples taken at one week postpartum.  
5.4.2.4. Disparities in metabolic profiles from samples taken at 3 months postpartum 
from infants born term versus preterm.  
A principal components analysis of urine samples was performed (Figure 5-15), which demonstrated 
a clear separation of samples according to their class; term (n=26) or preterm samples (n=17) taken 
at three months postpartum. OPLS-DA was performed on the urine data to further assess the 
difference between term and preterm samples taken three months postpartum. For this pairwise 
OPLS-DA model the metabolites with the highest correlation coefficient (Figure 5-16) were identified 
and metabolite assignments are summarised in table 5-7. 
Table 5-8 –  List of urinary metabolites assigned in the loadings plot of OPLS-DA models (shown in 
Figure 5-16)   
Metabolite name 1H NMR δ  (multiplicity group) Group observed 
Betaine 3.27 (s) Term 
Pseudouridine 7.68 (s) Term 
Dimethylglycine 2.93 (s) Term 
Dimethylamine 2.72 (s) Term 
N-acetylglutamate 2.05 (m), 2.04 Term 
Mannitol 3.82 (s) Preterm 
Bile Acid 0.76 (s) Preterm 
1-N-methylnicotinamide 4.48 (s), 8.19 (t), 8.97 (d), 9.28 (s) Preterm 
Fructose 3.78 (m) Preterm 
Lysine 1.73 (q) Preterm 
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Term infant’s urine at three months postpartum is related to betaine (3.27), dimethylglycine 
(2.93), dimethylamine (2.72); these metabolites were also discriminatory when modelling all the 
data points regardless on time point. N-acetylglutamate (2.04, 2.05) was also associated with term 
infants at 3 months postpartum. Preterm infant’s urine at three months postpartum had a higher 
concentration of mannitol (3.82), 1-N-methylnicotinamide (4.48, 8.19, 8.97, 9.28), fructose 
(3.78), lysine (1.73) as well as an unknown species of bile acid (0.76).
Figure 5-15: PCA of 1D 1H NMR urine spectral data from infants born term vs preterm at 3 
months’ postpartum: blue = term samples, red = preterm samples. R2X = 0.377 and Q2X=0.18.  
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Preterm samples 
Term samples 
Figure 5-16: Correlation Coefficient plot from OPLS-DA model (R2X= 0.3, and Q2Y=0.9) showing significant metabolites in faecal water 
separating between infants born term (positive) versus infants born preterm (negative) taken at three months postpartum. Metabolite ID: 
1. Bile acids (0.76), 2. N-acetyl-glycoproteins (2.04, 2.06), 3. Dimethylamine (2.73), 4. Dimethylglycine (2.93), 5. Betaine (3.27), 6. 
Fructose (3.78), 7. Mannitol (3.82), 8. 1-N-methylnicotinamide (4.48, 8.19, 8.97, 9.28), 9. Pseudouridine (7.68).  
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These infants were on different types of nutrition, which could contribute to their development and 
thus their metabolic profile; including being fed with breast milk, formula milk, parenteral nutrition 
or a combination of parenteral nutrition and formula milk. By re-colouring the scores plot of the 
previous PCA model by the type of feeding group the infants were on (Figure 5-17), it is clear that 
within the term born infants, there was no clear separation between infants which were fed breast 
milk versus formula fed in this model. But from the scores plot, the largest difference was seen 
between preterm infants, which were fed parenteral nutrition only compared to those which had 
some formula feeding (combination feeding) making them more like their term born counterparts. 
One sample, which was labelled as deriving from a breast milk fed baby clearly resembled those in 
metabolic composition from parenteral nutrition; this sample was most likely labelled incorrectly.  
 
BM 
FM 
PN 
Comb 
Figure 5-17: PCA of 1D 1H NMR urine spectral data from infants born term vs preterm at 3 
months postpartum:, red = Breast milk, blue = Formula milk, Green = parenteral nutrition, 
Yellow = combination of parenteral nutrition and formula/breast milk. R2X = 0.377 and 
Q2X=0.18.  
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Conversely, faecal water metabolic profiles at three months’ postpartum age show no separation 
between infants born at term compared to preterm born infants. This suggests that infant’s faecal 
water metabolic profiles are very similar once they are at this age. This may be due to the same 
amount of time outside the womb and therefore exposure to the environment is more influential 
than human development on the faecal metabolic profiling (supplementary Figure S6).  
5.4.3. GLOBAL URINARY METABOLIC PROFILING HILIC-MS   
5.4.3.1. Metabolic profiling using HILIC-MS of infants born term vs. preterm at all time 
points 
A principal component model performed on urine samples (Figure 5-18), demonstrated a clear 
separation of samples according to their class; born term (n=12) or preterm (n=55). Principal 
component one shows a clear separation between infants born term vs preterm, whereas the 
variation represented in component two is from the preterm infants’ samples increasing with 
postpartum age (Supplementary figure S7). Samples from term infants were only obtained at birth, 
whereas samples form preterm infants were gained from birth until 19 weeks postpartum. The 
supervised method of OPLS-DA was performed by separating samples into two classes, for both 
negative and positive ionisation mode of the urine MS data. Looking at the features, which cause the 
separation in urine data between the two groups, a number of metabolites were identified and are 
summarised in table 5-8.   
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For the negative ionisation mode data, infants who were born term separated due to metabolites 
including hydroylprolyl-leucine, a four polypeptide chain and acetylhomoserine. For the positive 
ionisation mode, infants who were born term separate due to metabolites including homocarnosine, 
linoleoylglycerophosphocholine and phenylalanyl-threonine.  
For the negative ionisation mode data, infants which were born preterm separated due to relatively 
higher concentrations of histidine and ascorbic acid, as well as N-acetylgalactosamine 6–sulphate, 
Indolepyruvate and hydroxyproline. For the positive ionisation mode data, infants which were born 
preterm separated due to metabolites including 7-methylguanine and 6-hydroxynicotinic acid.  
Figure 5-18: PCA of Global 
HILIC MS urine data from 
infants born term vs 
preterm; red = preterm, 
blue =term. Both models 
were built with four 
predictive components a) 
negative ionization mode 
R2X = 0.327, Q2X = 0.097. b) 
positive ionization mode 
R2X = 0.327, Q2X = 0.1 
a)  
b)  
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Table 5-9 - List of features assigned from urinary HILIC-MS data from S-plot of the OPLS-DA models 
between term and preterm.   
Potential Metabolite ID Mz/RT Group Observed Level of assignment 
Homogentistic acid 167/80 Term (ESI –ve) 2 
Hydroylprolyl-Leucine 225.1/301 Term (ESI –ve) 2 
Asp Ile Val Tyr 507.2/301 Term (ESI –ve) 3 
Acetylhomoserine 160.1/345 Term (ESI –ve) 2 
Unknown 1 511.3/347 Term (ESI –ve) 4 
N-acetylgalactosamine-6-sulphate  301/136 Preterm (ESI –ve) 2 
Indolepyruvate 202/349 Preterm (ESI –ve) 2 
Hydroxyproline 130.1/364 Preterm (ESI –ve) 2+ 
Histidine 154.1/525 Preterm (ESI –ve) 2+ 
Ascorbic Acid  175/567 Preterm (ESI –ve) 2 
Phenylalanyl Threonine  267.1/302 Term (ESI +ve) 2 
Linoleoylglycerophosphocholine 535.3/349 Term (ESI +ve) 2 
Unknown 2 201.2/356 Term (ESI +ve) 4 
Unknown 3 377.3/414 Term (ESI +ve) 4 
Homocarnosine 242.2/450 Term (ESI +ve) 2 
Unknown 4 160.2/569 Term (ESI +ve) 4 
7-methylguanine 166.1/171 Preterm (ESI +ve) 2+ 
6-Hydroxynicotinic Acid  140/559 Preterm (ESI +ve) 2 
 
5.4.3.2. Metabolic profiling using HILIC-MS of infants born term vs. preterm at birth 
A PCA model derived from urine samples collected at birth from infants born term or preterm was 
(Figure 5-19), demonstrated a clear separation of samples according to their class; born term (n=12) 
or preterm (n=14) at birth. An OPLS-DA was performed by separating samples into two classes, for 
both negative and positive ionisation mode of the urine data. The results of this model, yielded 
features which were mainly responsible for the separation in urine data between the two groups a 
number of metabolites which were identified and summarised in table 5-9.  
For the positive ionisation mode, infants who were born term separated due to metabolites 
including dipeptides and amino acids as well as citrate and homocarnosine. For the positive 
ionisation mode data, infants who were born preterm separated due to metabolites including 
glutamine, and 6-hydroxynicotinic acid.  
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For the negative ionisation mode, infants who were born term separate due to metabolites including 
hydroylprolyl-leucine, a four polypeptide chain and acetylhomoserine. For the negative ionisation 
mode data, infants which were born preterm separated due to relatively higher concentrations of 
ascorbic acid and 1,6-Naphthalenedisulfonic acid.   
Table 5-10 - List of variables assigned from urinary HILIC-MS data from S-plot of the OPLS-DA 
models between term and preterm at birth.    
Potential Metabolite ID Mz/rt Group Observed Level of  
assignment 
Homogentistic acid 167/80 Term (ESI –ve) 2 
Hydroylprolyl-Leucine 225.1/301 Term (ESI –ve) 2 
Asp Ile Val Tyr 507.2/301 Term (ESI –ve) 3 
Acetylhomoserine 160.1/345 Term (ESI –ve) 2 
1,6-Naphthalenedisulfonic acid 287/285 Preterm (ESI –ve) 2 
Ascorbic Acid (Vit C) 175/567  Preterm (ESI –ve) 2 
Citrate 193/189 Term (ESI +ve) 2 
Phenylalanyl-Threonine 267.1/302 Term (ESI +ve) 3 
Tryptophyl-Isoleucine 318.2/411 Term (ESI +ve) 3 
Homocarnosine 242.2/450 Term (ESI +ve) 2 
Proline  116.1/514 Term (ESI +ve) 2 
Glutamine 147/285 Preterm (ESI +ve) 2+ 
6-Hydroxynicotinic acid 140/559 Preterm (ESI +ve) 2 
 
5.4.3.3. Metabolic profiling using HILIC-MS of Term at birth vs. Preterm at term 
equivalent age 
A principal component analysis of urine samples was performed (Figure 5-20), which demonstrated 
a clear separation of samples according to their class; born term at birth (n=12) or preterm at term 
equivalent age (n=19). The supervised method of OPLS-DA was performed by separating samples 
into two classes, on both negative and positive ionisation mode of the urine data. Looking at the 
features which caused the separation in urine data between the two groups a number of 
metabolites were identified and summarised in table 5-10. 
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Table 5-11 - List of features assigned from urinary HILIC-MS data from S-plot of the OPLS-DA 
models between term at birth and preterm at term equivalent age 
Potential Metabolite ID Mz/rt Group Observed Level of 
assignment 
3-hydroxy-3-(3-hydroxyphenyl) 
propanoate 
261/39 Term (ESI –ve) 2 
Tetrapeptide 459.2/65 Term (ESI –ve) 3 
5-(2-Methylpropyl)tetrahydro-2-oxo-
3-furancarboxylic acid 
207.1/103 Term (ESI –ve) 2 
Tyrosol-4-sulfate 239/132 Term (ESI –ve) 2 
Prolyl Threonine 215.1/176 Term (ESI –ve) 3 
Unknown 1 361.1/274 Term (ESI –ve) 4 
Asp Ile Val Tyr 507.2/301 Term (ESI –ve) 3 
Acetylhomoserine 160.1/345 Term (ESI –ve) 2 
Oxyquinoline 144/42 Preterm(ESI –ve) 2 
4-Cresol 107/58 Preterm (ESI –ve) 2 
4-Pyridoxic acid 182/63 Preterm (ESI –ve) 2 
Lys-Trp-OH 439.2/346 Preterm (ESI –ve) 2 
Hydroxyproline 130.2/364 Preterm (ESI –ve) 2 
Histidine 154.1/528 Preterm (ESI –ve) 2+ 
Pantothenic Acid 218.21/218 Preterm (ESI –ve) 2+ 
Creatinine 136/174 Term (ESI +ve) 2+ 
Unknown 2 385.1/276 Term (ESI +ve) 4 
Unknown 3 201.2/356 Term (ESI +ve) 4 
Unknown 4 370.2/385 Term (ESI +ve) 4 
Unknown 5 377.3/414 Term (ESI +ve) 4 
Proline 116.1/514 Term (ESI +ve) 2 
Unknown 6 159.1/569 Term (ESI +ve) 4 
Unknown 7 163/98 Preterm (ESI +ve) 4 
Pantothenic Acid 221.1/216 Preterm (ESI +ve) 2+ 
1-N-methylnicotiniamide 137/332 Preterm (ESI +ve) 2 
 
For the positive ionisation mode, infants who were born at term separated higher concentration of 
the metabolites including creatinine and proline.  As expected, from the results of the 1H NMR data 
urinary, creatinine is positively correlated to infants born term. For the positive ionisation mode, 
infants who are born preterm are related to the metabolites 1-N-methylnicotinamide and 
pantothenic acid.  
For the negative ionisation mode, infants who are born term separate due to metabolites including 
3-hydroxy-3-(3-hydroxyphenyl) propanoic acid-o-sulphate, 5-(2-Methylpropyl)tetrahydro-2-oxo-3-
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furancarboxylic acid, Tyrosol-4-sulfate, acetylhomoserine as well as a number of different 
polypeptide chains. For the negative ionisation mode, infants which are born preterm separate due 
to metabolites included 4-cresol, oxyquinoline, histidine, 4-Hydroxy-D-proline, 4-Pyridoxic acid.  
5.4.4. IDENTIFYING BILE ACID DIFFERENCES IN INFANTS USING TARGETED MASS 
SPECTROMETRY PROFILING OF FAECAL SAMPLES  
Targeted bile acid profiling using UPLC-MS on faecal samples from infants born term and preterm 
was performed to further investigate the bile acid composition. Uni-variate statistical analysis was 
executed on the integrated bile acid integrated peaks to determine any difference between bile acid 
compositions in infants.  
Interestingly - even though previous 1H NMR data showed a separation in term samples from birth 
due to bile acids - targeted profiling showed no differences in bile acid composition between term 
versus preterm faecal samples. This may highlight that the global compositional profile of bile acids 
is different between classes but there are no specific bile acid species differences. Furthermore, 
meconium samples have a higher concentration of bile acids which may have caused the strong 
separation in previous models. 
Table 5-12. List of bile acids and p-values from univariate statistical analysis on integrated bile acid 
data from faecal samples taken from term versus preterm infants 
Number Bile Acid Name p-value 
1 3,7,12 Taurodehydrocholic acid 0.45 
2 Ursodeoxycholic acid 0.29 
3 Ursocholanic Acid 0.988 
4 Taurohyodeoxycholic Acid 0.7 
5 Taurohyocholic Acid 0.11 
6 Taurodeoxycholic Acid 0.25 
7 Taurocholic Acid 0.14 
8 Taurochenodeoxycholic Acid 0.23 
9 Tauro-ursodeoxycholic Acid 0.9 
10 Tauro-ursocholanic Acid 0.19 
11 Tauro-ß Muricholic Acid 0.91 
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12 Tauro-a Muricholic Acid 0.65 
13 Tauro omega-Muricholic Acid 0.77 
14 omega Muricholic Acid 0.85 
15 Murocholic Acid 0.34 
16 Lithocholic acid 0.26 
17 Isolithocholic Acid 0.94 
18 Isodeoxycholic Acid 0.25 
19 Hyocholic acid 0.49 
20 Glycoursodeoxycholic Acid 0.21 
21 Glycohyocholic Acid 0.2 
22 Glycodeoxycholic acid 0.06 
23 Glycochenodeoxycholic Acid 0.28 
24 Deoxycholic Acid 0.25 
25 Cholic acid 0.21 
26 Chenodeoxycholic Acid 0.33 
27 a-Muricholic 0.212 
28 9(11), (5ß)-Cholenic Acid-3a-ol-12-one 0.55 
29 8(14),(5ß)-Cholenic Acid-3a, 12a-diol 0.26 
30 5ß-Cholenic Acid-7a-ol-3-one 0.24 
31 5ß-Cholanic Acid-3ß, 12a-diol 0.45 
32 5ß-Cholanic Acid-3a, 6a-diol-7-one  0.86 
33 5a-Cholanic Acid-3, 6-dione 0.12 
34 5-Cholenic Acid-3ß-ol 0.9 
35 3a-Hydroxy-12 Ketolithocholic Acid 0.29 
36 3,7,12 Dehydrocholic acid 0.47 
37 3,7-Diketocholanic Acid 0.39 
38 3 Dehydrocholic Acid 0.19 
39 12 Dehydrocholic Acid 0.62 
40 3a-OH-7,12-Diketocholanic Acid 0.66 
 
5.4.5. COMPARATIVE METATAXONOMICS USING 16S rRNA ANALYSIS OF INFANT FAECAL 
SAMPLES 
DNA extraction and sequencing using Illumina technologies was applied to examine the differences 
in gut microbiome between infants born term or preterm. Extended error bar plots were 
constructed in STAMP, (Parks et al., 2014) from the MiSeq data and associated confidence intervals 
with bootstrapping in order to indicate the mean difference for each phyla, class and family in the 
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infant faecal samples generated. Information on samples used for this analysis can be found in 
section 5.3.1.  
5.4.5.1. Comparison of the gut microbiome composition in infants born term vs. 
preterm  
Gut microbiome composition is indicated as different between infants born term (n=130) and 
preterm (n=164), in particular bacteria from the class of Gammaproteobacteria, which is from the 
Proteobacteria phylum, are highly significant in preterm born samples compared to term born 
infants. More specifically, at a genus level, preterm infants have significant proportion of an 
unclassified Enterobacteriaceae, Finegoldia and an unclassified Staphylococcus (Figure 5-19a).  
Whereas, bacteria from the Actinobacteria and Bacteroidetes phyla are significantly higher in 
samples from infants born at term. Furthermore, term born infants have higher amounts of bacteria 
from the Alphaproteobacteria which is also from the Proteobacteria phyla similar to the preterm 
infants. At a genus level, term infants have more significant proportion of Streptococcus, 
Escherichia/Shigella, Lactobacillus, Clostridium_XI, Collinsella and Bacteroides (Figure 5-19b).   
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5.4.5.2. Comparison of the gut microbiome composition in infants born term at birth vs. 
preterm at term equivalent age 
Gut microbiome composition is indicated as different between samples from term infants at birth 
(n=28) compared to preterm infants when they reach term equivalent age (postnatal age > 37 
weeks; n=83). In particular bacteria from the Bacteriodetes phylum (Figure 5-20a), including the 
Bacteriodia and Clostridia classes, are highly significant in term infants samples at birth compared to 
preterm born infants at term equivalent age (Figure 20b). More specifically, at a genus level, term 
infants have significant proportion of Clostridium_XI, Bacteriodes, Methyloacterium, unclassified 
Comamonadaceae, Allobaculum, Escherichia/Shigella and Bradyrhizobium (Figure 5-20c). Whereas, 
a) 
b) 
c) 
Figure 5-19: Extended box plots constructed from MiSeq DNA sequencing data from faecal 
samples of infants born term (blue) versus preterm (red) a) phylum, b) class, c) genus 
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samples from preterm infants at term equivalent age, have higher proportions of unclassified 
Enterobacteriaceae.  
 
5.4.5.3. Comparison of the gut microbiome community in infants born term vs. preterm at 3 
months postpartum 
After three months postpartum, the gut microbiome composition is indicated as different between 
samples from term (n=31) compared to preterm infants (n=31). In particular bacteria from the 
Actinobacteria phylum are highly significant in term infant samples at 3 months compared to 
preterm born infants (Figure 5-21a).  More specifically, at a genus level, term infants have significant 
proportion of Actinomyces which is part of the Actinobacteria phylum. Whereas Clostridium_XVIII 
and Streptococcus compared to preterm infants (Figure 5-21c).  
a) 
b) 
c) 
Figure 5-20: Extended box plots constructed from MiSeq DNA sequencing data from birth faecal 
samples of infants at term (blue) versus preterm at term equivalent age (red) a) phylum, b) class, 
c) genus  
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5.4.5.4. Comparison of the gut microbiome community from term born infants born through 
different modes of delivery 
The gut microbiome composition is indicated as different between samples from term born infants 
born through caesearean section (n=71) compared to infants born vaginally (n=95). In particular 
bacteria at a genus level, vaginally delivered infants have significantly higher proportion of 
Escherichia or Shigella in their stool compared to infants which are born through caesarean section 
(Figure 5-22).  
 
 
a) 
b) 
c) 
Figure 5-21: Extended box plots constructed from MiSeq 16S rRNA sequencing data from faecal 
samples of infants born term (blue) versus preterm (red) taken at three months postpartum a) 
phylum, b) class, c) genus 
Figure 5-22: Extended box plots of genus constructed from MiSeq 16S rRNA sequencing data 
from faecal samples of infants born through vaginally delivery (red) versus caesarean section 
(blue).  
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5.5. DISCUSSION  
The current study has shown that there are clear differences in both metabolic profiling data using 
different platforms (e.g. 1H NMR and UPLC-MS) between infants born at term age (>37 week of 
gestation) compared to infants born preterm. Infant biofluids are a valuable resource to understand 
the development of the new-born infant after birth as well as during the first few months of life.  
This chapter demonstrates the different developmental trajectory between infant born term and 
preterm using metabonomics, metagenomics and microbiomics. Key metabolites involved in 
developing renal function, nutritional influence as well as gut microbiome interactions can clearly be 
recognised.  
5.5.1. METABOLIC AND MICROBIOMIC PROFILING TO CHARACTERISE BIOFLUIDS OF 
INFANTS BORN TERM VS. PRETERM 
From these results, it is clear that by using both NMR and HILIC-MS it can show differences in urine 
and faecal samples from infants born term and preterm at all time points. In particular, urinary 
metabolic profiling using NMR for term born infants correlated highly to choline specific metabolites 
(e.g. betaine, dimethylamine and dimethylglycine). Infants’ development continues after birth which 
is reiterated in these results as dietary choline isn’t being fully utilised due to their immature 
gastrointestinal and kidney system (Foxall et al., 1995; Trump et al., 2006; Nicholson et al., 2012). 
Betaine could be released due to the immaturity of the infant kidney, which is still developing 
postpartum even in term born infants. Infants born term are also highly associated to TMA in their 
urine; TMA is produced by the microbial bioconversion of choline and may be related to the 
developing gut microbiome (Chiu et al., 2016). Furthermore, the presence of TMA also indicates the 
gut microbiome successfully utilising choline from the diet. Furthermore, term infants’ urine is 
correlated to homogentisic acid which is an intermediate of the metabolic breakdown of tyrosine 
 206 
 
and phenylalanine; these metabolites are related to the developing gut microbiome (Marcobal et al., 
2012).  
From the urinary HILIC MS data it is in agreement with the urinary NMR data; also showing a higher 
concentration of di- and poly- peptides, which suggests a lack of full protein digestion by the 
digestive system. Term infant urine is also associated with linoleoyl-glycerophosphocholine, a 
common phospholipid bound choline found in human breast milk (Holmes-McNary et al., 1996, Ilcol 
et al., 2005). Preterm infant’s urine also has high concentrations of sugar in their urine (e.g. 
mannitol, fructose as well as unidentifiable sugars and carbohydrates) which may be due to a lack of 
absorption of the simple molecules in their immature organs or due to higher proportion of sugars in 
preterm nutritional feed in early life (Radmacher et al., 2016). Preterm infants also have the 
metabolite N-acetylgalactosamine-6–sulphate in their urine, this metabolite has previously been 
recognised in urine (Hopwood and Elliot, 1985). This sulphated N-acetylhexosamines has been 
identified as an important part in sulphated glycosaminoglycans, glycoproteins and sugar 
nucleotides. N-acetyl glycoproteins are commonly found in breast milk so this could have been 
sulphated by the infants before excreted in the urine (Tannock et al., 2013). Histidine is an amino 
acid which cannot be synthesised by the body and is taken up through our nutrition; it is known that 
a deficiency of histidine in the first 6 months of life can cause a decreased weight gain as well as the 
potential to cause dermatitis (Synderman et al., 1963). Hao et al., (2015), noted that there was a 
lower concentration of histidine, as well as other amino acids, found in the urine of preterm infants. 
They concluded that the lack of metabolic enzymes (Vockley et al., 2006) or lack the ability to absorb 
amino acids by the body was the cause.  
Faecal water 1H NMR metabolic profiles from infants born at term are highly associated to bile acids 
species. The distinction between bile acid species is very small, depending on the presence and 
absence of hydroxyl groups on positions 3, 7, and 12 and therefore many bile acid species are found 
at similar, if not the same, chemical shifts on an NMR spectra. This said however, cholate, a major 
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primary bile acid, was identified from the 1H NMR faecal water spectra and found to be highly 
correlated to term born infants; this bile acid is produced in the liver and usually conjugates with 
glycine or taurine (Begley et al., 2005). Bile acids have a role in digestion as it emulsifies and 
solubilises fats for intestinal absorption (Houten et al., 2006). Bile acids also repress the growth of 
microbiome by solubilising the membrane lipids, causing lysis and cell leakage. Faeces produced 
soon after birth is called the meconium; it is composed of materials which are ingested during the 
time in the womb. It typically consists of epithelial cells, hair, mucus and bile as well as water and 
therefore has a different consistency to stool later in life.  With the high proportion of meconium 
samples in term infants compared to preterm infants, this separation could be caused by term birth 
samples alone. 
From the 1H NMR urine data, N-1-methylnicotinamide (NMN) is related to preterm birth; this is an 
organic cation synthesized from niacin and tryptophan and is one of the end products in the 
nicotinamide pathway. It typically is excreted in the urine and can be used as a marker of proximal 
tubular necrosis and renal injury (Trump et al., 2006). Preterm infants renal function further 
develops outside of the womb, so this metabolite is likely to be part of this process.  
Urinary HILIC-MS data shows that preterm infants are related to the metabolite hydroxynicotinic 
acid; this metabolite is broken down by bacteria, specifically P.aeroginosa, by metabolising nicotinic 
acid. This metabolite can be used to diagnose urinary tract infections from urine samples and as 
preterm infants have many different complications from birth including infections, this diagnosis is 
not surprising (Gupta et al., 2005; Bauer et al., 2003).   
Additionally, urinary HILIC-MS data shows preterm infants are highly correlated with 7-
methylguanine. This metabolite, 7-methylguanine, is a methylated version of the nucleoside 
guanosine and may reflect an increased turnover of nucleic acids related to tissue modelling and 
development in early life. Infants excrete between six and ten times more RNA catabolites compared 
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to adults and this correlates to the higher protein turnover rates in new-born and preterm infants 
compared to adults (Sander et al., 1986).  
Furthermore, infants born preterm separate due to metabolites included histidine and ascorbic acid. 
Ascorbic acid is one form of vitamin C; this vitamin isn’t stored by the body so humans require it as 
part of their daily nutrition. Preterm infants usually are given a high amounts of calcium, phosphorus 
as well as ascorbic acid to protect them from bone deformities due to prematurity (Wojcik et al., 
2009). This may be the cause for an excessive amount of ascorbic acid excreted in the preterm urine 
(Schell-Feith et al., 2000, Darlow et al., 2005). Furthermore, preterm infants’ faecal water metabolic 
profile is highly associated with thiamine, also known as vitamin B1, which plays a key role in the 
metabolism of glucose and converting carbohydrates and fats into energy that the body utilises.  
Faecal water 1H NMR profiles of preterm infants are highly associated with glycerol compared to 
term infants. This is usually an exogenous metabolite and used widely in pharmaceutical 
formulations which preterm infants could potentially be subject to, for a range of different 
disorders. However, glycerol has previously been recorded in adult human faecal samples as an 
endogenous metabolite when comparing it across species (Saric et al., 2007) and is thought to be 
important in lipid metabolism (Fanos et al., 2013).  
In terms of the developing gut microbiome, differences between the two groups were observed.  
Bacterium from the Actinobacteria and Bacteroidetes phyla were significantly higher in samples from 
infants born at term. Bacteroidetes species of bacteria are known to break down dietary choline into 
TMA, which supports the metabolic data from this group (Romano et al., 2015). From previous 
research, it has been noted that lower levels of Bifidiobacterium and Bacteroides in infants born 
preterm compared to term born infants (Stark et al., 1982).  
Furthermore, term infants are highly associated to Lactobaccillus species, this bacterium is known to 
reside in breast milk and transferred to the infant. Term infants are feeding on more breast milk 
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than preterm infants which can be recognised in the high abundance of this bacterium as well as the 
metabolites found in their urine and faeces; including choline and linoleoyl-glycerophosphocholine.  
Infants born preterm usually have a reduced diversity and higher levels of pathogenic bacteria; this 
is mainly due to their time spent in hospitals so that they are exposed to these pathogens at a higher 
level as well as they are subject to potential antibiotic treatments causing dysbiosis (Cong et al., 
2016). Preterm infants in this study are more associated with Proteobacteria, it has been noted 
previously that these bacteria are related to the use of antibiotic treatments in early life (Fouhy et 
al., 2012; Cong et al., 2016).  
Preterm birth is highly associated with necrotising enterocolitis (NEC); an inflammatory intestinal 
disorder thought to be influenced by the gut microbiota. Unfortunately, for this project there was no 
additional information on whether these infants contracted NEC during this study or the mode of 
delivery for these infants. It is known that an increased abundance of Gammaproteobacteria is seen 
in NEC patients, suggesting that this class of bacteria may be predictive of this disease (Wang et al., 
2009). Preterm infants, also, have a higher association to Staphylococci and Finegoldia bacteria, 
which is usually found on the skin (Groer et al., 2014). This could be due to these infants being born 
through caesarean section and being exposed to the skin of the mother, especially during breast 
feeding. These bacterium are commonly found on the skin and regarded as commensal; however, 
they are also opportunistic pathogens and cause infections in open wounds.  
5.5.2. METABOLIC AND MICROBIOMIC PROFILING TO IDENTIFY DIFFERENCES IN INFANTS 
AT TIME OF BIRTH 
As we have discussed before, term and preterm infants can be anatomically and physiologically 
different to each other due to the difference in gestational age. Understanding the difference in 
metabolic profiles between these infants helps to understand the needs of a premature baby 
metabolically.  
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Term infants have higher concentrations of pseudouridine in their urine; the isomer of the 
nucleotide uridine found in RNA is a degradation product of transfer ribonucleic acid (tRNA). This 
metabolite has also been attributed as a metabolic marker for kidney nephrotoxicity in new born 
rats so may be an indication into the developing kidneys from birth (Hanna et al., 2013; Fanos et al., 
2013).  
Furthermore, term infant’s urine correlates to trimethylamine (TMA) which is related to choline 
metabolism (Trump et al., 2006). When there are high carnitine levels; bacteria from the gut 
microbiome degrade carnitine in the body to make TMA. This is an interesting find, as until recently 
infants were thought to be sterile inside the womb, but if it would be possible to attribute this 
metabolite to bacterial co-metabolism this would mean that bacterial activity was occurring in the 
womb. That said however, in my previous investigations (chapter 3) it has been noted that metabolic 
profiles of urine at birth is very similar to that of the mothers. Therefore, this metabolite could have 
been passed from mother to foetus in the womb through the placenta. With this in mind, this 
metabolite is related to term infants and not in preterm, suggesting that there is a lack of choline 
exchange from mother to infant in preterm infants or this exchange occurs later in gestation.  
From the urinary HILIC MS data, infants which are born term separate from preterm due to 
metabolites including dipeptides and amino acids, as well as citrate and homocarnosine. 
Homocarnosine is related to histidine and the brain-specific dipeptide, gamma-aminobutyric acid 
(GABA) as well as acetylhomoserine (Pearl et al., 2006). The presence of polypeptide chains in the 
urine could be to do with the lack of digesting diets fully. Furthermore, similar to term samples, 
urine samples were taken at birth and could be related to mother’s metabolic profile. These are the 
same features which caused the separation in the previous model which is to be expected as the 
only samples run by HILIC-MS from term born infants were obtained at birth only. 
Furthermore, term infants are related to citrate, this metabolite is an intermediate in the TCA cycle. 
This cycle is very important for humans as it produces energy through the oxidation of acetyl-CoA in 
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the mitochondria (Bender and Mayes, 2012). This metabolite has previously been seen in term 
infant urine when compared to preterm (Foxall et al., 1995).     
Faecal water NMR metabolic profiles from term infants at birth are highly associated with bile acids 
as well as an unknown metabolite which is highly associated to this region (0.65-0.85) suggesting 
that it could be a bile acid conjugated to taurine (Duarte et al., 2008). As discussed previously, 
meconium samples are composed of very different molecules compared to stool obtained from later 
postpartum samples. When an infant is born, the gastrointestinal tract sheds its protective layer 
consisting of bile, epithelial cells and hair which makeup the meconium. It is evident from this 
project that meconium samples have higher concentrations of bile acids and therefore a different 
faecal metabolic profile compared to samples taken at a later date. From targeted analysis of bile 
acids in these samples, there were no significant differences seen in infants born term compared to 
preterm which would suggest that there is an overall quantitative difference in bile acids rather than 
specific species. Furthermore, the gut microbiome, in particular Bacteroides species, can utilise the 
taurine conjugated bile acids by enzymatically deconjugating it. Thus releasing the amino acid side 
chain to use it as a source of carbon, nitrogen and energy sources (Begley et al., 2006).   
Urinary NMR metabolic profiles from preterm infants at birth are highly correlated to threonine, 1-
N-methylnicotinamide and myo-inositiol as well as an unknown metabolite which was tentatively 
assigned as -aminoisobutyrate. Threonine is a glucogenic amino acid, which is found in proteins, 
and is needed to generate glycine and serine for the production of muscle tissue; it has been 
previously associated with infants born small for gestation age (Moltu et al., 2014).  
Myo-insitol plays an important role in the structural component of lipids and various phosphates as 
well as a myriad of different roles within the body (Foxall et al., 1995). Inositol is produced by the 
human body from glucose and used for many cellular functions; it is also thought to be a marker of 
glucose intolerance (Mahan 2011). Preterm infants have altered glucose metabolism and potentially 
have developed a hypo-insulinemic condition (Dessi et al., 2014). Elevated abundance in preterm 
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infants of myo-inositol may also suggest differences in the synthesis of membrane phospholipids 
which act as lung surfactants (Diaz et al., 2015). Furthermore, myo-inositol is also found in breast 
milk and usually fully absorbed into the blood.  
However, it is seen to be increased in diabetic or renal failure patients due to the lack of absorption 
in the kidneys. Preterm infants have immature renal systems so probably lack the efficiency of taking 
up all the myo-insitol before it can be excreted. Furthermore, -aminoisobutyrate and 1-N-
methylnicotinamide are related to the renal function development after birth as well (Trump et al., 
2006).  
Urinary HILIC-MS data from infants born preterm separate due to metabolites including ascorbic 
acid and glutamine as well as hydroxynicotinic acid. Glutamine is an amino acid found at high 
concentrations in human breast milk. It has been previously noted that glutamine in cord blood 
positively correlated with birth weight in infants, which indicates the difference in anabolic rate that 
low birth weight infants have compared to term born infants (Ivorra et al., 2012).  Nicotinic acid 
metabolites have been linked to urine from children with ASD; preterm infants are at a higher risk of 
developing conditions including ASD (Yap et al., 2010).  
Preterm faecal metabolic profiles taken from birth was highly correlated to carbohydrates and 
sugars seen at NMR chemical shifts between 3-5ppm, which have many overlapped resonances from 
glucose, other sugars, polyols, N-methylated compounds and amino acids. Preterm infants are not 
fully developed, especially their digestive tract, therefore simple sugars from their diet are not fully 
absorbed and are lost in their faeces. Further to this, preterm infants stool samples are more 
associated to the amino acids; alanine and phenylalanine. Phenylalanine is naturally found in breast 
milk and included in nutrient supplements for preterm infants (Atzori et al., 2011). Therefore, again, 
due to the immaturity of the digestive tract, this amino acid is not fully absorbed into the body or 
there is an excess introduced into the body from the diet. 
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5.5.3. METABOLIC AND MICROBIOMIC PROFILING TO IDENTIFY DIFFERENCES BETWEEN 
TERM INFANTS AT BIRTH VS PRETERM AT TERM EQUIVALENT AGE 
Infants which are born preterm are deemed term equivalent age when they have reached 37 weeks’ 
gestation in the weeks spent postpartum. By comparing term infants birth samples and samples 
taken from preterm infants when they reach term equivalent age (37-41 gestation week) it gives a 
clearer idea as to how the preterm infants have developed compared to infants which are born at 
term. 
From the urinary NMR data, there was no significant difference in urinary metabolic profiles 
between term samples taken at birth compared to preterm samples taken at term equivalent age 
(Supplementary Figure S5). However, there was a significant difference between urinary global 
profiles using HILIC-MS. Infants born term separate due to metabolites including creatinine.  As 
expected from previous models of NMR data, creatinine is correlated to infants born term. This 
metabolite is related to muscle mass in humans and even though infants born preterm have reached 
term equivalent age in this model and we would expect them to have a higher muscle mass, this 
would suggest that term born infants still have a higher muscle mass from birth.   
Furthermore, infants born term separate due to nutritional metabolites including 3-hydroxy-3-(3-
hydroxyphenyl) propanoate, 5-(2-Methylpropyl)tetrahydro-2-oxo-3-furancarboxylic acid, tyrosol-4-
sulfate, as well as a number of different polypeptide chains and proline. 3-hydroxy-3-(3-
hydroxyphenyl) propanoate is a metabolite from the breakdown of phenylalanine which comes from 
nutritional sources or as these samples were taken at birth these metabolites could be related to the 
maternal metabolic profile which has been exchanged through the placenta in the womb (Kumps et 
al., 2002). 5-(2-Methylpropyl)tetrahydro-2-oxo-3-furancarboxylic acid is typically found in milk 
products and tyrosol-4-sulphate is a common polyphenol metabolite found in dietary sources 
including infant formulas (Pande and Akoh, 2015; Neveu et al., 2010). Additionally, if these samples 
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were taken after the first feed from the mother, this would alter the metabolic profile, which 
supports the need to standardise and be aware of time records of samples in infants.  
Infants born preterm separate due to metabolites including 1-N-methylnicotinamide and 
pantothenic acid. 1-N-methylnicotinamide was also a metabolite which caused the separation of 
classes in the NMR data. As previously mentioned, this metabolite is an organic cation synthesized 
from niacin and tryptophan and is one of the end products in the nicotinamide pathway which can 
be excreted in the urine (Trump et al., 2006). Pantothenic acid and 4-pyridoxic acid, which were also 
identified by HILIC-MS, are also known as vitamin B5 and a catabolic product of vitamin B6 
respectively. These metabolites are not synthesised by the human body and is found in breast milk 
as well as synthesised from many different species bacteria which reside in the gut (Hooper et al., 
2001, Kau et al., 2011). Breastmilk concentration of this metabolite increases over time from 
mothers of full time as well as preterm mothers (Ford et al., 1983). Therefore, it is reasonable that 
preterm infants which have been developing outside the womb, are exposed to more bacterial co-
metabolism as well as ingesting breastmilk or exposed to other dietary factors, will have a higher 
concentration of this metabolite in their system.  
Preterm infants separate due to 4-cresol; this metabolite is a phenol derivative and a microbial co-
metabolite which is produced by the fermentation of protein by the gut microbiome (Maitre et al., 
2014). This gives further evidence for the microbial activity in the preterm infant’s intestinal system 
is contributing to their metabolic health.  
Infants which are born preterm separate due to the metabolite histidine, this amino acid used in the 
synthesis of proteins and known to be essential for infants up until 6 months. (Synderman et al., 
1963) This metabolite has also previously been seen to be higher in preterm infants when compared 
to term infants (Hao et al., 2015). Preterm NMR metabolic profiles are highly associated to amino 
acids (including alanine, leucine, lysine and tyramine) compared to term infants. Even at a later stage 
of development preterm infants are still not fully developed, therefore amino acids from their diet 
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are not fully absorbed and are lost in their faeces. Tyramine is a monoamine compound which is 
derived from tyrosine and related to phenylalanine; it is naturally found in breast milk, as well as 
contained in many parenteral nutritional supplements.  
Furthermore, infants born preterm correlated to hydroxyproline, this metabolite is a major 
component of collagen, the main protein to produce the extracellular space in tissues. This 
metabolite is regularly excreted in urine and is thought to be a reliable indicator of collagen turnover 
and the concentration excreted is related to rapid growth (Younoszai, et al., 1969). As this 
metabolite is higher in preterm infants it would suggest that these infants are rapidly growing 
compared to their term urine taken at birth.    
Faecal NMR metabolic profiles also showed a significant separation according to class; there is a 
higher correlation of bile acid in the term infant samples compared to the preterm babies, which 
was seen in the previous models in this chapter. The bile acids in term babies are associated with the 
different composition of the meconium. Bile acids also repress the growth of microbiome by 
solubilising the membrane lipids, causing lysis and cell leakage, this may be an important factor to 
protect the foetus from bacterial growth in the developing intestine whilst in the womb.    
The extended box plot shows that the phylum level, Bacteroidetes is highly associated with term 
infants at birth compared to preterm infants at term equivalent age. Bacteroidetes and Firmicutes 
are the most prominent phyla in the adult gut microbiome, Bacteroidetes in infant samples are 
related to breast milk as previously mentioned. Delving deeper into the differences of genus 
between term and preterm, there are many different species of bacteria associated to the term 
infant. This supports the notion that term infants have a much higher diversity of bacterium in their 
gut compared to preterm infants. Additionally, Allobaculum, which is part of the Firmicutes phyla, is 
associated to term infants and found in healthy infants and not influenced by the mode of delivery 
(Rutayisire et al., 2016). Interestingly, bacterium genera, Methylobacterium and Bradyrhizobium are 
related to term infants. This bacterium is usually found in soil and tap water, even though they have 
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been found in human microbiome samples, including the ocular surface, they have not been 
recognised in infant studies before (Dong et al., 2011).  
Early life exposures can affect the development of the gut microbiome, especially preterm birth and 
antibiotic use can have long term effects on the microbial diversity. Infants born preterm have a 
higher association to the aerobic, Enterobacteriaceae at the time of term equivalent age. It has been 
discovered that this particular bacterium is related to the hospitalisation in a NICU for infants (Parm 
et al., 2011). Nutritional factors are believed not to be related to the colonisation of this bacterium 
but it is potentially related to antibiotic use.  
This data shows that even after preterm infants have reached term equivalent age, where they have 
been exposed to the environment longer compared to the term infants where samples were taken 
in the first day still have a perturbed microbiome development. 
From previous investigations within this thesis, it has been repeatedly noted that birth samples from 
infants have a different composition compared to samples taken later postpartum. Therefore, 
modelling term birth samples against later samples from preterm infants was evident that there 
were going to be disparities. Consequently, it was decided to produce another model where samples 
from term infants were from weeks 1-2 postpartum rather than birth samples. Another benefit of 
this model is that metabolites contributed from maternal metabolism aren’t regarded in the analysis 
and the focus’ is purely on the infant metabolic profile. Preterm samples have relatively elevated 
concentrations of N-acetyl glycoproteins, which are found in breast and formula milk so this 
metabolite is likely to have come from the diet.  
Interestingly, the previous model when term birth samples were modelled, preterm samples were 
associated with tyramine; however, in this updated model, when term samples were taken at one 
week postpartum, tyramine is associated with term infants conversely. Tyramine is the break down 
product of tyrosine, a common amino acid which can be executed by lactic bacteria (Marcobal et al., 
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2012). This result suggests that after a week postpartum, lactic acid bacteria colonising term infants 
are utilising more tyrosine for nutrients at this time compared to at birth and compared to preterm 
infants, when they would have had a much lower gut microbiome diversity.  
5.5.4. METABOLIC AND MICROBIOMIC PROFILING TO IDENTIFY DISPARITIES BETWEEN 
INFANTS AFTER THREE MONTHS POST-PARTUM 
After three months of development outside of the womb and interactions within the environment, 
infants born preterm have been exposed firstly to the hospital environment, which is staggeringly 
different to their term born counterparts. Equally, infants born preterm are usually subject to many 
different therapies to treat with their numerous medical conditions. These first experiences can 
have a huge effect on the developing body of the new born infant and thus has the potential to 
dramatically change their metabolic profile; therefore, by comparing metabolic profiles at three 
months after birth these differences have been assessed.    
Urinary NMR data from term infants at three months postpartum is highly associated with betaine, 
dimethylglycine, dimethylamine. As discussed previously, these metabolites related to the 
metabolism of dietary choline where there may be an imbalance of the utilisation of choline from 
the immature gut.  Furthermore, betaine could be released due to the immaturity of the infant 
kidney (Foxall et al., 1995).  N-acetylglutamate is also highly associated with this class, this 
metabolite is related to breast milk that the infants diet consists of (Andreas et al., 2015).  
Preterm infant’s urine at three months postpartum is highly associated with mannitol, fructose and a 
species of bile acid. Mannitol is a monosaccharide and is used widely in medical use; it is used for 
the reduction of intracranial pressure as well as prevents swelling of the endothelial cells in the 
kidney. Furthermore, it can be used for the evaluation of intestinal permeability of the small 
intestine; many preterm infants have immature gut maturation and as a result have underdeveloped 
gut mucosal barrier.  Fructose, which is also a monosaccharide, is shown to be the principal sugar of 
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fetal blood while it is found in minute amounts in the maternal blood (Trindade et al., 2011). The 
elevated concentration of this sugar in the preterm infant’s urine could be that the preterm infant is 
continuing to produce this sugar as an alternative pathway in glucose pathway which they would 
have done as a fetus.   
The preterm infant urine has higher concentrations of 1-N-methylnicotinamide (NMN), an organic 
cation which was identified in previous models. As it is still causing a separation between preterm 
and term samples it could mean that the preterm renal function is still underdeveloped compared to 
term infants. Furthermore, preterm infants had elevated bile acid concentration at this time point 
compared to term infants. This has previously been recognised and thought to be an over 
production or clearance of bile acids by the preterm body (Yamato et al., 2001). Although, another 
reason for this could be that preterm infants are not as efficient at reabsorbing bile acids from the 
colon and therefore are excreted more readily compared to the term infant.  
Lysine is an essential amino acid for protein synthesis and found in protein rich foods, it is also the 
first limiting amino acid in milk fed mammalian newborns. If the amount of protein in the diet is not 
adequate, the rate of protein synthesis and growth will be determined by the amount of lysine (van 
der Schoor et al., 2004). From this model, different feeding types contributed to the metabolic 
profiles, which is reiterated when investigating the specific metabolites causing this difference. With 
an elevated relative abundance found in preterm infants, this would suggest that they are being fed 
a high protein diet or are not utilising all the lysine from their diet and therefore may be subject to 
slow growth rates.  
Conversely, faecal water metabolic profiles at three months’ post-partum age was not 
distinguishable between infants born term compared to preterm born infants. This age dependant 
similarity in metabolic profiles may be due to the same environmental exposures and diet is the 
most influential factor on the faecal profile rather than human development.  
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 The gut microbiome is constantly changing in the first few months of life and doesn’t completely 
stabilise until we are toddlers. This is due to the consistent introduction to new environmental 
exposures (e.g. changes in diet from milk to solid food) as well as the general maturity of the human 
body. It was observed that bacteria from the Actinobacteria phylum are significantly higher in 
samples from infants born at term. Other studies have concluded that the main bacterial species 
found in the infant microbiome are Bacteroidetes and Bifidiobacterium, the latter is part of the 
Actinobacteria phylum and supports this result.   
At the genus level, term infants are highly correlated to the Actinomyces from the Actinobacteria 
phylum as well as Streptococcus and Clostridium XVIII from the Firmicutes phylum. Actinomyces 
genus are related to higher fat content found in breast milk, specifically the oleic and cis-vaccenic 
acid content (Taft et al., 2016). From the metabolic data, urine profiles separate according to the 
particular nutrition, further linking metabolome and microbiome information as complementary.  
Streptococcus bacterium are commonly found in breast milk and as more term infants are on a diet 
of breast milk compared to preterm infants who are on a combination of parenteral nutrition and 
milk this result is predictable (Musilova et al., 2014). However, Clostridium species are commonly 
associated with formula fed infants (Penders et al., 2006), which suggests that both Clostridium and 
Streptococcus are highly associated with term infants due to the fact that preterm infants are 
subject to parenteral nutrition and perhaps have a lower diversity of bacterial species in their gut 
microbiome.   
5.6. CONCLUSION 
Using multi-analytical platforms provides an extensive range of biochemical and microbiome related 
information. The findings from this study show that the metabolic profile of urine and faecal water is 
strongly affected by gestational age at birth and increasing postnatal age. Specifically, choline 
metabolism is positively correlated to infants born at term whereas other dietary metabolites can be 
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found in preterm infants, including amino acids and other organic acids. This could be a key finding 
for future dietary management in the developing preterm infant. Interestingly, no disparities in 
SCFAs were recognised in this study between term and preterm infants; these compounds are 
produced by the fermentation of polysaccharides by the gut microbiome. This is intriguing as the gut 
microbiome has been documented as different between the two groups but this suggests that their 
functionality of utilising these as a nutrient source are equal.   
Furthermore, there is a large range of metabolites being excreted in term and preterm infant urine 
which were related to kidney development and potential injury or damage. This would suggest that 
the development of renal function is different in term and preterm infants from birth. Further 
investigation into the effects of these different metabolites have on the body needs to be a priority.  
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CHAPTER 6 
 
GENERAL DISCUSSION 
 
 
 
The investigations that form this thesis have determined the metabolic development trajectory of 
infants in their first two years of life. Using 1H NMR, UPLC-MS and metagenomics profiling 
techniques to generate urine and faecal samples from healthy neonates and infants shows the 
breadth of knowledge we can gain from a further understanding these profiles. Characterising the 
metabolic profile is critical in the role to understand the normal development trajectory in the first 
years of life and can be used as a benchmark for future research studies.  
6.1  KEY FINDINGS 
From the results in this thesis the key findings revolve around establishing clear differences in 
urinary and faecal metabolic profiles from developing infants, influenced by environmental 
exposures early in life; including gestational age, mode of delivery and nutrition.  
Firstly, my aim was standardising protocols and standard operating procedures for infant biofluid 
collection and metabolic profiling using mainly 1H NMR analysis, followed by acquisition of urine and 
faecal profiles over the first two years of life. One of the most interesting findings was the striking 
similarity of the urinary metabolic profile from infants at birth compared to the maternal urine, 
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which has not been reported previously (Jackson et al 2016). The age variability in the urinary 
metabolic profile was key in the focus of this PhD as it was evident that the metabolic trajectory of 
the infant metabolome, especially the faecal metabolic profile, has not been properly examined 
particularly with respect to characterizing the metabolic evolution over regular increments.  
Two infant studies were used to further our knowledge of metabolic profiling from this critical 
developmental stage of life. In chapter 4, faecal samples taken in early life ( ≤120 days postpartum) 
discriminate according to early life exposures: including gestational age, birth weight, mode of 
delivery, nutrition, as well as BMI status at 1 and 2 years of age. Interestingly, faecal samples taken 
at 1 and 2 years postpartum showed very little discrimination between classes (gestational age, birth 
weight, mode of delivery and nutrition) except for BMI status. This suggests that the differential 
effect of birth weight, gestational age, mode of delivery and nutrition on the faecal metabolic profile 
doesn’t persist once the infant is over 1 years old. 
For chapter 5, a deeper exploration of the early life metabolic differences between infants born term 
and preterm from birth and until 3 months postpartum. To accompany the faecal metabolomes, 
which gave insight into the functionality of the gut bacteria, profiling of gut microbiome of infants 
provided information pertaining to the composition of the gut microbiome. Further evidence for 
little discrimination for faecal metabolic profile between term and preterm infants after the 
neonatal period was established in this study, as faecal samples at 3 months also show very little 
difference between profiles.  
Sources of metabolite variation in infant urine and faecal samples from both studies can be assigned 
to classes of compounds or specific biochemical pathways from these two studies (Table 6-1 and 6-
2).    
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6.2  STANDARDISING INFANT BIOFLUID PROTOCOLS FOR METABOLIC    
PROFILING 
It became apparent at the beginning of this project that infant metabolic profiling studies were not 
as common as adult studies. Therefore, specific protocols for infant biofluid collection and 
preparation were not as available (Goodpaster et al 2011). Thus a significant aspect of this project 
involved the optimisation of protocols before confident evaluations could be accomplished. Being 
aware of contamination from collection materials (cotton wool and nappies) is essential to the 
success of an infant metabolic profiling project. For example, propylene glycol was found to be a 
contaminant coming from collection materials but it can also be produced in the body and by the gut 
microbiome from glutamine (Jackson et al 2016). Additionally, infant studies come with the difficulty 
of low volume samples making multiplatform analysis difficult. Evaluating and analysing dilution 
series in biofluids using 1H NMR, this problem has been addressed and the technique successfully 
utilised in this project.  
Profiling faecal material is a relatively novel tactic for delving deeper into the metabolic profile 
(Jacobs et al 2008; Saric et al 2007; Chow et al 2015; Martin et al 2014).  This biofluid is ideal for 
further understand the mutualistic relationship between the gut microbiome and host through 
gaining further knowledge on the functional qualities of this community. Furthermore, similar to 
urine, this biofluid is ideal for testing as it is a waste product and therefore non-invasive; which is 
particularly beneficial for infant studies. As mentioned previously, volume of samples from infants 
(especially preterm born infants) was consistently low and represented a particular limitation in this 
project, therefore producing a faecal water preparation protocol to get as much information from 
the single sample using multi-platform techniques was essential for this project. This work was 
successful especially as infant samples are regarded as precious commodities and often hard to 
obtain due to sensitivities around sample collection, limited volume and difficulties in obtaining 
ethics. I would expect that this work will be utilised further in adult studies as it significantly reduced 
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preparation time as well as preparatory inaccuracy for faecal samples between different analytical 
methods (NMR and UPLC-MS).  
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Table 6-1. Summary of the main faecal water discriminatory metabolites and their biochemical pathway from infants at 4 days to 2 years postpartum from the 
NoMic Study. Key: Amino Acids 3 letter key used.GA- gestation age, MoD – Mode of delivery,  BMI – Body mass index, 3’-FSL – 3’fucosyllactose, 4-HPA – 4-
hydroxyphenylacetate, TMA – trimethylamine, DMA- dimethylamine, TMAO – trimethylamine-N-oxide, N3-TML – NNN-trimethyllysine, 3-HB- 3-hydroxybutyrate, 
GABA – -aminobutyrate. (*overlapped resonances from glucose, other sugars and polyols, N-methylated compounds and amino acids) 
Class of compound/ 
biochemical pathway 
Discriminatory metabolites correlated to groups from multivariate statistics (OPLS, OPLS-DA) and time series analysis 
Age variability Term vs.Preterm Birth weight Birth GA MoD Nutrition BMI 
TCA cycle intermediates 
(e.g. succinate, citrate) 
      ≥ 120d pp -    
      succinate 
     Term - 
     succinate 
    HBW-succinate     HGA –  
   succinate 
   
Sugars and oligosaccharides 
(e.g. glucose, fructose, 
mannitol) 
      ≤ 30d pp –  
      Sugars* 
 
     Preterm,  
    Sugars*,  
    3’-FSL  
 
     Term  
     Sugars*,     
     glucose 
    LBW -3’FSL 
 
    HBW – Sugars*,  
                 Glucose 
    LGA -3’FSL 
 
    HGA –Sugars*,  
             Glucose 
    VD – sugars*   
N-acetylglycoproteins 
(e.g N-acetylglutamate) 
     ≤ 30d pp 
 
        More excl.BM   
SCFA (e.g. acetate, 
butyrate, propionate) 
      ≥ 120d pp –  
      Butyrate,  
      Propionate,      
      Acetate 
   Preterm – 
   Butyrate 
    LBW – 
    Butyrate,  
    Propionate 
    LGA – 
    Butyrate,  
    Propionate 
      less excl.BM  
     Butyrate,  
     Propionate,  
     Acetate 
 
BCAA (e.g. leucine, valine)       ≥ 120d pp –  
      Val 
   Term - Leu     HBW-Leu, Val     HGA -  
    Leu, Val 
     VD – Ala   
Amino acid and derivatives 
(e.g. tyramine, lysine, 
aspartate) 
      ≥ 120d pp –  
      Ala, Asp,  
      Phe, Tyr 
       
 
    Preterm –Tyr 
 
    Term – Ty,  
    Ala, N
3
-TML,    
    Phe 
    LBW – Tyr  
 
    HBW- Ty, Ala,  
               N
3
-TML 
    LGA –Ala,   
              Tyr 
 
    HGA – Ty,  
    N
3
-TML, Phe 
     VD – Tyr,  
              GABA  
 
     CS – Ty 
     less excl. BM 
     Lys 
 
     more excl.BM  
    3-HB 
   HBMI-  
    4-HPA 
 
   LBMI –Asp,  
    4-HPA, Gln 
Methylamines & choline 
metabolism (e.g. Betaine) 
     120d pp –  
    Methylamine 
 
    Term-  
    Choline,  
    Betaine 
    HBW –  
    Choline 
    HGA –  
    Choline 
    VD – DMA,  
    TMAO 
    more excl. BM  
    choline 
   HBMI-TMA 
Bile acids 
(e.g cholate and 
unidentified) 
     120d pp –  
     unidentified 
    Term –  
    unidentified 
   HBW –  
   unidentified 
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Lipids (e.g. L1) 
 
     Preterm -L1    LBW –L1     LGA – L1    
Nucleotide salvage (e.g. 
uracil, adenine) 
     ≥ 120d pp –  
     uracil,  
     adenine 
       VD - adenine   
Other compounds 
(e.g. myo-inositol, 4-cresol) 
      120d pp 
      4-cresol-  
      glucuronide 
   Preterm –  
   glycerol 
      VD- Acetone   
 
 
 
 
Table 6-2. Summary of the main urine (blue) and faecal water (black) discriminatory metabolites and their biochemical pathway from infants born term and 
preterm. Key: Amino Acids 3 letter key used. TMA – trimethylamine, DMA- dimethylamine, DMG- dimethylglycine, TMAO – trimethylamine-N-oxide, NMN – N-1-
methylnicotinamide, N-AGlu - N-acetylglutamate, N-AGalS- N-acetylgalactosamine 6–sulphate, HomoGen - Homogentistic acid, AcetylHomoSer- 
Acetylhomoserine, PhoCho – Linoleoylglycerophosphocholine,  6HNA- Hydroxynicotinic Acid, N7-MeG- 7-methylguanine, HPHPA -3-hydroxy-3-(3-
hydroxyphenyl) propanoate, MTFCA- 5-(2-Methylpropyl)tetrahydro-2-oxo-3-furancarboxylic acid. (*overlapped resonances from glucose, other sugars and 
polyols, N-methylated compounds and amino acids) 
Class of compound/ 
biochemical pathway 
Discriminatory metabolites correlated to groups from multivariate statistics (OPLS, OPLS-DA) 
Term vs Preterm Term vs Preterm at birth Term at birth vs Preterm at TEA Term vs Preterm at 3m PP 
TCA cycle intermediates 
(e.g. succinate, citrate) 
    Term - Citrate   
Sugars and oligosaccharides 
(e.g. glucose, fructose, mannitol) 
     Preterm – fructose,  
     mannitol 
   Preterm – sugars* 
 
     Preterm – fructose,     
   mannitol 
N-acetylglycoproteins intermediates 
and derivatives 
     Preterm – N-AGalS         Term – N-AGlu 
BCAA (e.g. leucine, valine, -
aminoisobutyrate) 
    Preterm – -    
   aminoisobutyrate 
   Preterm- Leu  
Amino acid and derivatives 
(e.g. tyramine, lysine, aspartate) 
    Preterm – Lys, His 
 
    Term – HomoGen,  
                  AcetylHomoSer 
   Preterm – Thr, Gln 
 
   Preterm – Ala, Phe 
 
   Term – Pro, HomoGen,  
                 AcetylHomoSer 
   Preterm – Hyp, His  
 
   Preterm – Ala, Lys, Ty 
 
   Term – Pro, HomoGen, His 
   Preterm - Lys 
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Methylamines or choline metabolism 
(e.g. Betaine, TMA, DMG, DMA and 
TMAO) 
    Term – TMA, DMA,  
    DMG, Betaine, PhoCho 
   Term – TMA      Term – DMA, DMG &  
                Betaine 
Bile acids 
(e.g cholate and unidentified) 
    Term – unidentified,  
                 cholate 
    Term – unidentified    Term – unidentified    Preterm – unidentified  
Nutritional metabolites and 
Peptides, Protein degradation 
    Term – polypeptides 
 
   Term – MG, Peptides 
 
  Term – Peptides, HPHPA,  
    MTFCA, Tyrosol-4-sulfate,  
 
   Preterm – polypeptide, 
                     4- cresol 
 
NAD cycle, nicotinamide pathway 
(e.g. NMN) 
   Preterm – NMN, 6HNA 
 
   Preterm - NMN    Preterm - NMN    Preterm - NMN 
Polyol e.g. glycerol      Preterm – Glycerol 
 
   
Vitamins (e.g. Vit B5 and B6)    Preterm – Vit B1  
 
   Preterm - Vit C 
 
   Preterm- Vit C    Preterm – Vit B5, Vit B6  
Nucleontide salvage (e.g. uracil, 
adenine) 
   Term - Pseudouridine  
 
   Preterm- N7-MeG 
 
   Term - Pseudouridine  
 
    
   Term - Pseudouridine  
Other organic acids 
(e.g. myo-inositol, 4-cresol) 
   Term – Malonate 
 
   Preterm – Myo-inositol 
 
   Preterm – Myo-inositol    Term - Creatinine  
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6.3  NUTRITIONAL INFLUENCE ON INFANT DEVELOPMENT 
Nutrition in early life has always been an interesting subject for studies into infant development. 
Breastfeeding is recommended in infants due to the complex mixture human oligosaccharides 
present in the milk as well as the immunological benefit for the child. Human milk oligosaccharides 
(HMO) are unique complex carbohydrates and are not digested by human enzymes so can reach the 
intestinal to promote the growth of beneficial bacteria; so act as a prebiotic. Also, HMOs purpose is 
to help to prevent neonatal diarrhoea and respiratory tract infections (Andreas et al 2015). Within 
this project, many nutritional metabolites, and energy production metabolites were evidently 
imperative for infant development. Changes in the excretion rates of components from the TCA 
cycle, amino acids, sugars and choline oxidation pathway featured in nearly all of the investigations 
in this thesis.  
 
Figure 6-1: Schematic to represent metabolic pathways in developing infants 
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Choline and methylamine derivatives, were shown to exhibit considerable differences in all the 
investigations; including term versus preterm, mode of delivery, nutrition and BMI status. 
Trimethylamine (TMA), dimethylamine (DMA), dimethylglycine (DMG) and betaine are derived from 
choline, which can be obtained from the diet or endogenous sources by the breakdown of 
phospholipids. From the literature, betaine has been previously noted to be high at birth and 
increasing in concentration through the neonatal period (Trump et al 2006; Foxall et al 1995; Gu et al 
2009). It is thought that at birth, betaine is elevated due to the high concentration of choline 
transport from the mother through the placenta to the foetus in late pregnancy. In this project, 
samples taken at 3 months postpartum from term born infants had elevated levels of betaine, which 
agrees with these reports (Foxall et al 1995; Trump et al 2006). Infant nutrition, whether breast milk 
or formula, is relatively high in dietary choline so this may exceed the needs of the infant and 
therefore betaine, a metabolic product of choline is excreted in the urine.  
From the results, N-acetylglycoprotein fragments, sugars and choline are important for nutritional 
sources in infants. When stratifying the data into different lengths of time during which the infants 
were exclusively breast fed, they were not related to the amount of sugars excreted suggesting that 
this metabolite is unrelated to specific nutrition. However, choline derivatives and N-
acetylglycoprotein fragments as well as 3-hydroxybutryate are related to infants exclusively fed 
breast milk for longer which agrees with the literature (Martin et al 2014).  
Furthermore, once infants reach about 4-6 months of age, their nutrition changes and are typically 
weaned off milk onto solid foods. This change in nutrition can clearly be recognised in the faecal 
metabolic profile. Elevated concentration of succinate is available for the infant at this time point, 
suggesting a higher production of energy. Additionally, more SCFAs and 4-cresyl glucuronide are 
being produced at this time point compared to earlier samples which suggests a richer nutrient 
source for the gut microbiome.  
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6.4  GUT MICROBIOME INTERACTIONS 
The gut microbiome plays a key role in the human health and disease, with dysbiosis causing 
complex diseases, including inflammatory bowel disease, celiac disease and colorectal cancer. 
However, this mutualistic relationship is essential for fermentation of carbohydrates and production 
of essential vitamins as well as inducing immune development. Host-microbe interactions and 
microbial co-metabolites can be recognised in all the investigations in this thesis.  
SCFAs are generally regarded as beneficial to health as they prevent diarrhoea and are a nutrient 
source for colonic cells as well as taken up into the human body as an energy source. The most 
surprising results from the term vs preterm study is that there were no significantly different short 
chain fatty acids (SCFAs) between the two groups of infants. This is interesting as these molecules 
are produced by bacterial metabolism of undigestible carbohydrates and as preterm infants usually 
have perturbed bacterial communities this could be an expected difference between the infants. 
However, the NoMic study showed significant elevated concentrations of butyrate in preterm 
infants as well as propionate in low birth weight infants. These SCFAs are related to consuming less 
breast milk during the neonatal period and in high concentrations has been recognised in the 
potential contribution to necrotising enterocolitis (NEC) in preterm infants (Pourcyrous et al 2014; 
Favre et al 2002; Cristofalo et al 2013). Furthermore, SCFAs were significantly higher in infants fed 
formula milk, which suggests that their bacterial community were differentially dependent on 
nutrition. This is especially interesting as acetate was elevated in these infants, which is usually 
attributed to breast milk fed babies, and propionate and butyrate to formula fed infants (Parrett et 
al 1997). 
Human breast milk contains oligosaccharides, these are undigested by the human bowel and utilised 
by the infant gut microbiome. The oligosaccharide, 3’fucosyllactose, was positively correlated to 
preterm infants implying that the gut microbiome was not fully utilising this source of nutrition, and 
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also supporting evidence that the preterm gut microbiome is less diverse compared to term infants 
(Cong et al 2016). This said however, the preterm gut microbiome is contributing to metabolic health 
as samples from preterm infants had elevated levels of 4-cresol.  
As previously mentioned, choline and its intermediates are being utilised by the gut microbiome and 
are positively correlated in term born infants, vaginally delivered and exclusively fed on breast milk 
for longer periods. Interestingly, TMA was positively correlated to term infants at the time of birth 
which gives further evidence that the birth metabolic profile is influenced by the maternal metabolic 
profile or that there is bacterial activity in the foetus. Interestingly, vaginally delivered infants had 
elevated levels of bacterial co-metabolites including TMAO and GABA. Furthermore, TMA is elevated 
in higher BMI status infants suggesting that the gut microbiome has a role in the risk of obesity. 
Additionally, 4-HPA is positively correlated to infants with low and high BMI status at different time 
points, adding to the implication that further understanding of the composition of the gut 
microbiome is needed.  
These microbial co-metabolites demonstrate the importance of the gut microbiome on human 
health especially as they are contributing to infant metabolism early in life and therefore have an 
impact on infant development.  
6.5  KIDNEY DEVELOPMENT 
At birth, renal function is sufficient for the needs of the infant to regulate electrolytes in the blood 
and remove waste products from the body.  However, it is believed the filtration function is still 
developing after birth (Drukker et al 2002).  
Choline metabolites including, TMAO, TMA, betaine and methylamine also function as renal 
osmolytes and elevation in urine and faces may be indicative of medullary damage (Foxall et al 
1995). This can be been attributed to the capability of the medullary cells in the kidneys being 
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inefficient to take up betaine into the cell. As many of these metabolites were elevated in term 
infants compared to preterm infants, it suggests that renal function is not fully formed at birth and 
the kidneys mature further during the neonatal period. Furthermore, term infants have elevated 
urinary levels of pseudouridine, which has been attributed as a metabolic marker for kidney 
nephrotoxicity. However, preterm infants have relatively higher concentrations of 1-N-
methylnicotiamide which is a marker of proximal tubular necrosis and renal injury (Trump et al 
2006). Also, preterm infants excrete larger rates of myo-inositol in their urine which suggests that 
renal function is less efficient than term born infants as the kidneys are not fully absorbing all the 
myo-inositol before it is excreted.  
Metabolites related to renal function from term and preterm infants are recognised up until 3 
months of age postpartum. These kidney related metabolites found in term and preterm infant 
urinary metabolic profiles gives evidence that there is further development of kidney function from 
birth. This difference has previously been recorded. However, from this project it is evident that 
term and preterm infant excrete different kidney related metabolites, suggesting that the 
developmental trajectory are not the same depending on gestational age at birth.  
6.6  STRENGTHS AND WEAKNESSES 
A particular strength of this PhD thesis was the ability to standardise and explore infant collection 
and preparation protocols for infant profiling. This was important due to the nature of infant 
samples being low in volume and different analytical platforms were required for this investigation.   
The NoMic study has given us the ability for pioneering exploration into the faecal metabolic profile 
and infant development. Human faecal metabolic profiling is still in its infancy but recently more 
studies are utilising this biofluid; giving further understanding into interactions among host, 
microbial communities and nutritional interventions. Only a handful of papers have used this 
biofluid for infant studies and what makes this PhD project more unique is the large participant 
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numbers; large participant numbers increase the strength of multivariate models and therefore the 
confidence in findings concluded. However, a significant limitation in this study is that matching 
urine samples were not available for metabolic profiling. Using urine samples gives us further 
understanding of which metabolites have systemically entered the body and therefore contributed 
to the human metabolism. This data combined with the faecal data would deepen our knowledge of 
metabolic profiling in the developing infant.  
Unfortunately, the second study used in this thesis was actually two studies put together; term and 
preterm samples were obtained separately. This meant that there are many pieces of specific 
information missing from the metadata and a further in depth investigation into potential 
confounders was not possible; this included antibiotic use as well as mode of delivery. However, this 
study has shown the importance of further understanding the neonatal period metabolically 
depending on gestational age at birth to improve strategies for neonatal care of preterm infants 
especially in regard to the gut microbiome health and nutrition.   
6.7. FUTURE WORK 
Within this PhD, the two clinical projects described in chapters 4 and 5 can be taken further by 
future work described here. The term versus preterm at birth study would benefit by correlating 
metabolites from both NMR and HILIC-MS to specific microbial species. The functionality of the gut 
microbiome can be further explored by linking certain metabolites and microbial species which are 
typically found in term or preterm infant guts. This deeper investigation may open up new areas of 
research and understanding into the early life gut microbiome establishment and composition. 
Furthermore, future work with the NoMic sample set would be to use these samples for targeted 
metabolic profiling, especially obtaining quantitative data of SCFA and 16S data to further explore 
the infant microbiome. Additionally, this data can be correlated to further investigate the 
functionality of the gut microbiome in early life.    
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SUPPLEMENTARY 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1 – Dilution Series  
Figure S2 –  Falcon centrifuge apparatus for urine contaminant investigation 
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Figure S3 – Integral of TSP peak in increasing scans NMR analysis 
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Figure S4 – PCA depicting faecal water acquired with different number of scans   
Figure S5 – PCA urinary NMR spectral data – Term at birth vs. Preterm 
at term equivalent age 
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Figure S6 – PCA faecal NMR spectral data – Term vs. Preterm at 3 months 
postpartum 
a)  
b)  
Figure S7 – HILIC-MS – 
Term vs Preterm 
coloured by increases 
postpartum age – blue 
through to red a) 
negative mode b) 
positive mode 
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Figure S8 – NoMic multivariate statistic values.  
Model name Model 
type 
Time 
points 
 No. of 
samples 
R2X 
(cum) 
RYX 
(cum) 
Q2 
(cum) 
Time point PCA ALL 1802 0.34  0.33 
 OPLS All 1802 0.32 0.78 0.73 
Birth GA OPLS All 1802 0.34 0.44 0.22 
  4 287 0.29 0.51 0.28 
  10 288 0.33 0.84 0.59 
  30 270 0.33 0.8 0.45 
  120 234 0.27 0.57 0.17 
  365 398 0.08 0.37 0.0044 
  730 298 0.13 0.31 -0.12 
Birth weight OPLS All 1802 0.32 0.34 0.13 
  4 287 0.35 0.75 0.29 
  10 288 0.33 0.79 0.44 
  30 270 0.31 0.68 0.31 
  120 234 0.24 0.35 0.13 
  365 398 0.16 0.25 -0.07 
  730 298 0.15 0.29 -0.17 
Breastfeeding - 
exclusive 
OPLS All 1310 0.29 0.14 0.06 
  4 188 0.23 0.37 0.02 
  10 200 0.22 0.42 0.2 
  30 187 0.24 0.44 0.23 
  120 167 0.26 0.51 0.34 
  365 314 0.17 0.23 0.091 
  730 242 0.14 0.31 -0.17 
Mode of Delivery OPLS-DA All 1784 0.31 0.15 0.05 
  4 283 0.14 0.36 0.16 
  10 284 0.25 0.49 0.16 
  30 268 0.18 0.32 0.07 
  120 231 0.22 0.32 -0.029 
  365 393 0.081 0.35 -0.19 
  730 299 0.14 0.38 -0.25 
Term v Preterm OPLS-DA All 1801 0.27 0.15 0.09 
  4 287 0.21 0.39 0.11 
  10 288 0.2 0.49 0.31 
  30 270 0.23 0.42 0.25 
  120 234 0.26 0.56 0.19 
  365 398 0.129 0.29 -0.006 
  730 298 0.15 0.29 0.19 
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